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Detection of Pathogenic Bacteria and Fecal Enterococci in 
 
Recreational Water With an Evanescent Wave Fiber Optic Biosensor 
 
Maria Theresa Trindade 
 
ABSTRACT 
Development of a rapid method for the detection of fecal enterococci and 
pathogenic microorganisms in beach water was attempted utilizing an evanescent wave 
fiber optic biosensor.  Various assay formats including a sandwich immunoassay were 
tested in the development of a rapid assay.  Fluorophore labeled antibodies were used for 
specific detection of bacteria captured or adsorbed directly to the surface of a polystyrene 
fiber optic waveguide.  Binding of the fluorescent labeled antibody to its specific target 
or binding of a fluorescent labeled anti-IgG within 100-1000 nm of the waveguide 
surface caused excitation of the fluorescent conjugate resulting in a quantifiable signal. 
     Enterococcus faecalis, Staphylococcus aureus, Escherichia coli O157:H7, and Vibrio 
cholerae were used as model organisms for biosensor detection in phosphate buffered 
saline and seawater.  Seawater samples were selectively enriched for the presence of 
these model organisms, which were later detected on the biosensor.  The sensitivity and 
specificity of the biosensor was examined by testing various assay formats, sample 
preparations, and molecules for capture and detection.  Finally, an enrichment protocol 
combined with filter concentration was utilized to enhance detection of low levels of 
enterococci. 
 x 
 
 The fiber optic biosensor has the potential to be a sensitive and specific system for the 
detection of fecal enterococci.  The lower limit of detection in seawater and phosphate 
buffered saline was 2.8 x 106 CFU/ml.  As few as 6 CFU/100ml (0.06CFU/ml) could be 
detected in seawater following a 14-24 hour enrichment and concentration step.  Vibrio 
alginolyticus was found to grow under the same enrichment conditions as the 
enterococci.  V. alginolyticus crossreacted with the polyclonal anti-Strep group D 
antibody used in the immunoassay at high cell concentrations.  Staphylococcus aureus 
was the only other organism which showed significant cross-reactivity with this antibody. 
     The biosensor was also able to detect other bacterial pathogens in PBS and seawater.  
The lower limit for detection of E. coli O157:H7 was 3.6 x 105 CFU/ml.  The lower limit 
for detection of Vibrio cholerae O1 was 1.3 x 108 CFU/ml.  The antibodies used in these 
assays were found to crossreact with other gram negative microorganisms.  The biosensor 
was not able to detect Staphylococcus aureus.  
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INTRODUCTION 
Biosensors 
 Background.  A biosensor is an analytical detection system that exploits the specific 
nature of a biological recognition element for its target analyte. This definition is broad 
and encompasses the most basic systems such as over the counter home pregnancy tests 
and sophisticated platforms to detect bioterrorist agents in complex matrices.  The 
coupling of a specific biological recognition element with its specific ligand can take 
many forms in biology including antibody-antigen binding, enzyme-substrate reactions, 
and receptor-ligand binding.  These dynamic interactions have all been incorporated into 
biosensor technology for the specific detection of a number of biological agents including 
bacteria, viruses, and toxin molecules (63, 69,159).  The technology has also been 
developed for the monitoring of basic elements like oxygen (biological oxygen demand; 
BOD) or phosphate concentrations (44, 78).             
 Biosensors work on the principle that through specific receptor-ligand interactions, a 
signal will be generated that is proportional to the number of interactions between the 
recognition element and the target (Figure 1).  A transducer ultimately receives that 
signal and produces an electronic signal that can be recorded.  The coupling mechanisms 
between the recognition element and the transducer vary.  The biological recognition 
molecules can be covalently attached to the surface of the transducer, passively adsorbed 
to the transducer surface through hyrdrophobic interactions, linked to each other through 
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molecules such as avidin and biotin, or a prosthetic group attached to the transducer 
surface can be arranged to bind an apoenzyme (280). 
 
   Reaction Surface                                                         Transducer 
 
 
 
      
                                                                                                                                   Electric                         
                                                                                                                                    Signal 
 
 
     Biological Recognition Elements                             Conversion 
 FIGURE 1.  Biosensor principles as described by Nakamura et al. (185). 
 
Many different biological recognition elements have been tested for use in biosensor 
experimentation which exploit the specific binding relationships between a receptor and a 
ligand.  These molecules include low molecular weight carbohydrates and peptides, 
synthetic polymers, enzymes, receptors, cells, bacteria, and antibodies.  They have been 
incorporated into a variety of different types of biosensors for the specific capture and 
detection of several target pathogens (viral or bacterial), toxins, and chemicals like 
pesticides or herbicides (280).  The biosensor field has expanded to include an array of 
instruments incorporating intricate technologies such as fiber optic biosensors, surface 
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plasmon resonance sensors, piezoelectric immunosensors, and colorimetric biosensors 
(280). 
 Biosensor technology has been in development for over 30 years, and the field has 
seen many changes during this period.  The most common sensors have been those used 
to detect glucose.  This was the first type of sensor developed by Clark and Lyons in 
1962 (48).  This sensor technology has brought much commercial success to the 
biosensor field with the invention of portable glucose monitors which measure blood 
sugar concentration.  The success of this technology sparked research efforts toward 
making these instruments diverse, versatile, and widely applicable (260).  The use of this 
technology in other fields of science is expanding.  One such application is the 
monitoring of bacterial contamination in food and water.  Developing sensitive assays is 
very difficult for many bacterial pathogens such as E. coli O157:H7 because the 
infectious dose of this organism is very low (23).  This is true for immunoassays where 
high affinity antibody can make the difference between a sensitive assay and an assay 
which does not work at all.  Detection can also be difficult because of the limitations on 
biomolecules used to detect these pathogens.  Antibodies, for example, can be very 
crossreactive with other similar targets and this can hinder the development of a specific 
assay.  A complex matrix such as seawater or food can further impair assay performance 
due to inhibitors and debris that inhibit ligand-target interaction.  Many systems are still 
in development to overcome these obstacles, but biosensors show promise in this field.  
This is evident as biosensors are now being used to detect biological warfare agents in 
substances such as talc-based powders and cornstarch (256).   
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 Biosensor instruments have evolved from large bulky machines feasible only for 
laboratory use to small, portable, automated machines that can fit in one’s pocket and 
give rapid results (135).   There are still many obstacles facing the further evolution of 
biosensor technologies, such as cost reduction and development of systems sensitive 
enough to detect low levels of agents without enrichment or concentration (135).  
 Piezoelectric biosensors.  Piezoelectric biosensors (PZ) were first described by Shons 
and Najarian who reported a sensor based on a quartz crystal microbalance (229).  A 
quartz crystal microbalance (QCM) is made up of a thin quartz disc with electrodes 
plated on its surface.  The QCM is piezoelectric so an oscillating field applied to the 
balance induces an acoustic wave that is propagated throughout the crystal.  The 
frequency of this wave fluctuates in response to material deposited on the surface of the 
crystal.  Changes in the resonant frequency are related to the mass built up on the crystal 
surface.  Antibodies can be immobilized on the surface of the crystal and with increased 
binding of the target, the resonant frequency decreases.  Piezoelectric biosensors have 
been used to detect several viral agents such as herpes virus and hepatitis C virus as well 
as bacteria such as E. coli O157:H7 and byproducts of bacteria like staphylococcal 
enterotoxin B (141, 159, 240, 248).  Piezoelectric biosensors have been used for 
environmental monitoring by immobilizing protein on the crystal surface.  One such 
protein, formaldehyde dehydrogenase, has been used to successfully assay for 
formaldehyde without interference from other air pollutants.  The bioterrorist agent, ricin 
and herbicides like atrazine have also been assayed with PZ biosensors (32, 101, 181).  
There are several commercial piezoelectric biosensors available from companies such as 
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Elchema (Potsdam, NY) and Maxtek (Torrance, CA) which have been used to test for 
substances like estrogen and organophosphates (29, 102). 
 While PZ biosensors are promising, several issues still must be addressed for this type 
of sensor to have a wider applicability.  Reproducible immobilization of protein on the 
crystal surface must be achieved as well as elimination of non-specific binding of other 
proteins to the crystal surface.  The issue of reuse of the quartz crystal needs to be 
addressed as well (193).  
 Surface plasmon resonance biosensors.  Surface plasmon resonance (SPR) biosensors 
are real-time, label-free, optical detection systems for examining the interactions of 
soluble analyte with immobilized ligand.  They are some of the most successful 
biosensors on the market.  SPR occurs when light is reflected off thin metal films placed 
between a medium of high refractive index and a medium of low refractive index.  A 
fraction of the light energy incident at a sharply defined angle can interact with the 
delocalized electrons in the metal film and reduces the reflected light intensity (94).  The 
precise angle of incidence at which this occurs is determined by several factors, like the 
refractive index on the backside of the metal film where target molecules can be 
immobilized and bind ligands in the mobile phase.  An electromagnetic field called an 
evanescent wave is formed which extends into the lower refractive media on the other 
side of the metal.  The propagation of the evanescent wave depends on the refractive 
index of the thin layer adjacent to the light interface.  The evanescent wave decays 
exponentially with increased distance from the reaction interface.  If binding of the target 
occurs, the refractive index changes.  The result is a change in SPR angle which can be 
monitored in real-time by detecting changes in the intensity of the reflected light and will 
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produce a sensorgram.  Theoretically, the size of the change in SPR signals is directly 
proportional to the immobilized mass and this change can be used to calculate the 
concentration of analyte being assayed.  The rate of change of the SPR signal can also be 
tracked to rate constants for the association and disassociation of a receptor for its target.  
SPR has been used in many fields of science including medicine and biotechnology.  This 
technology has given much insight into kinetic rate constants for analyte-ligand 
relationships as well as aiding in the characterization of the mechanism of certain 
biomolecular interactions (94). 
 Colorimetric biosensors.  Colorimetric biosensors rely on an obvious color change to 
distinguish a positive from a negative result.  Modern colorimetric instruments do not 
rely on the addition of a chromogenic substrate to provide that color change.  Novel 
polymers called polydiacetylenes (PDAs) have unique color properties which are 
dependent on several factors including the exposure of the material to environmental 
conditions such as heat, mechanical stress, or solvents.  Substituted PDAs undergo 
dramatic color changes from blue to red.  Biosensors have been designed to induce the 
PDA blue to red conversion by specific binding of the biological target (e.g. antigen) and 
the molecular recognition element which is directly linked to the transducer (PDA).  An 
example of such a biosensor is a system to detect influenza A virus by the binding of its 
viral hemagglutinin to sialic acid residues incorporated into the PDA resulting in a color 
change to red (42, 43).  Another colorimetric biosensor has been developed based on the 
red color of gold nanoparticles for the detection of lead.  DNA-functionalized gold 
nanoparticles are incubated with complementary strands labeled with a specific enzyme 
(DNAzyme).  When complementary sequences come together, they form aggregations 
 7 
 
that cause a chromogenic change from red to blue.  This aggregation is reversible.  When 
the aggregates are in the presence of lead, the enzyme on the DNAzyme catalyzes the 
cleavage of the complementary strand leading to disruption of the nanoparticle assembly 
and a color change to red (162).   
 Molecular recognition elements used in biosensor development.  The list of biological 
molecules that have been used in biosensor assay development is extensive.  It is the 
recognition element which is the heart of the system and makes a useful biosensor.  There 
are two categories of molecular recognition elements, catalytic (enzymes or bacteria) and 
affinity-based (antibodies or receptors).  More recently, synthetic recognition elements 
such as peptide nucleic acids (PNA) have been developed for biosensor use as well (21).  
 Whole living cells of yeast, bacteria, and fungi have been manipulated for several 
different detection needs, especially in the environmental and clinical fields (241).  
Biological oxygen demand (BOD) sensing yeast have been genetically engineered for 
luminous BOD sensing in environmental biosensor experiments.  Thiobacillus 
ferrooxidans has been used as a novel microbial sensor for detecting sulfate in rainwater.  
This bacterium is known to oxidize Fe (II) in the presence of sulfate and the decrease in 
current at the microbial electrode of the sensor correlates to the sulfate concentration 
(221).  A similar approach has also been done by using recombinant luminescent 
bacteria.  These bacteria were patterned onto a slide and exposed to toxic compounds.  
When the target compound is present, a cascade is set off within the cell that ultimately 
results in bioluminescence which can be recorded (147, 196). 
Enzymes have been used for years to detect metabolites such as lactate, urea and 
creatinine (268).  Enzymatic biosensors have been developed mainly for the detection of 
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pesticides, clinical testing of metabolites such as glucose, and detection of 
organophosphates in foods and environmental samples (268). The most common 
enzymes used in biosensor detection are acetylcholinesterase (AChE), 
butyrilcholinesterase, horse radish peroxidase, tyrosinase, and urease (168).  These 
enzymes cleave their particular substrate and the end result is a product which shows an 
obvious color change or is fluorescent and can be detected.  Once isolated and purified, 
enzymes can be manipulated genetically for specific detection purposes.  Pyruvate 
oxidase from Pediococcus sp. has been isolated and used to detect phosphate in river 
water (145).  The enzyme cyanidase has been purified and genetically modified to 
increase its binding affinity for cyanide, which can be a dangerous contaminant of river 
water (116, 269).    
 Affinity molecules such as antibodies have been very useful for development of 
detection assays.  They are probably the most popular biological recognition elements in 
use today because of their great specificity and ease of use.  Antibodies, both polyclonal 
and monoclonal, have been a huge asset to the field of immunoassays and rapid detection.  
They are stable when stored under the proper concentrations and conditions and are easy 
to use.   
 Antibodies are a group of glycoproteins present in the serum and tissue fluids of all 
mammals.  They are produced by the B cells of the mammalian immune system in 
response to exposure to foreign antigen.  IgG molecules commonly used in 
immunoassays have an approximate molecular weight of 150,000 -160,000 (152).  The 
complex and efficient nature of the immune system causes the body to react to the 
presence of a foreign antigen with the production of many different antibody species 
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which are specific for different epitopes on a particular target.  Several genetic 
mechanisms are responsible for the diverse nature of antibodies produced by different B 
cells in response to an antigen, including gene recombination and genetic conversion (49, 
228).  This cocktail of antibodies can be extracted as whole serum from whatever host 
(usually rabbit, goat, or donkey) has been exposed to the foreign material and are referred 
to as polyclonal antibodies.  Polyclonal antibodies are commonly used in the field of 
biosensor immunoassays and have been useful in detecting E. coli O157:H7 in ground 
beef and Salmonella in sprout wash (63, 142).  Monoclonal antibody production, 
introduced by Kohler and Milstein in 1975, has been a valuable tool for achieving a large 
amount of specific antibody by using hybridoma technology to fuse mouse splenocytes 
with a B cell myeloma (140, 215).  These immortal clones can be maintained indefinitely 
and can produce unlimited quantities of antibody.  While adding enhanced specificity to 
any immunoassay, this technique could also be limiting by generating a recognition 
molecule specific only to one epitope on the antigen.  In an assay that is designed to 
maximize the chance of detecting a pathogen with several antigenic determinants, there 
are advantages to using an antibody mixture which is specific for more than one target on 
that cell.   
 There are ways to make these two types of antibodies work synergistically and to the 
advantage of the assay.  A polyclonal antibody can be used to capture the target 
pathogen, and a monoclonal antibody can be used for detection in a sandwich 
immunoassay.  Another strategy to increase the efficacy of monoclonal antibodies is to 
make several monoclonal antibodies to many antigens on a particular pathogen or target.  
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The monoclonal antibody species could then be mixed together to form a “custom 
polyclonal” or an antibody cocktail.   
 In addition to the drawbacks listed above, monoclonal antibodies are very expensive.  
Furthermore, the immunogenicity (ability to elicit an immune response) of the antigen 
could limit the use of this strategy.  This problem was encountered in this study when 
monoclonal antibodies were made to teichoic acid from Enterococcus cells.  The best 
results obtained were of IgM which has high avidity (combined strength of the 
interactions between a multivalent antibody and a multivalent antigen), but the affinity 
(binding strength between an epitope and an antibody paratope) is not very good.  
Nonetheless, since the advent of the technique, numerous monoclonal antibodies have 
been developed against an array of different agents including the anthrax lethal toxin, the 
envelope glycoprotein of the Ebola virus, and botulinum neurotoxin A (103, 114, 167, 
203).   
 The last decade has seen the development of recombinant antibodies using phage 
display, which shows great promise for improving specificity for detection of biological 
agents.  Phage display uses bacteria and bacteriophage to produce and select synthetic 
antibodies that have all the target recognition attributes of natural antibodies (202).  
These synthetic antibodies are made by the same genes that encode for the variable 
region (antigen recognition region) of natural antibodies in mammalian systems (202).  In 
phage display, a library of variant DNA sequences (derived from mammalian B cells) 
encoding antibody fragments is created and cloned into phage as a fusion to a viral coat 
protein (274).  This phage library displaying antibody fragments is exposed to the target 
antigen.  Any unbound phage are washed away.  Bound phage are eluted and used to 
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infect a bacterial host to amplify the phage population (274).   The phage display 
technique is especially advantageous for the production of antibodies to antigens which it 
has previously been very difficult to raise antibodies against (77, 174).  Phage display is 
advantageous because antibody production no longer relies upon the immune response of 
a mammalian host.  Phage libraries can contain up to a billion different antibodies (202).  
Phage display has been utilized to generate target specific antibodies in many fields of 
science.  The technique has been used in clinical applications to identify epitopes which 
are produced in the early onset of infection with the hepatitis C virus in an effort to 
develop tests for early diagnosis (124).  Another clinical application has been the 
development of recombinant antibodies against thyroid stimulating hormone (TSH) for 
the diagnosis of thyroid diseases (144). 
 Certain ligands have native receptors through which they exert their effects, and 
receptor-ligand relationships can be effective recognition strategies for biosensor assays.   
For example, cholera toxin binds to the ganglioside receptor GM1 on the surface of 
human intestinal cells (236).  Receptor-ligand binding has also been utilized for hormone 
detection (241).  The estrogen receptor can identify ligands which can act as estrogen-like 
compounds in humans (60).  This research has been conducted to develop drugs which 
provide the benefits of estrogen and less of the detrimental effects of the hormone (60).  
Receptor-ligand pairs have the potential to be diversified into detection systems for other 
molecules like bacterial toxins (236).  
 Some of the most recent advances in recognition elements have been on the 
molecular level, with the incorporation of nucleic acids as detection molecules. One such 
group of molecules are peptide nucleic acids (PNA) invented by Peter Nielsen (189).  
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Peptide nucleic acid oligomers are synthetic DNA analogs with an amide backbone. 
PNAs have several advantageous features; eg, they are stable under acidic conditions and 
are resistant to nucleases and proteases (20, 189).  Their neutrally charged backbones 
increase their binding strength when bound to complementary DNA sequences, and also 
enable the probe sequences to enter whole cells if necessary (20).  PNAs are also stable 
across a wide range of temperatures and pHs; however they are expensive.  Nonetheless, 
PNA is an alternative to less specific and less stable recognition elements available, and 
has been used to detect E. coli, Salmonella, and S. aureus (21, 246).   
 Aptamers are another nucleic acid alternative.  They are DNA sequences (less than 
100 nucleotides in length) designed to bind proteins much as an antibody would bind its 
target.  Their binding affinity is similar to that of antibodies.  Anti-lysosyme and anti-
ricin aptamers have already been created for use on detection systems such as the 
electronic tongue sensor array (134).  Aptamers display high affinity and specificity for 
target molecules, but they can be unstable and vulnerable to degredation by nucleases.   
 Lectins are a group of plant proteins with the ability to agglutinate cells and 
precipitate carbohydrates.  They interact with bacterial cell surface structures  including 
teichoic acid, teichuronic acids, peptidoglycan, lipopolysaccharide, glycoprotein, group 
specific polysaccharides, and capsular polysaccharides (70).  Lectin-based technologies 
have numerous applications, including the ability to distinguish bacteria from each other.    
For example, Bacillus anthracis can be distinguished from other bacilli by growth at 
37°C and aggregation with the glycine max (soybean) lectin (50).  Lectins can also be 
used to type blood groups, purify teichoic acids, and to investigate microbial 
ultrastructure (70, 277).    The most widely characterized lectins are wheat germ 
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agglutinin (WGA) and concanavalin A (conA).  ConA binds to α-D-glucopyranosyl or α-
D-mannopyranosyl groups on the cell surface of gram positive bacteria and WGA binds 
the teichoic acid of gram positive bacteria (10).  Enzyme linked lectinsorbent assay 
(ELLA) has been used to detect and characterize extracellular polysaccharides and 
bacteria (99, 151).  Biosensors are now being developed to exploit the specific binding 
properties of lectins. A nano-gold plasmon resonance biosensor utilizing gold labeled 
conA has been developed for the detection of blood glucose levels (11, 172).  The current 
study utilized conA and WGA for the detection of enterococci in a sandwich assay format 
on a fiber optic biosensor because of their ability to bind carbohydrate groups on the 
surface of these cells.(27).  The applicability of lectins is expanding and there are obvious 
advantages to their use.  Lectin agglutination assays are rapid, inexpensive, and 
reproducible.  Lectins are also stable, easy to store, readily available from commercial 
suppliers and reactive at low concentrations (70). 
 Evanescent wave fiber optic biosensors, immunoassays, and their applications.  
Immunosensors have been developed using the principles of well established 
immunoassay techniques as models (197).  The effectiveness of an immunoassay relies 
on the following elements: i) the antigen to be detected, ii) the antibody or antiserum used 
to detect the target, iii)  the method to separate bound antigen antibody complexes from 
free reactants, and iv) the mechanism of signal generation (8).  Immunoassays date back 
as far as 1959 when Yalow and Berson introduced the radioimmunoassay (RIA) for 
insulin detection (279).  The techniques of the immunoassay using labeled molecules, 
specifically antibodies, to detect antigens or vice versa are economical.  They can also be 
sensitive depending on the target molecule.  Solid phase assays employing ligands 
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labeled with radioisotopes or enzymes (enzyme-linked immunosorbent assay) are the 
most widely used immunoassays because of the large sample throughput that can be 
attained.  Radioisotopes and enzyme labels are now being replaced by fluorophores and 
chemiluminescent markers to further increase sensitivity and shelf life of these assays.  
Two typical immunoassay formats are depicted in Figure 2a and 2 b, a sandwich 
immunoassay and an indirect immunoassay. 
 
a) 
 
 
  
 
b)   
 
 
 
 
 FIGURE  2 a.) Sandwich immunoassay and b.) Indirect immunoassay. 
 
Immunosensors allow for the real time measurement of interactions between antibodies 
and antigens, receptors and ligands, and membrane reactions between cells.  Optical 
biosensors have made it possible to measure the kinetics of such biomolecular reactions 
in a rapid and simple fashion (215).   
Y
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 Evanescent wave, fiber optic biosensors combine fiber-optic technology with the 
many facets of biology and physics.  The instrumentation for this type of biosensor is 
composed of three parts: i) the optics, which includes the platform or waveguide used to 
collect emitted fluorescence, the light source for excitation, and the detector; ii) the 
fluidics for delivering solutions; and iii) electronics and a computer system to convert the 
signally electronically and record it numerically (216).  Evanescent wave excitation for 
use in fluorescent immunoassays was first reported by Kronick and Little in 1975 (143).  
Evanescent waves work on the principle that light launched into a waveguide placed into 
a fluid medium will be reflected internally.  Consequently, an electromagnetic field or 
evanescent wave is generated extending from the waveguide surface into the surrounding 
medium and any fluorescent molecule within that evanescent wave is excited.  
Evanescent wave sensors must satisfy several criteria, beginning with a platform that is 
transparent to the wavelength used.  The platform used must also be as free from 
impurities as possible so as not to scatter the laser light or cause shifts in the refractive 
index (216).  This type of biosensor has been used to detect viral agents and toxins such 
botulinum toxin A and staphylococcal enterotoxin B with much success (69, 194, 237, 
251). The Analyte 2000 (Research International; Monroe, WA) biosensor used in this 
study uses polystyrene fibers as waveguides to collect fluorescence emitted perpendicular 
to the waveguide (216).   
 The Analyte 2000 biosensor used in this study has been developed to exploit the 
sensitive and specific nature of antibody-antigen interactions in a sandwich immunoassay 
format (157, 230). This biosensor platform is multi-functional and has the unique 
capability of detecting pollutants and pesticides in the environment, monitoring food-
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borne pathogens in the food supply, and detecting biological warfare agents (158, 260).  
Evanescent wave fiber-optic biosensors are very well suited for the sandwich 
immunofluorescence assay.   Biotinylated capture antibodies can be affixed on the 
surface of the waveguide by biotin-avidin binding where they can bind target molecules 
of interest.  The sample is incubated with a detection antibody conjugated to a fluorescent 
molecule.  If this fluorophore conjugated antibody is within the evanescent wave, the 
fluorescent molecule is excited creating a detectable signal (157).  This sandwich 
immunoassay has been used to detect pathogenic bacteria and viruses on the Analyte 
2000 biosensor including vaccinia virus, E. coli O157:H7, Listeria monocytogenes, and 
Salmonella (63, 64, 91, 142,157).  The sandwich immunoassay is not the only assay 
format that can be adapted to this instrument for pathogen detection.  An indirect 
immunoassay format (Figure 2b) has been adapted to the Analyte 2000 biosensor in this 
study for the detection of fecal enterococci in beach water.  
 The Analyte 2000 biosensor has the ability to detect pathogens in a complex matrix.  
This is a desirable characteristic for treating recreational water samples that can be laden 
with particulate matter and debris.   High sensitivity is great importance in waterborne 
pathogen detection because some bacteria such as E.coli O157:H7 have a low infectious 
dose (157, 254).  The Analyte 2000 biosensor has been used to detect E. coli O157:H7 in 
a homogenate of ground beef and in apple cider at low levels.  The overall assay time is 
20 minutes (63, 64). These results are encouraging for applying this instrument to 
detection of pathogens in water, especially considering the diverse matrix of beach water.   
 The future of biosensor technology.  Biosensors are a cutting edge technology with 
universal appeal across many fields of science.  Over the past decade, there has been 
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increased interest in biosensors for use in environmental, medical, toxicological, and 
defense applications (197).   They are being developed as instruments for the rapid 
detection of possible bioterrorism agents such as ricin, botulinum toxin, and anthrax 
spores (32, 194, 256).  Biosensors like glucose monitors have been used as efficient tools 
for tracking  blood sugar level fluctuations observed in diseases like diabetes (18).  
Research is ongoing to adapt these instruments and concepts to other areas of science 
such as drug discovery and pharmaceuticals.  Newly designed biosensors are smaller and 
more versatile than their predecessors.  They are being assembled with miniature 
components that will enable them to one day be assembled into small multi analyte 
detection chips (175).  A single biosensor could theoretically serve as a chip array with 
multiple detection capabilities in various simple and complex matrices (175).  Biosensors 
such as the fiber optic evanescent wave Analyte 2000 biosensor have been developed as 
reusable instruments thereby reducing cost.  Continued research and advancements in the 
fields of biochemistry, fiber optics, engineering, proteomics, and genomics will continue 
to drive further developments of rapid detection methods using biosensor instrumentation 
(216).  
Indicators of Fecal Contamination 
 Starting with the first documented case of waterborne illness in 1854, a cholera 
outbreak in England (243), waterborne disease has been a public concern.  A major focus 
of public health programs has been to prevent waterborne disease outbreaks from 
occurring.  This is especially important during times of crisis, such as the events 
associated with recent hurricane Katrina, which left the city of New Orleans vulnerable to 
the dissemination of pathogenic bacteria and disease.  Documented illness stemming 
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from V. vulnificus infections did indeed occur (34).  For over 100 years, U.S. public 
health officials have relied on indicator organisms to assess the microbiological quality of 
water (188).  Directly assaying for specific pathogens is not easy and can be expensive.  
Fecal indicator bacteria provide an estimate of the amount of feces and, indirectly, the 
presence and quantity of fecal pathogens in water (261).  Initially, indicators were applied 
to asses the quality of drinking water and, over time, indicator measurements combined 
with chlorination drastically reduced the incidence of disease associated with drinking 
water like cholera and typhoid (188).  Presently, indicator levels are a standard guideline 
by which the extent of fecal contamination of all types of water are assessed (261, 262).  
Over the long history of indicators, assays for their detection have been standardized and 
made relatively easy to use for the enumeration of these organisms in water, with the 
drawback that results still take 24-48 hours (71, 179).   
 The study of waterborne illness began with an outbreak of cholera in England in 1854 
(243) which was studied by John Snow.  A prominent physician, Snow conducted an 
epidemiological study showing that drinking water from a contaminated well caused the 
outbreak (243).  In 1885, Theodor Escherich showed the frequency of coliform bacteria, 
specifically E.coli, in human fecal matter.  The term “indicator” was coined in the 19th 
century by Klein and Houston who also reported findings on the prevalence of coliform 
bacteria in sewage contaminated water in (137).  Based on the findings of Escherich, 
Theobold Smith, an employee of the State of New York Department of Health, developed 
a presumptive test for the presence of E. coli based on its ability to ferment lactose in 
contaminated samples.  This test later became known as the coliform test (242).   In 1932, 
Scott proposed using coliform concentrations as a guideline to indicate sewage 
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contamination in coastal beaches in Connecticut (223).  It was later discovered, however, 
that some of the bacteria that tested positive in the coliform test were not always of fecal 
origin.  Tests based on higher incubation temperatures (44.5 °C) and detection of β-
glucoronidase activity in fecal coliforms, a subset of the coliform group, were then 
developed.  This method is still used today to enumerate fecal coliforms in contaminated 
waters.  One such method is the Colilert system (54) developed by Idexx Laboratories 
(Westbrook, ME). 
 The contamination of recreational bodies of water has become an escalating problem 
along the coastal United States.  There are five commonly-recognized elements involved 
in the transmission of disease through water: i) the source of the infectious agent, ii) 
specific mode of water related transmission, iii) characteristics of the organism that allow 
it to survive and perhaps multiply and move into and within the environment, iv) the 
infectious dose and virulence of the pathogen, and v) host susceptibility (19).  Water-
related diseases were described by Bradley and have provided a framework for the 
classification of waterborne illness (19).  In this scheme, water related infections are 
divided into four groups i) waterborne infections ii) water-washed infections, iii) water-
based infections, and iv) infections with water related insect vectors.   
 The present study focused on the rapid detection of indicator organisms as a means of 
assessing the extent of fecal contamination in beach water to prevent the incidence of 
waterborne infectious disease.  Along with detection of these organisms comes the 
sometimes difficult issue of pinpointing the source of that contaminant.  Point source 
discharge of waste from wastewater treatment plants into coastal waters has necessitated 
the implementation of precise environmental regulations for treatment and disposal of 
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such waste (80).  A bigger problem than point source discharge such as sewage and 
industrial waste is nonpoint source contamination.  Nonpoint source pollution such as 
urban and agricultural runoff and overflowing storm drains has generally not been 
regulated and, therefore, this type of pollution in the past has gone untreated and persists 
in the environment (41, 93).  Human and animal feces contribute to nonpoint source 
contamination and are one of the most hazardous forms of pollution.   Animals and 
humans can harbor highly pathogenic organisms such as E.coli O157:H7 or hepatitis 
virus.  The result is contaminated coastal beaches, which are unsuitable for the swimming 
public.  Tainted beaches can cause economic impacts due to lagging tourism but, most 
importantly, the health of the public suffers (90).   
 In response to disease acquired from recreational water use, many programs have 
been implemented to monitor coastal water pollution and establish water quality 
standards.  In 1972, Congress passed the Clean Water Act and established the U.S. 
Environmental Protection Agency (EPA).  National regulations for water quality were 
established based on coliform densities, and research began to find other indicators which 
could be more accurate for assessing water contamination.  In that same year, the EPA 
launched a series of epidemiological studies to test the correlation between indicator 
organisms and recreational water illness.  Discriminant comparisons between fecal 
indicators and disease incidence revealed that elevated levels of enterococci strongly 
correlated with disease in freshwater and marine waters (25, 26).  In 1986, the EPA 
released Ambient Water Quality Criteria for Bacteria revealing the results of those 
studies and new guidelines for indicator levels in freshwater and marine water beaches 
(261).  E. coli (a member of the fecal coliform group) was found to correlate positively 
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with gastroenteritis in freshwaters.  Total coliforms and fecal coliform counts, which 
were routinely monitored at that time, only weakly correlated with disease (25).  It was at 
this time that well defined criteria for enterococci and coliforms as indicators were 
developed.   In freshwater, levels of E.coli should not exceed 126 CFU/100 ml and levels 
of enterococci should not exceed a geometric mean of 33 CFU/100ml (261).  In marine 
waters, levels of enterococci should not exceed a geometric mean of 35 CFU/100 ml 
(261).  There is still no single indicator which can be used to assess contamination of all 
types of water.  The specific criteria for an ideal indicator organism as well as for the 
methods required to detect each indicator are listed in Table 1. 
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 TABLE 1. Criteria for ideal indicator organisms and methods for their detection  
(90, 188).  
 
 
 E.coli is considered to be a good indicator of freshwater fecal contamination.  The 
contamination source is presumed to be warm-blooded animals.  Fecal coliforms are not 
good indicators for beach water.  The presence of fecal coliforms does not directly 
  
                           Criteria for an ideal indicator of fecal contamination  
 
• Correlates to health risks  
• Found consistently in the feces   
   at higher concentrations than  
   other fecal pathogen s  
• Should not multiply outside the   
  human intestinal tract   
• As resistant to disinfection 
   as other pathogens 
• Should correlate to the presence  
   of fecal pathogens 
• Persists in the environment 
   as long as other fecal pathogens 
• Should be a simple, easy and   
   reliable test to assay for the organism 
• Specific to a fecal source or identifiable as 
   to source of origin 
 
  
      Criteria for ideal methods to detect indicator organisms 
 
• Specific for the target organism 
• Broad applicability 
• Precision 
• Appropriate sensitivity 
• Quick results 
• Allows for enumeration 
• Can measure viability or infectivity 
• Logistically feasible 
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correlate to the increased incidence of gastrointestinal disease among swimmers (261).  
E. coli  has been isolated from freshwater collected from  leaf axilae of bromeliads in a 
tropical rainforest suggesting that E.coli is indigenous to the water environment (213).  
Clostridium perfringens, Staphylococcus aureus, phages of Bacteroides fragilis have 
been mentioned as possible indicators of fecal contamination (90).  The saturated sterol 
coprostanol has also been as an indicator because it is specific to higher mammals (117).  
The EPA recommends enterococci as the most reliable indicator of fecal contamination in 
marine waters because it positively correlates with human illness (261).  
Enterococci-Indicators of Fecal Contamination 
 Biochemical properties and characterization.  The enterococci are Gram positive 
organisms that occur singly, in pairs or in short chains.  These microorganisms are 
characterized by their ability to grow at 10°C and 45°C, in the presence of high sodium 
chloride (NaCl) concentrations, and broad pH ranges.  They are capable of survival at 
60°C for 30 minutes.  Enterococci are aerotolerant fermentative organisms which grow 
optimally at 35°C and hydrolyze esculin in the presence of 40% bile salts.   
 Some species of enterococci can be motile and most hydrolyze pyrrolidonyl-β-
naphthylamide (PYR).  All strains produce leucine aminopeptidase.  Most strains are 
homofermentative, producing lactic acid without gas from glucose.  The enterococci are 
biochemically distinct from streptococci and have been placed in a unique genus, 
(Enterococcus).  Enterococci are found in the gastrointestinal tract of warm-blooded 
mammals.  These bacteria can be shed through fecal matter into soil, water, and food.  As 
of 2002, 23 distinct species of Enterococcus were recognized (Table 2). 
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 TABLE 2.  Species included in the genus Enterococcus (81). 
 
 Many methods have been developed for the biochemical identification of 
Enterococcus species.  The API 20S (BioMerieux; Hazelwood, MO), the API Rapid ID 
32 (BioMerieux; Hazelwood, MO), and the Vitek Gram-Positive Identification Card 
(BioMerieux; Hazelwood, MO) are examples of miniaturized biochemical test kits.  
These rapid tests often result in inaccurate identifications, particularly for Ent. gallinarum 
and Ent. casseliflavus isolates.  Molecular techniques have offered a promising tool for 
the rapid and accurate identification of Ent. faecalis and Ent. faecium.  Examples are 
PCR amplification of the Enterococcus protein A genes efaAfs from Ent. faecalis and 
efaAfm  from Ent. faecium and amplification of the Ent. faecalis ace (adhesion for 
collagen) gene (239).  Biochemical tests, although more time consuming, are considered 
by some to be cost effective and user friendly than these molecular methods (81).  
 Reservoirs of enterococci; human and non human.  As described previously, the 
enterococci (previously grouped as streptococci) are native inhabitants of the mammalian 
and avian gastrointestinal tract and comprise approximately 1% of the overall microflora 
(105 to 107 organims/gram) in the feces (105, 224).  They have also been isolated from 
reptiles and insects on occasion (62). With the emergence of antibiotic resistance within 
Ent. faecalis Ent. raffinosus Ent. haemoperoxidus 
Ent. faecium Ent.  pseudoavium Ent. moraviensis 
Ent. avium Ent. cecorum Ent. ratti 
Ent. casseliflavus Ent. columbae  Ent. pallens 
Ent. durans Ent. saccharolyticus Ent. gilvus 
Ent. gallinarum Ent. dispar                                     
Ent. malodoratus Ent. sulfurous                               
Ent. hirae Ent. asini                                       
Ent. mundtii Ent. villorum 
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the genus, there has been increasing interest in identifying the reservoirs of these 
organisms and their antibiotic resistance genes.  There is a concern that the use of 
antimicrobial compounds on food animals that has created a large reservoir of 
antimicrobial resistant enterococci which have the potential to be passed onto human 
hosts (2, 13). 
 Enterococci have been isolated from plants, soil, and water as fecal contaminants.  In 
water, the predominating species are Ent. faecalis and Ent. faecium.  Other species have 
been associated with a particular environment or animal host.  Examples of host specific 
species include Ent. assini found in donkeys and Ent. columbae, which is specific to 
pigeons (61, 67).  Ent. faecalis and Ent. faecium have a broad distribution in the 
environment.    Methods have been developed (microbial source tracking) to divide 
Enterococcus species into host-specific ecovars.  These methods are based on genotypic 
and phenotypic traits that ultimately discern the possible source of contamination.  For 
example, Ent. faecium isolated from poultry retained the ability to ferment raffinose, 
whereas strains isolated from other origins did not (66).  Pinpointing the source of 
contamination, especially in beach water, can benefit the public health.  Preventative 
measures to stop contamination at the source are more likely to prevent illness altogether 
(1). 
 Group D antigen and lipoteichoic acid.  Teichoic acids were discovered in gram 
positive bacteria in 1958 by Baddiley and Davison (12).  Most gram positive bacteria 
produce a cell-wall associated teichoic acid and a membrane associated teichoic acid 
(lipoteichoic acid or LTA).  Lipoteichoic acids are a class of phosphate-containing 
polymers that are covalently linked to membrane glycolipids of the plasma membranes of 
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gram positive bacteria (138).  They are not synthesized by gram negative bacteria.  There 
are two types of teichoic acids, glycerol phosphates or ribitol phosphates substituted with 
various glycosyl and D-alanyl ester groups (Figure 3) (55, 138, 273).  In enterococci, the 
LTA is referred to as the group D antigen (74-76, 272).  
 
         
 
 FIGURE 3. Structure of ribitol and glycerol teichoic acids (55). 
 
The group D antigen is located below the Enterococcus cell wall and constitutes 
approximately 1-2% of the bacterial mass (12, 125,126).  This location contributes to the 
difficulty of raising a good immune response against LTA, which is evident in studies 
dating back to the Lancefield classification schemes (146, 170).  Watson et al. discovered 
that a good immune response to LTA in group D streptococci could be obtained only 
when the cells were enzymatically digested with lysozyme to reveal the LTA under the 
bacterial cell wall (270).  The limited availability of LTA on the cell surface of intact 
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cells deters the formation of an antibody response against this antigen.  Knox and Wicken 
also noted this difficulty in raising antiserum to LTA using whole cells, but were able to 
prepare cell fractions which produced a strong antibody response (138). The cell wall 
structure of a typical Ent. faecalis cell is shown in Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 FIGURE 4. Structure of the Enterococcus cell wall (55).  Enterococci have cell wall-
associated teichoic acid and membrane-associated lipoteichoic acid (group D antigen).  
The group D antigen is located beneath the cell surface. 
 
Several methods have been used to extract LTA from gram positive bacteria.  These 
methods vary from the preparation of a crude extract using enzymes like DNase and 
lysozyme to the more complicated hot or cold phenol extraction method (127).   Ideally, 
for a good immune response against teichoic acid, LTA must be extracted/separated from 
protein or extracted with some protein.   A single extraction technique does not work for 
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all bacteria especially when bacteria contain LTA and cell wall-associated teichoic acid 
(138).   
 LTA is a complex and important antigenic structure in gram positive bacteria.  
Comparisons have been made between the LTA of gram positive bacteria and the LPS of 
gram negative bacteria.  The teichoic acid portion is thought to be analogous to the core 
polysaccharide of gram negative cells.  While previously thought to be poorly 
immunogenic, LTA’s location within the bacterial cell prevented the generation of 
antibodies when whole cells were used as the immunogen.  To date, however, several 
monoclonal antibodies have been successfully made against LTA (104, 119).  This study 
will show that disruption of Enterococcus cells leads to a good immune response in 
rabbits against these bacteria.   
 LTA biosynthesis has been extensively studied.  LTA is continually synthesized even 
when bacterial cells are under starvation conditions.  Growth conditions also have a large 
effect on the extent of LTA synthesis.  Synthesis of the group D antigen is dependent on 
the glucose concentration and final pH of the bacterial growth medium.  Glucose 
concentration increases the sugar group substitution of the LTA.  Antibodies are typically 
formed against these carbohydrate components of the LTA.  Other studies have also 
shown that production of LTA is greatest during exponential phase of growth (86).   
  Public health significance of enterococci and use as an indicator of fecal pollution.  
Fecal enterococci were first discovered in the late 1880s as commensals of the 
gastrointestinal tract of humans and animals.  They have been useful in monitoring the 
water quality of bathing beaches due to their abundance in human feces.  Ent. faecalis 
was initially named Micrococcus ovalis by Escherich, and later renamed by Andrewes 
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and Horder in 1906 (9).  Ent. faecium was first identified in 1899 (195).  These two 
species stand out because they were the main species isolated from sewage-contaminated 
waters.  By 1900, enterococci were recognized as being of fecal origin and were proposed 
as potentially useful indicators.  The genus name Enterococcus was first used by 
Thiercelin and Jouhaud in 1903 (253).  Controversy has followed the classification of the 
enterococci since the turn of the century.  Dible in 1921 proposed that Ent. faecalis be 
renamed Streptococcus faecalis (68) and Sherman in 1931 proposed that the bacteria 
known as enterococci be reclassified as Streptococcus (226).   Sherman coined the term 
fecal streptococci instead of fecal enterococci for these indicators.  This group of bacteria 
was characterized as gram positive catalase negative non sporeforming facultative 
anaerobes which belonged to the Lancefield group D streptococci.  In 1984, based on 
immunological and molecular methods, the fecal Streptococcus group was reclassified as 
Enterococcus once again.  Only a few group D streptococci remained as Streptococcus 
including Streptococcus bovis and Streptococcus equinus.  Beginning in the 1940s and 
1950s, the development of a method to enumerate fecal enterococci began.  Cabelli at the 
EPA developed a reliable membrane filtration technique for detecting enterococci in 
water in 1970 (25).  The experiments were conducted as prospective epidemiologic-
microbiological studies to compare rates of gastrointestinal illness in swimmers and non-
swimmers at freshwater and marine water beaches.   As a result, the presence of fecal 
enterococci in marine water has been considered indicative of fecal contamination.  The 
presence of fecal enterococci can also be correlated to the incidence of gastrointestinal 
illness in swimmers (26, 72, 95, 259, 265, 283).  Mean Enterococcus densities were 
designated as a result of these studies.  Enterococci were not to exceed a geometric mean 
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value (over at least 5 samples) of 35 CFU per 100 ml and no one sample should carry 
greater than 104 CFU of enterococci per 100 ml (261).  As previously mentioned, 1986 
was marked as the year when strict guidelines for water quality were established and the 
EPA recommended that Enterococcus counts be used to monitor water quality for marine 
and coastal areas (261).   
 Coastal states across the U.S. have implemented EPA guidelines for the routine 
monitoring of recreational bodies of water using coliform or Enterococcus counts or 
both.  The State of Hawaii added a third indicator, Clostridium perfringens, that is 
routinely monitored, (89).   Since the 1986 guidelines were published, several countries 
have sponsored studies for the further assessment of the relationship between indicator 
organism densities and disease incidence (45, 53, 83).   Some results support the 1986 
findings of the EPA, that enterococci should be used to monitor marine waters (261).  
Noble et al. found that a more integrated approach for monitoring these organisms should 
be used (190) where more than one organism is assayed to monitor marine water in order 
to obtain additional information on the overall quality of the water (259).  The State of 
Florida monitors fecal coliforms and enterococci in marine water (87).  Regardless, the 
enterococci have been found to be reliable and to retain attributes that other indicators 
have not.  Enterococci are not as ubiquitous as coliforms, are always present in the feces 
of humans and animals, are unable to multiply in contaminated waters, die off less 
rapidly than coliforms in water, and persist in the water as long as specific pathogens 
(258).  There are disadvantages to using enterococci including their ability to become 
viable but non culturable, to survive associated with zooplankton, and to survive in 
sediments and sand resulting in resuspension of the organisms at high tide (6).  All 
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factors need to be considered when developing rapid methods for the detection of fecal 
enterococci. 
 Methods for the detection of fecal enterococci.  Improved methods for the detection 
of enterococci have been developed that are rapid and simple.  Table 3 shows a 
comparison of the most recent methods developed to detect bacteria by desirable 
characteristics. 
 
 TABLE 3.  Comparison of common methods to detect bacteria by desirable attributes 
(188).  The three types of detection methods were rated from low to high for each 
criterion listed. 
 
 
Method attributes Culture Immunological Nucleic acid 
Specificity to desired Low to Moderate High High 
 target 
 
Broad applicability High High  High 
 
Repeatability Moderate Low-High High 
 
Sensitivity Moderate/High Low-High High 
 
Speed of results Low/Moderate Moderate/Fast Moderate/Fast
 
Quantifiable Moderate Low  Low/Moderate
 
Measures viability or Yes No  No/ Is possible
 infectivity 
 
Feasibility 
 Training and personnel Low/High Moderate Moderate 
 requirements 
 Can be used in the  Low/High Moderate/High Moderate/High
 field 
 Cost Low/High Moderate Moderate 
 Volume requirements Low/High Low  Low 
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The easiest, less labor intensive, most reliable, and most feasible method for the detection 
of fecal enterococci today are still culture methods.  Enrichment culture methods 
combined with filtration permit bacteria from contaminated samples to be enumerated. 
Selective plate media and broth cultures can be used to enrich for specific enzymatic 
activity in enterococci.  In both cases, the medium has been created to target growth of 
desired bacteria by adding selective agents that will repress the growth and proliferation 
of the undesired background flora.   The medium also contains components that cause the 
growth of the target bacteria to appear unique and distinguishable from non-targets.  The 
most common method to date has been the use of membrane filtration of beach water.  
The filter is then placed on selective and differential agar and enterococci are 
enumerated.  This is the standard method used today by local, county, and state public 
health agencies across the United States (263).   
 Levin et al. described a two-step membrane filtration (MF) method for the 
enumeration of enterococci from beach water (153).  This method involved the filtration 
of a sample of water through a 0.45µm filter.  The filter was placed onto primary 
selective isolation medium (mE) containing nalidixic acid (NA), cycloheximide, and 
triphenyltetrazolium chloride (TTC).  The NA inhibited the presence of gram negative 
organisms; the TTC permitted for the differentiation of enterococci from other organisms 
and cyclohexamide inhibited fungi.  The medium was then incubated at 41°C.  Following 
primary isolation, the filter was transferred to EIA media (esculin-iron media).  Pink to 
red colonies on mE would produce a brown-black precipitate on EIA if they were 
enterococci due to the hydrolysis of esculin by the enzyme β-glucosidase.  While this 
medium was convenient at the time, it took 48 hours to obtain a result.   
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 Years later, the two-step MF technique developed by Levin was modified by the EPA 
(263).  Building on the foundation of the two step method, the process was made easier 
and more rapid by addition of the chromogenic substrate indoxyl β-D-glucoside (0.75 g/l) 
to the primary isolation media and reducing the concentration of TTC (from 0.15 g/l to 
0.02 g/l).  The addition of indoxyl β-D-glucoside to the medium resulted in β-glucosidase 
positive colonies of enterococci.  The β-glucosidase produced an indigo blue complex 
which diffused into the surrounding agar forming a blue halo around the colony.  The 
modified medium was termed mEI and was referred to by the EPA as Method 1600 (179, 
263).  All colonies regardless of color were counted as enterococci if they had a blue halo 
surrounding them.  This method offered several advantages including reduction of overall 
assay time from 48 hours to 24 hours, and elimination of the need to prepare a secondary 
medium (EIA) for identification of enterococci, using the existing mE base which was 
commercially available.  Colonies were smaller and more distinct making them more 
easily counted, and the specificity was better than the two step method (only 6% false 
positive rate compared to 10% with the two step method) (179).  Both the two-step 
method (using mE and EIA agars) and the modified method (using mEI) are listed in the 
Method 1600 Manual published by the EPA (263).  Unfortunately, the indoxyl β-D-
glucoside substrate is expensive so that the 2-step method is still used by some 
laboratories. 
 Enterolert developed by Idexx Laboratories is a semi-automated most probable 
number (MPN) technique that can enumerate enterococci.  It is intended to be less labor 
intensive, requires fewer confirmatory tests, less skilled labor, and provides results in 24 
hours.  The test is based on the activity of the Enterococcus β-glucosidase enzyme.  The 
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Enterolert medium contains the substrate 4-methylumbelliferone-β-D-glucoside which is 
cleaved by β-glucosidase to the fluorescent product 4-methylumbelliferylone.  4-
methylumbelliferylone can be seen when exposed to long wave UV light of 365 nm.  
Enterolert is used to test for the presence of enterococci in freshwater and marine waters.  
This method has been found to be just as effective as membrane filtration techniques, less 
labor intensive requiring shorter incubation time for results (24, 71, 191, 192).  However, 
because samples need to be diluted, this method is incapable of detecting very low levels 
of enterococci (71). 
 Newer Molecular methods are now available that do not have the limitations of 
culture methods, specifically, the sensitivity and the time it takes for results.  Polymerase 
chain reaction (PCR) to amplify specific DNA sequences from enterococci has been used 
to overcome the limitations of traditional current methods (57, 220).  This method uses 
DNA polymerase to make thousands of copies of a particular gene sequence from a 
bacterial genome.  The product is then assayed by common laboratory techniques such as 
gel electrophoresis.  Realtime PCR, which uses fluorescent dyes that can intercalate into 
double stranded DNA, is a variation of PCR and is quantitative.  Several PCR assays 
have been developed for the detection of enterococci.  Danbing et al. developed a novel 
procedure by amplifying the tuf gene in enterococci which encodes for an elongation 
factor; however, this procedure has been used for clinical applications only (57).  Most 
procedures are developed to amplify conserved sequences such as the 16S or the 23S 
rRNA sequences from enterococci (111).  A procedure developed by Santo-Domingo et 
al. showed the potential for using PCR for detecting enterococci in environmental water 
samples by amplifying a segment of the 16S rRNA region (220).  This procedure was 
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successful for detecting levels of enterococci greater than 600 CFU/100ml, but was not 
able detect lower concentrations directly from water.  In addition; enterococci could not 
be detected in samples with heavy fecal contamination because of inhibitory materials.  
Nonetheless, detection of clean samples took only about three hours, and therefore, this 
procedure has potential for further development (220).  A comparative study has been 
done between PCR, specifically quantitative PCR (QPCR), and the membrane filtration 
methods and a positive correlation has been observed (110).  Whether this technique 
could potentially replace MF is yet to be seen because epidemiological studies need to be 
performed.   
Emerging and Reemerging Waterborne Pathogens 
 Indicator organisms have long been used as a standard in water quality testing.  
Ideally, an integrated method for the universal detection of pathogens, known and 
reemerging, needs to be developed to prevent waterborne disease, especially in those 
third world countries where disease is prevalent due to poverty (247).  Cholera in Asia, 
Africa and now South America remains a concern and has been a constant problem in 
these areas for years.  Other waterborne pathogens including E. coli O157:H7, 
Cryptosporidium parvum, and microsporidia are also a health concern (Table 4) (225, 
252).   
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 TABLE 4.   Emerging and reemerging waterborne pathogens (188, 247).   
 
Group Pathogen (Source)          Diseases  
Viruses Enteroviruses (polio, Coxsackie) meningitis, paralysis 
 (human feces) rash, fever, respiratory 
  disease, diarrhea 
 Hepatitis A and E infectious Hepatitis,  
 (human feces) jaundice, fatigue 
 Human Caliciviruses  
 (human feces)  
 Norwalk viruses diarrhea, gastroenteritis
 Rotavirus diarrhea, gastroenteritis
 
Bacteria Salmonella typhoid, gastroenteritis 
 (human and animal feces) 
 Shigella diarrhea 
 (human feces) 
 Campylobacter diarrhea 
 (human and animal feces) 
 Yersinia enterocolitica diarrhea 
 (animal feces and urine) 
 E.coli O157:H7 diarrhea, can lead to  
 (human and animal feces) hemolytic uremic  
   syndrome in children 
 Legionella pneumophila respiratory pneumonia 
 (freshwater and soil) 
 
Protozoa Naegleria meningoencephalitis 
 (freshwater in warm temps. 
 Entamoeba hystolitica amoebic dysentery 
 (human feces) 
 Giardia lamblia chronic diarrhea 
 (human and animal feces) 
 Cryptosporidium parvum acute diarrhea 
 (human and animal feces) 
 Microsporidia diarrhea in  
 (feces) immunocompromised 
   and immunocompetent 
   travelers 
 
Cyanobacteria Microcystis diarrhea from toxins 
 (cyanobacterial blooms) produced  
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Vibrio cholerae 
 Vibrio cholerae, the etiological agent of cholera, is a facultatively anaerobic, motile, 
curved or straight, gram negative rod that is 1-3 mm in length.  A minimum of 5 mM 
sodium chloride (NaCl) is required for optimum growth; however, the bacterium can 
grow without  NaCl and in alkaline conditions up to pH 10 (204).  Recent and ongoing 
research indicates that this organism is a native member of the aquatic microbial 
community (129).  V. cholerae has caused numerous epidemics in the past and more 
recently in South America (35).  Approximately 200 serovars of V. cholerae have been 
reported; however, only two serovars, O1 and O139, have been associated with major 
epidemics.  There are two biotypes of V. cholerae O1, classical and El Tor.  V. cholerae 
O1 is classified into two serotypes, Inaba and Ogawa, based on agglutination in 
antiserum (218).  A third serotype, Hikojima, has been described, but has rarely been 
encountered (218).  Isolates of V.cholerae O1 and O139 which produce cholera toxin 
(CT) are considered virulent and capable of causing epidemic cholera.  Some isolates of 
V. cholerae O1 have been found that do not produce CT and do not cause epidemic 
cholera.  These nontoxigenic isolates are implicated in sporadic diarrheal disease (51).   
Epidemic and non-epidemic strains of V. cholerae are compared in Table 5. 
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 TABLE 5. Comparison of epidemic and non-epidemic strains of V. cholerae (131). 
a Cholera toxin 
  
 Historical background.  The Ganges Delta in the Indian subcontinent is considered to 
be the source of cholera disease (14).  Pandemics of cholera spread through the world in 
the nineteenth century.  The massive epidemic in Southeast Asia in 1961 was the 
beginning of the seventh cholera pandemic.  The biotype responsible for this pandemic 
was V. cholerae O1, El Tor, which spread rapidly through south Asia, the Middle East, 
and southeastern Europe, eventually reaching Africa in 1970 (35, 97, 275).  Epidemic 
cholera reappeared in 1991, but this time in South America, specifically, the coastal cities 
of Peru (35).  V. cholerae O1 El Tor serotype Inaba was found to be responsible for this 
epidemic.  It spread swiftly and by 1996, the disease had spread to 21 countries in Latin 
America.  Over one million cases were reported and close to 12,000 deaths resulted 
(210).  In recent times, an increase in cholera cases has been reported from western 
Africa and Asia.  Cholera in the United States dates back to 1832 in New York (14).  
Disease spread rapidly and intermittent illness was reported between 1832 and 1875.  
Cholera then disappeared.  No notable cases were reported until 1941 from a New 
Typing Systems                        Epidemic-associated         Non-epidemic associated 
Serogroups O1, O139 Non-O1 (>150) 
Biotypes for V. cholerae O1 Classical and El Tor Biotypes do not apply to  
 (does not apply to  non-O1 V. cholerae 
  O139) 
Serotypes for serogroup O1 Inaba, Ogawa, and Serotypes do not apply 
 Hikojima to non-O1 V. cholerae 
 (does not apply to 
  O139) 
CTa  production Produce cholera toxin Typically not CT producers
  may produce other toxins 
 39 
 
Orleans longshoreman and then in 1973 from a shrimp fisherman in Texas (98, 271).  
Later findings revealed that V. cholerae is indigenous to the U.S. Gulf of Mexico coast 
and in waters of other countries (129, 200). The majority of isolates from the U.S. Gulf of 
Mexico coast have been non-O1, but,  on occasion, toxigenic V. cholerae has been 
isolated (65, 155). 
 V. cholerae O139.  Prior to the seventh pandemic, outbreaks of cholera were traced 
back to the classical biotype.  By 1961, El Tor strains had replaced the classical biotype 
and this strain was determined to be responsible for epidemic cholera which appeared in 
Peru beginning in 1991 (30).  Today, the El Tor biotype is responsible for virtually all of 
the cholera cases throughout the world.  Classical isolates are not found outside of 
Bangladesh.  V. cholerae O139 first emerged in 1992 in southeastern India and the Bay 
of Bengal (209).  This serotype appears to have arisen from genetic exchange with V. 
cholerae O1 El Tor (209).  Prior to the seventh pandemic, V. cholerae O139 and non-
agglutinating strains of V. cholerae were considered to be a different species of Vibrio.  
Biochemical and molecular analysis studies have shown that these strains were all of V. 
cholerae.  The only distinguishing factor between V. cholerae O1 and V. cholerae O139 
is that V. cholerae O139 will not agglutinate with O1 antiserum.  O139 antiserum is 
necessary for identification of this organism.  Eleven countries reported cases of O139 
cholera to the World Health Organization through 1998 (276).  While V. cholerae O139 
seems to be confined to Asia, imported cases have been reported in the United States as 
well as other countries (51).   
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 Ecology.  The ecology of Vibrio cholerae appears to be complex and depends on 
several different environmental factors.  This is especially true since V. cholerae is now 
known to be indigenous in some aquatic environments.  Cholera displays a distinct 
seasonal pattern, especially in those areas where it is endemic (51).  The patterns are 
related to the ecology of V.cholerae.  Higher cell numbers are seen when water is warmer 
and when there is an increase in zooplankton blooms (51, 115).  Plankton blooms 
influence the bacterium’s attachment, growth, and multiplication in the aquatic 
environment, particularly when associated with copepods (121).  The physical factors 
that affect the proliferation of V. cholerae in the environment include warmer 
temperatures and salinity combined with elevated pH.  The incidence of V. cholerae in 
the environment is thought to follow a predictive pattern that can be monitored in order to 
predict outbreaks before they occur (165).  Those methods include remote sensing to 
monitor sea surface temperature, sea surface height, and plankton blooms (165).  
Monitoring would at least serve as a preventative measure when the potential for 
outbreaks is high.   
 The mechanisms of survival utilized by endemic V.cholerae are being further 
characterized.  The survival of V. cholerae in the environment is enhanced by their close 
association with zooplankton and, in particular, copepods whose chitin provides a good 
source of nutrients for the growth or regrowth of V.cholerae (115).  Viable but non-
culturable (VBNC) phenomenon in V. cholerae is also a survival mechanism (37, 267).  
V. cholerae O1 and O139 cells have been found to retain viability and pathogenicity for 
up to one year in the VBNC state (37). 
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 Virulence genes and pathogenesis.  Virulence of V. cholerae is due to the production 
of a heat labile enterotoxin (CT).  V. cholerae has two chromosomes, large and a small, 
and the genes encoding CT are located on the large chromosome (51).  Most 
environmental strains lack the genes necessary to produce toxin.  Virulence genes are 
distributed among strains of V. cholerae (51).  There is the potential of acquiring those 
genes from these and other pathogenic bacteria, allowing for the emergence of new 
toxigenic strains of V. cholerae.  In fact, the V. cholerae O139 serovar acquired novel 
DNA from the environment (82).  Bacterial viruses also play a role in development of 
new toxigenic variants and in imparting antibiotic resistance (51, 160).  
The primary site of infection is the small intestine.  Cholera toxin causes an 
electrolyte imbalance resulting in profuse watery diarrhea (154).  Pathogenicity of 
toxigenic V. cholerae depends on several factors, including the presence of a colonization 
factor (TcpA), production of CT, and the presence of associated outer membrane proteins 
(199, 250).  After colonization in the body, production of CT activates adenylate cyclase 
elevating the levels of cyclic AMP in the body and ultimately leading to extreme 
diarrhea. A distinctive symptom of cholera is rice water stool (210).  The resultant side-
effects of the massive diarrhea include loss of circulation and blood volume, metabolic 
acidosis, potassium depletion, and finally vascular collapse and death (210).  After onset 
of disease, death can result from extreme dehydration due to lack of fluids and 
electrolytes (16, 36).  In severe cases, the severe diarrhea results in the loss of up to 10% 
of human body weight, leading to hypovolemic shock and death.  Infection with V 
cholerae can vary depending on the amount of exposure.  Lower infecting doses may 
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cause, at most, mild illness and discomfort.  Only 2% of patients who are infected with 
V.cholerae see a progression of the disease to a life-threatening condition (36).   
   Research has shown that strains of non-O1 V. cholerae (NT V. cholerae) are capable 
of causing disease.  Some studies describe pathogenenesis from NT V. cholerae strains 
that produce a novel toxin that is not CT  (238).  Sporadic cases of disease from non-O1 
V. cholerae have been reported to the CDC.  Symptoms ranged from fever, nausea, and 
cramps to mild diarrhea (3, 56).  None of the cases from NT V. cholerae have been 
considered life-threatening (17). 
 Public health significance and epidemiology.  Transmission of V. cholerae occurs as 
a result of poor sanitation in highly populated areas where the organism is endemic.  The 
vehicles of transmission are contaminated water and undercooked food (180, 207).  
Water contaminated with free living V. cholerae cells is the main origin of epidemics, 
followed by the food-borne ingestion of shellfish.  The infectious dose of V. cholerae is 
high and varies between 104 and 1011 CFU, depending on the matrix (33).  Cases of 
cholera in the U.S. have been sporadic since the epidemic of 1832 in N.Y. (14).  More 
recently, cases of cholera that have emerged in the southern U.S. have been near the Gulf 
of Mexico, where V. cholerae appears to be endemic (155).    These cases have been few 
and have not resulted in epidemics,  and some have been reported to be caused by non-
O1 V.cholerae (184).  Non-O1 V.cholerae has been found to be native to the Gulf of 
Mexico.   
 Two of the survival mechanisms in V. cholerae that are being further investigated are 
the VBNC phenomenon and their close association with copepods in the environment.  
These mechanisms combined with environmental conditions that allow for the 
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proliferation of this bacterium are factors that need further study.  It is still unknown how 
an epidemic begins in the absence of any clinical cases of cholera.  A summary of the 
factors influencing the survival of V. cholerae in the environment are listed in Table 6. A 
sensitive and rapid method is necessary to monitor V.cholerae concentrations in water so 
that the public can be warned when cell numbers begin to increase.  Such a method 
would be an important tool to prevent the spread of cholera. 
 
 TABLE 6.  Factors affecting the survival and growth of V. cholerae in the 
environment (133). 
 
 
 Detection Methods.  Detection methods for Vibrio cholerae in water are largely 
culture based (132).  A sample first has to be enriched in liquid alkaline peptone medium 
with 1% sodium chloride.   Incubation at 37°C is followed by subculture onto selective 
plating medium.  For over twenty years, the medium of choice has been Thiosulfate-
Citrate-Bile salt-Sucrose Agar (TCBS) (73, 201).  TCBS distinguishes sucrose 
fermenting V. cholerae from other non-sucrose fermenting vibrios. This medium is 
commonly used because it is commercially available, easy to make, and needs no 
 Factor Effects 
Temp Refrigeration extends survival; growth occurs above 10°C
pH  Optimum 7.0-8.5; survives at 6-10 
Water activity (aw)   >.93 
NaCl content  Best survival, .25-3%; optimum 2%; requires Na+ 
Degree of contamination  Longer survival with more contamination 
Exposure to sunlight  Survival is reduced 
Presence of organic matter Survival is prolonged 
Osmotic pressure  Survival is unfavorable at high pressure 
Carbohydrate content  Survival is reduced when high concentrations present 
Other microflora  Survival and growth suppressed by competitors 
Humidity  Survival is longer in high moisture environment  
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autoclaving.  Enumeration of V. cholerae in water requires a most probable number 
method (MPN) for selection because of the large number of vibrios in environmental 
water samples.  Following isolation on TCBS agar, the bacteria are inoculated into non-
selective media for further biochemical and serological testing.  Those tests include the 
oxidase test, the string test (to differentiate vibrios from non-vibrios), and triple sugar 
iron test.  Serological identification is performed by testing the isolate for agglutination 
with V. cholerae O1 or O139 antiserum (131, 132).  Unfortunately, VBNC V. cholerae 
cannot be detected by such methods.   
E. coli O157:H7 
 E. coli O157:H7 is a foodborne and waterborne pathogen, whose main reservoir is 
cattle; however, the bacterium can be passed by human fecal matter.  It was first 
recognized as a human pathogen following two outbreaks in 1982 in Oregon and 
Michigan (212).  These outbreaks were traced back to ground beef tainted with feces.  
Transmission of this pathogen occurs from food or water contaminated with animal and 
human feces or sewage.  E.coli O157:H7 produces a vero-cytotoxin, that causes 
haemorrhagic colitis (HC) (123).  HC manifests as severe abdominal pain, diarrhea and 
bloody stools.  Progression of the disease to hemolytic uremic syndrome could lead to 
kidney failure and death (187).  Of particular importance to public health officials is the 
infectious dose which has been reported to be lower than 50 CFU (254).   
 While E.coli O157:H7 typically is transmitted via undercooked meat or raw milk, 
waterborne cases have been reported and are a concern.  The first case of waterborne  
E. coli O157:H7 was reported in 1986 in Philadelphia (176).  The bacterium was isolated 
from a reservoir outside the city and was presumed to have a non-human origin.  The 
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majority of waterborne infections are from tainted lake or municipal water (38).   
Beaches with higher bather densities and especially those close to sewage treatment 
plants present a high threat of infection with E.coli O157: H7, especially since this 
pathogen is capable of entering a viable but non-culturable state in the water prolonging 
its survival (106).   E.coli O157:H7 can also survive in saltwater for up to 15 days (182).  
 Methods for the detection of E. coli O157:H7 include PCR assays to detect the 
presence of genes encoding shiga-like toxins, or by coupling molecular techniques with 
culture methods.  Culture methods involve direct plating on sorbitol MacConkey agar 
supplemented with cefixime and tellurite (CT-SMAC) followed by serotyping (112).  E. 
coli O157:H7 is unable to ferment sorbitol, resulting in colorless colonies on CT-SMAC 
agar.  Some laboratories test E. coli O157:H7 strains for the enzyme β- glucuronidase 
using a broth or agar medium containing the substrate 4-methylumbelliferyl-β-D-
glucuronide (MUG) (84).  Cleavage of MUG produces a fluorescent product is produced.  
E. coli O157:H7 strains are MUG negative.   Immunomagnetic separation (IMS) is also 
an isolation technique developed to detect E. coli O157:H7 in food and stool samples 
(130).  IMS uses magnetic beads with covalently attached antibodies specific for E. coli 
O157:H7.  E. coli O157:H7 cells in a a sample bind to the antibodies.  The antibody 
coated beads can then be isolated from the rest of the sample using a magnet.  This 
strategy was used in this study for the isolation of E. coli O157:H7 from beach water.  E. 
coli O157:H7 has been successfully detected at low levels in apple juice and ground beef 
using a sandwich immunoassay format with an evanescent wave fiber optic biosensor 
(63, 64).  The same instrument was used in this study for the detection of E. coli 
O157:H7 in sea water.  
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Staphylococcus aureus 
 Staphylococcus aureus is a gram positive pathogen which has been considered for use 
as a parameter for assessing the water quality of recreational waters (72, 90).  It is a 
normal inhabitant of the human flora being present in the nose, hands, and respiratory 
tract.   Its overabundance on the body allows it to be easily shed into recreational water.  
Once in water, this bacterium can infect cuts or abrasions on the skin or mucous 
membranes of the nose and eyes.  Such infections can result in skin rashes, boils and eye 
infections and other forms of disease.  The increase in resistance of Staphylococcus 
aureus to methicillin makes infection even more life-threatening.  A rapid method for 
detection is therefore imperative (39). 
Summary 
 A rapid method for detection and enumeration of indicator bacteria and microbial 
pathogens in water is desirable and necessary.  In 1997, the EPA launched the Beaches 
Environmental Assessment Closure and Health program (BEACH) to further improve the 
quality of the nation’s beaches (262).  In 1999, broad goals for the BEACH program were 
established.  These goals included development of methods to detect water pollution 
within a few hours so that swimmers can be warned of a contamination event before they 
are exposed (262).  Public policy and water quality research is now directed towards 
preventing the incidence of water-borne disease.   
 Biosensor immunoassays that can be highly specific and sensitive are an attractive 
approach for detecting pathogens and indicators in mixed samples.  If a high affinity 
antibody is available, a rapid, near real-time assay can be developed for the analysis of 
contaminated water.  The purpose of this study is to use the biosensor to detect the 
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presence of these pathogens and/or indicators in beach water samples from Clearwater, 
FL. and St. Petersburg, FL. and to provide a quantitative assessment of water quality. 
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MATERIALS AND METHODS 
Bacterial Strains 
 Enterococcus faecalis (ATCC 19433) was used as a model organism in all 
experiments in seawater and in phosphate-buffered saline pH 7.4 (PBS) to detect fecal 
enterococci.  Additional strains used in this study are listed in Table 7. 
 TABLE 7.  Bacteria used in Enterococcus assay development. 
     Microorganism                                                                                           Strain 
Aerococcus viridans…………………………………………………….ATCC 700406 
Aeromonas hydrophila ………………………………………………………..USF 530 
Enterococcus casseliflavus……………………………………………………USF 691 
Enterococcus casseliflavus……………………………………………………USF 707 
Enterococcus casseliflavus……………………………………………………USF 740 
Enterococcus casseliflavus……………………………………………………USF 703 
Enterococcus durans ………………………………………………………….USF 694 
Enterococcus durans ………………………………………………………….USF 699 
Enterococcus durans……………… …………………………………………USF 732 
Enterococcus faecalis…………………………………………………….ATCC 19433 
Enterococcus faecalis…………………………………………………………USF 693 
Enterococcus faecalis…………………………………………………………USF 696 
Enterococcus faecalis…………………………………………………………USF 700 
Enterococcus faecalis ………………………………………………………...USF 708 
Enterococcus faecalis…………………………………………………………USF 709 
Enterococcus faecalis…………………………………………………………USF 710 
Enterococcus faecalis ………………………………………………………...USF 711 
Enterococcus faecalis…………………………………………………………USF 713 
Enterococcus faecalis ………………………………………………………...USF 715 
Enterococcus faecalis…………………………………………………………USF 719 
Enterococcus faecalis ………………………………………………………...USF 720 
Enterococcus faecalis  ………………………………………………………..USF 721 
Enterococcus faecalis ………………………………………………………...USF 723 
Enterococcus faecalis ………………………………………………………...USF 724 
Enterococcus faecalis ………………………………………………………...USF 726 
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Enterococcus faecalis ………………………………………………………...USF 727 
Enterococcus faecalis ………………………………………………………...USF 730 
Enterococcus faecalis ………………………………………………………...USF 734 
Enterococcus faecalis ………………………………………………………...USF 741 
Enterococcus faecalis ………………………………………………………...USF 747 
Enterococcus faecalis ………………………………………………………...USF 751 
Enterococcus faecalis ………………………………………………………...USF 764 
Enterococcus faecalis ………………………………………………………...USF 769 
Enterococcus faecalis  ………………………………………………………..USF 807 
Enterococcus faecium ……………………………………………………ATCC 19434 
Enterococcus faecium  ………………………………………………………..USF 691 
Enterococcus faecium  ………………………………………………………..USF 692 
Enterococcus faecium  ………………………………………………………..USF 725 
Enterococcus faecium  ………………………………………………………..USF 730 
Enterococcus faecium ………………………………………………………...USF 746 
Enterococcus faecium ………………………………………………………...USF 753 
Enterococcus faecium  ………………………………………………………..USF 754 
Enterococcus faecium  ………………………………………………………..USF 759 
Enterococcus faecium  ………………………………………………………..USF 763 
Enterococcus faecium  ………………………………………………………..USF 768 
Enterococcus gallinarum  …………………………………………………….USF 767 
Escherichia coli  …………………………………………………………ATCC 29417 
Escherichia coli O157:H7 ……………………………………………………USF 640 
Group A Streptococcus  ………………………………………………….8-R291 TGH 
Group B Streptococcus ………………………………………………1215-RNSJ183V 
Lactobaccillus arabinosa  …………………………………………………….USF 541 
Lactococcus lactis ……………………………………………………….ATCC 11454 
Leuconcostoc …………………………………………………………………USF 706 
Non Protein A Staphylococcus aureus  ………………………………….ATCC 10832 
Pediococcus dextrinicus …………………………………………………ATCC 33087 
Providencia rettgeri  ………………………………………………………….USF 517 
Staphylococcus aureus  ………………………………………………………USF 645 
Staphylococcus aureus Cowan I  ……………………………………………..USF 613 
Streptococcus bovis ……………………………………………………...ATCC 15351 
Streptococcus bovis  ……………………………………………………..ATCC 49133 
Vibrio alginolyticus  …………………………………………………………..USF 516 
Weissella confusa ………………………………………………………..ATCC 14434 
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All Enterococcus strains without ATCC numbers were environmental isolates obtained 
from the following sources: Tumblin Creek, Gainesville, FL; Tampa Palms sewer station 
(Tampa, FL); sewage from California; and beach water from Pinellas County beaches. 
These isolates were provided by the laboratory of Dr. Valerie J. Harwood (University of 
South Florida, Tampa, FL) and identified as isolates from various hosts including cows, 
humans, seagulls and dogs.  Another sample of Enterococcus faecalis (ATCC 19433) and 
one of Enterococcus faecium (ATCC 19434) was obtained from Dr. Al Dufour (U.S. 
Environmental Protection Agency, Cincinnati, OH).  The remaining isolates were clinical 
and environmental isolates obtained from USF freezer stocks.  The Aeromonas 
hydrophila strain was isolated from Naples Bay (Naples, FL). The Vibrio alginolyticus 
strain was a seawater isolate obtained from Courtney Campbell Causeway beach 
(Clearwater, FL). 
 Escherichia coli O157:H7 (USF 640) isolated from hamburger meat from a taco stand 
in Massachusetts following an outbreak was used to develop biosensor assays for E.coli 
O157:H7 in seawater.  Staphylococcus aureus USF 645 and Vibrio cholerae biotype O1 
El Tor serotype Inaba (CDC E5906-1018) were used as model organisms to develop 
biosensor assays.  All other bacterial strains used in experiments for Vibrio cholerae are 
listed in Table 8. 
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 TABLE 8.  Bacteria used in V. cholerae assay development. 
 
All Vibrio cholerae isolates were clinical isolates obtained from either the Centers for 
Disease Control and Prevention (CDC) (Atlanta, GA) or from Dr. Mark Tamplin (United 
States Department of Agriculture; Wyndmor, PA) who was at the University of Florida, 
Gainesville, FL when these cultures were donated.  All other isolates without ATCC 
numbers are environmental isolates.  The Aeromonas hydrophila and the Vibrio 
alginolyticus strain were the same as those used in the Enterococcus experiments. 
Media, Culture Conditions, and Sample Collection 
  Stock cultures.  Cultures of all isolates were obtained from stock cultures maintained 
at -80° C.  The cultures were grown on trypticase soy agar (TSA) (BD, Sparks, MD) or in 
trypticase soy broth (TSB) (BD) for 18-24 hours at 36°C.  This working stock was 
maintained at 4°C for up to 1 month.  Once grown, the cells were resuspended in one of 
three solutions: 0.01M phosphate buffered saline, pH 7.4 (PBS); 0.1M carbonate-
bicarbonate buffer, pH 9.3; or seawater. This culture procedure was standard in all assays 
and viable counts unless otherwise indicated. 
     Microorganism                                                                                         Strains 
Aeromonas hydrophila ………………………………………………………USF 530 
Escherichia coli …………………………………………………………ATCC 29417 
Pseudomonas aeruginosa ……………………………………………….ATCC 15442 
Pseudomonas aeruginosa ……………………………………………………USF 620 
Salmonella typhimurium ………………………………………………...ATCC 23564 
Salmonella typhimurium ……………………………………………………..USF 515 
Vibrio alginolyticus  ………………………………………………………….USF 516 
Vibrio cholerae O1  …………………………………………………………..USF 646 
Vibrio cholerae biotype O1 El Tor Inaba cholera toxin (+) ………..CDC E5906-1018 
Vibrio cholerae biotype O1 El Tor Ogawa cholera toxin (-) ……..CDC1074-78-1019 
Vibrio cholerae O139  ………………………………………………………..USF 647 
V. cholerae O139 ……………………………………………………….CDC 2412-93 
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 Enrichment and recovery media for enterococci.  Azide dextrose broth and Todd-
Hewitt broth were prepared in single strength concentrations according to the recipes in 
Standard Methods for the Examination of Water and Wastewater for the growth of 
Enterococcus faecalis (ATCC 19433) in teichoic acid extraction experiments (4).  Bile 
esculin azide broth (4), mE broth, mEI broth (263), brain heart infusion broth (BD), and 
brain heart infusion broth (BD) with 6.5% NaCl were evaluated for rapid and selective 
growth of enterococci by Dr. Allyson Bissing, a postdoctoral fellow formerly associated 
with our laboratory.  Based on her findings, the fastest growth rate for enterococci 
occurred in bile esculin broth (personal communication).  Due to its lack of selectivity, 
this medium was replaced with mE broth.  Modified mE broth was prepared in 0.1 M 
carbonate-bicarbonate buffer, pH 9.3 instead of deionized water (DI H2O).  All 
enrichments were performed at 37° C in a shaking water bath. 
     mE agar (BD) supplemented with nalidixic acid (0.24 g/l) and triphenyltetrazolium 
chloride (TTC) (0.02 g/l) was used to prepare the standard mEI medium as suggested by 
the EPA Method 1600 (263).  Indoxyl β-D glucoside was added at .75 g/L.  mEI agar was 
used for the recovery of enterococci in all seawater samples analyzed.  Environmental 
water samples were enriched in mE broth at 37°C before biosensor analysis.  These 
samples were serially diluted in PBS and plated onto mEI agar and assayed on the 
biosensor.  These plates were incubated in a 36° C incubator and allowed to grow for 18-
24 hours.  Initial counts of environmental water samples were obtained from filtering 50 
and 100 ml samples of seawater through a 0.45µm filter (Milipore, Bedford, PA) and this 
filter was placed on mEI agar to grow at 41°C for 18-24 hours.  Alternatively, counts 
 53 
 
were obtained from David Wingfield at the Florida Department of Health Tampa Branch 
Laboratory.  
 Water samples.  One liter volumes of seawater were obtained biweekly from the 
Florida Department of Health Tampa Branch Laboratory.  These samples were collected 
according to standard practices in Standard Methods for the Examination of Water and 
Wastewater (4).  Seawater samples were collected from two beaches: North Shore beach 
(St. Petersburg, FL) and Courtney Campbell Causeway beach (Clearwater, FL).  These 
two beaches were the sources of seawater samples in all experiments where bacteria were 
enriched and recovered in this study.  Figure 5 shows the locations of these beaches on 
the Florida Coast. 
 
 FIGURE 5. Map showing Tampa Bay beaches where seawater samples were 
collected.  Diamond   (   )  – Courtney Campbell Beach; Star (   )- North Shore Beach       
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 Enrichment and recovery methods for E. coli O157:H7 in seawater.  Seawater 
samples were analyzed for E. coli O157:H7 by filtering a volume of seawater (100-300 
ml) first through a Whatman #5 filter and then through a 0.45 µm filter using a vacuum 
pump model number 5KH33DN16AX (General Electric; Ft. Wayne Indiana).  The filters 
were placed onto selective media for growth which included mFC agar (BD) and eosin 
methylene blue agar (EMB) (BD).  The plates were grown at 36°C and at 44.5°C for 24 
hours to evaluate which temperature showed greater recovery.  Any suspect E. coli 
O157:H7 isolates (green sheen colonies on EMB or blue colonies on m FC agar) were 
streaked on Sorbitol MacConkey agar (Remel; Lenexa, KS) supplemented with 0.05 
mg/ml Cefixime and 2.5 mg/ml Potassium tellurite (CT, Dynal; Oslo, Norway) (CT-
SMAC).  Any colorless colonies were tested for agglutination with anti-E. coli O157:H7 
polyclonal antibody (Kirkegaard and Perry (KPL); Gaithersburg, MD). 
 Later experiments to recover E. coli O157:H7 were performed using 
immunomagnetic separation with Dynabeads (Dynal Inc.,Oslo, Norway) conjugated to 
anti-E.coli O157:H7 according to manufacturer’s instructions and as reported by Liu and 
Li and LeJeune et al. (149, 163).   The day before the assay, one liter of seawater was 
filtered through a 0.45 µm filter.  This filter was placed in 90 ml of TSB modified with  
20 mg/ml novobiocin to inhibit gram positive organisms.  The sample was incubated at 
36°C for 6-18 hours.  The following day, 20 µl of resuspended Dynabeads conjugated to 
anti-E.coli O157:H7   polyclonal antibody was added to 1 ml of the pre-enriched sample. 
The studies were done in triplicate.  These tubes were mounted onto the Dynal magnetic 
particle concentrator rack.  The rack was placed on a rotator at 24°C and allowed to rock 
for 10 minutes with continuous agitation to prevent the beads from settling.  A strip 
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magnet was inserted into the back of the rack and the rack was placed on a rotator to 
concentrate the beads into a pellet on the side of the tube.  This was done at 24° C for 3 
minutes to allow for proper recovery.  The supernatant fluid was discarded and the 
magnetic plate was removed.  The beads were washed with 1 ml PBST.  The strip magnet 
was reinserted into the rack and the suspension was rotated again for 3 minutes.  The 
supernatant fluid was discarded and the beads were washed twice more by the same 
method. Following the washes, 100 µl of PBST was used to resuspend the beads and  
50 µl of this solution was plated onto CT-SMAC agar.  Any col orless colonies on CT-
SMAC were further tested by slide agglutination with anti-E. coli O157:H7 polyclonal 
antibody and then identified through API (BioMerieux; Hazelwood, MO).   
 Enrichment and recovery methods for V. cholerae in seawater.  Seawater samples 
were analyzed in 100 ml volumes.  The seawater was filtered initially through a sterile 
Whatman #5 filter to remove any large debris in the water.  Samples were analyzed 
undiluted and diluted 10-fold and 100-fold.  Seawater samples were processed by 
filtering through a 0.45 µm filter using a vacuum pump (General Electric).  The filter was 
removed from the filtration manifold with sterile forceps and placed onto Thiosulfate 
citrate bile salts (TCBS) agar (BD) (244).  Plates were grown at 36° C and at a more 
selective temperature, 42°C for 18-24 h.  All samples were filtered in duplicate.  The 
following day any yellow colonies that were 2-3 mm in diameter were removed from the 
filter with a sterile toothpick and inoculated on TSA and allowed to grow for 18-24 h at 
36°C.  These isolates were further characterized. 
 Characterization of V. cholerae isolates: API identification and PCR amplification.    
All isolates that appeared yellow on TCBS agar and were 2-3 mm in diameter were 
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identified.  A gram stain and an oxidase test were performed on all suspect isolates.  If 
the oxidase test was positive and the cells were gram negative rods, the arginine 
dihydrolase test and iron esculin hydrolysis test were performed to presumptively identify 
any suspect isolates according to the two-test method (46).  If the arginine dihydrolase 
test and the iron esculin hydrolysis were both negative, these isolates were identified 
using the API 20 E biochemical test strip (BioMerieux).  Any putative V. cholerae 
isolates were tested for O1 somatic antigen (Inaba or Ogawa) by agglutination with 
polyclonal antiserum to V.cholerae O1 (Difco Laboratories; Franklin Lakes, NJ).  All 
isolates identified as Vibrio cholerae through API were further identified using 
polymerase chain reaction (PCR) (47).  Figure 6 outlines the identification process 
followed.   
 
 
 
 
 
 
 
 
 
 
 
 
 57 
 
 FIGURE 6.  Identification scheme for V. cholerae isolates. 
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Primers (IDT; Coralville,IA) ) targeted to a 300 base pair region of the 16S-23S rRNA 
intergenic spacer (ITS) region of Vibrio cholerae (47, 161) were used for PCR.  Both the 
forward and reverse primers were diluted to a 20 µM stock concentration.  For each PCR, 
2-4 µl of whole Vibrio cholerae cells suspended in sterile H2O was added to a 96-98 µl 
master mix prepared for each sample by using a TaKaRa TaqTM PCR kit from TaKaRa 
Biomedicals (Shiga, Japan).  All reaction mixtures included 10 µl of 10X PCR buffer,  
2.5 mM  (each) deoxynucleoside triphosphates (dNTP), 0.2 µM (each) forward and 
reverse primers, TaKaRa Taq DNA polymerase (5 units/ µl) (TaKaRa Biomedicals), and 
sterile H2O to raise the total volume to 100 µl.   The primer sequences are listed in Table 
9.  All PCR reactions were performed on the Bio-Rad I Cycler (Bio-Rad Laboratories; 
Hercules, CA).  The PCR protocol to identify isolates of V. cholerae is outlined in Table 
10. 
 
 TABLE 9. PCR primers for the identification of V. cholerae isolates (161). 
 
 
 
 
 
 
    Target                                                 Sequence                                           Length 
 
Vibrio cholerae ITS   F       5´TTA AGC STT TTC RCT GAG AAT G 3´       ~ 300 bp 
                                   R       5´AGT CAC TTA ACC ATA CAA CCC G 3´ 
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 TABLE 10. PCR protocol for V. cholerae isolatesa. 
a PCR was performed using 100 µl volumes in the I Cycler thermocycler (Bio-Rad 
Laboratories). Primers to the 16S-23S rRNA ITS region of V.cholerae were amplified to 
identify environmental isolates. 
 
 
Four microliters of the PCR product was combined with 1 µl of the gel loading dye (Bio-
Rad Laboratories).  Five microliter samples were loaded into a 1% agarose gel and run in 
TBE  electrophoresis buffer (1X working solution: 89 mM Tris base, 89 mM boric acid, 2 
mM EDTA) at 100 volts. The marker used was a 1 KB benchtop PCR marker (Promega; 
Madison, WI).   
 Enrichment and recovery methods for S. aureus.  Vogel Johnson agar (BD) and Baird 
Parker agar (BD) were tested for recovery efficiency.  These culture media were found to 
be successful in isolation of S. aureus in swimming pool water (136).  Baird Parker agar 
was chosen as the recovery medium because of its better recovery of S. aureus from 
seawater when compared to Vogel Johnson agar in preliminary experiments.  Seawater 
samples were analyzed in 100 ml volumes.  The seawater was pre-filtered through a 
sterile Whatman #5 filter to remove any large debris in the water.  Samples were 
analyzed undiluted and diluted 10-fold and 100-fold. Seawater samples were processed 
by filtering through a 0.45 µm filter using a vacuum pump (General Electric).  The filter 
was removed from the filtration manifold with sterile forceps and placed onto Baird 
   Segment                        Number of Cycles                 Temperature            Duration
        1                                           1                                         95° C                       2 mins 
        2                                          30                                        95° C                       1 mins 
                                                                                                58° C                       1 mins 
                                                                                                72° C                       2 mins 
        3                                           1                                         72° C                     10 mins 
        Holding mode                                                                   4°C                         ∞ 
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Parker agar.  These plates were placed in a 36°C incubator and allowed to grow for 48 
hours.   
 Characterization of S. aureus isolates.  Any black colonies with surrounding clear 
halo area were removed from the culture plate with a sterile toothpick and restreaked on 
TSA.  These isolates were grown for 18-24 hours in a 36°C incubator.  A gram stain and 
a catalase test were performed on all suspect isolates.  Any catalase positive isolates were 
streaked on Mannitol Salt Agar (MSA) (Difco Laboratories).  Any isolates which tested 
positive for mannitol fermentation were tested for coagulase and DNase activity.  
Citrated rabbit plasma (Remel; Lenexa KS) was rehydrated according to manufacturer’s 
instructions.  A heavy inoculation of the suspect isolate was made in 0.5 ml fractions of 
citrated rabbit plasma.  These tubes were incubated for up to 4 hours in a 36°C water 
bath.  Visible clotting of the plasma was considered a positive result.  DNase test agar 
(Difco Laboratories) was made according to manufacturer’s instructions.  Suspect 
isolates and a positive control were streaked onto the agar.  After 18-24 h of growth, the 
agar was flooded with hydrochloric acid.  Any visible clearing of the agar around the 
growth was considered a positive result.  Any isolates which were positive for one or 
both coagulase and DNase were frozen down in tubes of TSB and glycerol.  They were 
stored in a -80°C freezer.  The identification scheme for S. aureus is outlined in Figure 7. 
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 FIGURE 7.  Identification scheme for S. aureus isolates. 
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Antibodies 
 Sources.  Antibodies were purchased from the following companies: rabbit polyclonal 
anti-Strep Group D antibody, American Research Products (ARP) (Belmont, MA); rabbit 
polyclonal anti-Enterococcus antibody, Virostat (Portland, ME); rabbit polyclonal Group 
D antiserum, Lee Laboratories (Franklin Lakes, NJ); affinity purified polyclonal anti-
E.coli O157:H7,  Kirkegaard and Perry (KPL) (Gaithersburg, MD); rabbit polyclonal 
anti-Vibrio cholerae O1 serotypes Inaba, Ogawa, Hikojima, Difco Laboratories (Detroit 
MI); rabbit polyclonal anti-Vibrio cholerae O1, Murex (Lenexa, KS); rabbit polyclonal 
anti-Vibrio cholerae serotypes Ogawa, Inaba, Denka Seiken (Tokyo, Japan); monoclonal 
anti-Vibrio cholerae O1, AUSTRAL Biologicals (San Ramon, CA); monoclonal anti-
Vibrio cholerae O1, New Horizons Diagnostics Inc.(Columbia, MD); polyclonal rabbit-
anti-S. aureus antibody Maine Biotechnology Services Inc. (Portland, ME); goat anti-
rabbit IgG labeled with Cy5 (Jackson Immunoresearch;  West Grove, PA)and 
monoclonal anti-peptidoglycan, Chemicon International (Temecula, CA).  Antibodies 
used in development of assays for S. aureus were screened through ELISA by Dr. 
Marianne Kramer, University of South Florida, Tampa, FL.  All commercial antibodies 
were screened by enzyme linked immunosorbent assay (ELISA).    
 Custom prepared antibodies were also tested.  A rabbit polyclonal antibody was made 
by Strategic Biosolutions (SBS) (Newark, DE).  Two rabbits were injected with 2.0 x 109 
CFU/ml of heat-killed Enterococccus faecalis, ATCC 19433.  Cells were serially diluted 
in PBS and a viable count was performed.  All cell preparations were heat killed by 
boiling for 20 minutes before being sent for injection.  Test bleeds and final 
exsanguination samples were screened through ELISA.  Any antibodies which showed 
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high binding affinity for the target antigen were purified and used to develop the 
biosensor immunoassay.   
 A monoclonal antibody to the immunodeterminants of Ent. faecalis and Ent. faecium 
was made by the Hybridoma Core Laboratory at the University of Florida, Gainesville, 
FL.  Six mice were injected with heat-killed cell preparations of Ent. faecalis and Ent. 
faecium.  Two of the mice were injected with 3.5 x 108 CFU/ml of Ent. faecium (ATCC 
19434) cells, two were injected with 1.2 x 109 CFU/ml of Ent. faecalis (ATCC 19433) 
cells and two were injected with a mixture of both types of bacteria.  The cells were heat-
killed by boiling for 20 minutes before injection.  IgM from Clone HL 1869 was screened 
through ELISA for assay development.  A second set of six mice was immunized after 
the first monoclonal antibody project was finished.  Three mice were immunized with 5.0 
x 108 CFU/ml of Ent. faecalis cells (ATCC 19433) cells.  Two mice were immunized 
with 1.0 x 108 CFU/ml of Ent. faecium (ATCC 19434) cells.  One mouse was immunized 
with 25 µg of a crude extract of teichoic acid prepared from Ent. faecalis (ATCC 19433) 
cells.  IgG from clone 1H8-3E8 was screened through ELISA for assay development.   
 Purification methods.  Polyclonal anti-E.coli O157:H7 (KPL) was affinity purified by 
the manufacturer. The antibody was rehydrated according to manufacturer’s instructions 
to a final concentration of 1 mg/ml.  IgG purification using a protein A column kit 
(Amersham Biosciences; Piscataway, NJ) was utilized to purify whole serum used in this 
study.  The purification was done according to manufacturer’s instructions.  A 1 ml 
aliquot of antibody was passed through the IgG column.  The column was washed with 
10 ml of 0.1 M sodium phosphate buffer (pH 7.0) to remove any unbound antibody.  The 
IgG was eluted with 6 ml of 0.1 M sodium citrate (pH 3.0) and collected in 0.5 ml 
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fractions in microcentrifuge tubes containing 0.5 ml of 0.1M carbonate-bicarbonate 
buffer (pH 9.3) to neutralize the eluted samples.  A DU-64 spectrophotometer was used 
to analyse fractions for protein content.  The samples with highest A280 nm readings 
were combined for labeling.   A buffer exchange was performed using 0.1 M carbonate-
bicarbonate buffer (pH 8.5) for labeling purposes and to prevent denaturation of the 
antibody.  The exchange was done in an Amicon Ultra-4 centrifugal filter (Milipore) with 
a 30,000 molecular weight cutoff and by centrifugation in an Allegra 6R centrifuge at 
4,000 x g for 30 minutes.  This exchange was performed three times. 
 In preliminary experiments, ARP polyclonal antibody was affinity purified through a 
procedure developed by Dr. My Lien Dao, University of South Florida, Tampa, FL.  A 
high concentration of cells (~108 CFU/ml) was passively adsorbed to nitrocellulose paper 
by incubating the membrane with the bacterial cells at 24°C for 1 h with continuous 
agitation.  The membrane was washed with 2 ml of 0.01 M phosphate-buffered saline 
0.1% Tween 20 (PBST).  Two hundred microliters of antibody was incubated with the 
nitrocellulose membrane at 24°C for 1 h with continuous agitation. The antibody was 
aspirated and the filter was washed with 2 ml of PBST.  The antibody was eluted with  
0.1 M glycine for 10 minutes.  Protein concentration was calculated by measurement of 
A280 on a DU-64 spectrophotometer.  A buffer exchange was performed as described 
previously. 
 A Carbo-Link affinity column kit from Pierce Biotechnology (Rockford, IL) was 
tested for its effectiveness in affinity purification of the ARP antibody.  A sample of 
lipoteichoic acid was prepared for conjugation to the gel column.  Two methods were 
attempted to obtain a crude extract of teichoic acid for attachement to the Carbo-Link 
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affinity column.  The first method was one used for serological identification of group D 
Streptococci in Standard Methods for the Examination of Water and Wastewater (4). 
Cells of Ent. faecalis were grown in Todd-Hewitt broth and concentrated by 
centrifugation in an Allegra 6R centrifuge at 3,000 x g for 5 minutes.  Cells were 
resuspended in 0.5 ml saline and autoclaved for 15 minutes at 121 °C.  The bacteria were 
centrifuged again as described above and the supernatant fluid was screened by ELISA 
for teichoic acid.  Another method of extracting teichoic acid was performed by taking a 
heavy suspension of Ent. faecalis cells in 10 ml PBS and adding a pinch of lysozyme, 
DNase and RNase to the suspension and allowing the sample to sit at 24°C for 24-48 
hours.  Ethanol was added at two and a half times greater volume than the original 
volume.   The entire sample was then centrifuged in an Allegra 6R centrifuge at 4,000 x g 
for 1 minute.  The supernatant fluid was decanted and 1 ml of water was added to the 
pellet.  The sample was centrifuged once more at 1,500 x g for 30 seconds to remove all 
insoluble debris (76).  The concentration of the sample was calculated by extrapolation 
from a calibration curve (Figure 8).  This calibration curve was created by analyzing 
known glucose concentrations on a DU-64 spectrophotometer after reacting the glucose 
with phenol and sulfuric acid (58).   
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 FIGURE 8.  Standard curve of glucose.  The phenol and sulfuric acid reaction with 
different glucose concentrations was monitored by DU-64 spectrophotometer at 488 nm 
and the readings were used to create a standard curve (58).  A concentration between 0.5-
10 mg of carbohydrate was needed to attach to the affinity column.    
 
 The crude extract was conjugated to the carbo-link column according to 
manufacturer’s instructions.  The teichoic acid sample was oxidized using sodium-meta-
periodate provided in the kit.  The sample was allowed to react at 24°C for 30 minutes. 
The oxidized sample was then applied to a desalting column and three 2 ml fractions 
were collected.  These fractions were analyzed on a spectrophotometer DU-64 
spectrophotometer at 488 nm.  The fraction with the highest absorbance contained the 
oxidized carbohydrate.  A carbo-link gel column was equilibrated with 6 ml of PBS.  A 
porous polyethylene disc was used to pack the column and the Carbo-link gel slurry was 
added to the column (~4 ml slurry containing 2 ml gel).  The liquid from the column was 
drained and the oxidized sample was applied to the gel matrix.  The column was gently 
rotated end-over-end for 6-24 h at 24°C.  Following incubation, the liquid was drained 
from the column.  The fractions were analyzed by a DU-64 spectrophotometer at 488 nm 
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and based on those reading, the coupling efficiency was calculated.  After conjugation, 
the column was stored in PBS 0.02% sodium azide.  Antibody was purified according to 
manufacturer’s instructions.  The column was equilibrated with 6 ml of column buffer 
(0.01M PBS, pH 7.4).  One and a half milliliters of the antiserum was applied to the 
column and allowed to enter the gel bed and react with the affinity column for 1 h at 
24°C.  After incubation, the column was washed with 12 ml of column buffer.  The 
bound antibody was eluted with 100 mM glycine buffer (pH 3.0).  One milliliter fractions 
were collected in 1.5 ml microcentrifuge tubes containing 0.1 M carbonate-bicarbonate 
buffer (pH 9.3) to neutralize the fractions.  The fractions were analyzed using a DU-64 
spectrophotometer at 280 nm.  The fractions of interest were pooled and a buffer 
exchange was performed as described previously.      
  All antibody samples were screened initially as whole serum using ELISA.  Those 
which showed high affinity to the target cells were purified by one of the methods 
mentioned above.  Antibodies were then labeled with biotin and or cyanine 5 (Cy5) as 
needed.  Only those which showed high binding affinity to the target of interest on 
ELISA were eventually tested on the fiber optic biosensor.   
 Labeling.  A labeling kit (FluoroLink Cy5 Reactive 5-pack; Amersham Biosciences, 
Piscataway, NewJersey) was used for labeling antibodies with cyanine 5 (Cy5) dye 
molecules.  The labeling was done according to manufacturer’s instructions.  A 
concentration of at least 1 mg/ml of antibody was necessary to efficiently label.  
Following purification, 0.5 ml of antibody diluted with 0.1 M carbonate-bicarbonate 
buffer (pH 9.3) was added to a Cy5 reactive dye pack.  The dye vial was incubated in the 
dark at 24°C for at least 1 h or alternatively, the vial was incubated at 4°C for 18-24 h.  
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After incubation, free dye was separated from labeled antibody by separation on a Bio-
Gel P-10 (Bio-Rad Laboratories, Hercules,CA) column with an exclusion limit of 1,500-
20,000 molecular weight.  The column was equilibrated with PBS- 0.02% sodium azide.  
Labeled antibodies were collected in 0.5 ml fractions and analyzed on a DU-64 
spectrophotometer for protein content.  Molar concentrations of dye and protein were 
calculated and the final dye to protein ratio was also calculated.   
 At least 1 mg of antibody was necessary for efficient biotin labeling.  Biotin labeling 
was performed according to manufacturer’s instructions using EZ-Link NHS-LC-LC-
Biotin (succinimidyl-6-(biotinamido) hexanoate) (Pierce; Rockford , IL).  One mg of EZ-
Link NHS-LC-LC-Biotin was dissolved in 1 ml of N,N-dimethylformamide (DMF).  
Seventy five microliters of this solution was mixed with 425 µl of antibody (~1mg/ml).  
This solution was incubated at 4° C for 18-24 h.  Unattached biotin was separated from 
the labeled antibody by using gel filtration on a Bio-Gel P10 column equilibrated with 
PBS with .02% sodium azide.  Labeled antibodies were collected in 0.5 ml fractions and 
analyzed on a DU-64 spectrophotometer (Beckman Coulter) for protein content.  
Antibody samples whose final concentration was less than 1 mg/ml were stabilized by 
adding bovine serum albumin (BSA) to raise the concentration to 1 mg/ml.  All labeled 
antibodies were stored at 4°C until needed. Whole serum samples that were unpurified 
and unlabeled were stored in a -20°C freezer indefinitely.  
 Screening.  All antibodies, commercial and custom made, were screened using 
ELISA.  Enterococcus faecalis (ATCC 19433) and the other organisms listed in Tables 7 
and 8 were serially diluted in PBS and placed in a 96-well ELISA plate (Nunc, 
Rochester, NY).  The plate was incubated for 18-24 h at 4°C.  The following day, the 
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plate was washed with PBST.  The plate was blocked with PBS containing 2mg/ml 
Casein and 2 mg/ml bovine serum albumin (BSA) for 1 h and then washed again with 
PBST.  Primary antibody specific to the target antigen was diluted in PBS to a 
concentration of 10 µg/ml.  The antibody was incubated on the plate at 24°C for 1 h and 
then the plate was washed again with PBST.  A 1 mg/ml solution of anti-rabbit IgG 
(Jackson ImmunoResearch, West Grove, PA) conjugated to horse radish peroxidase 
(HRP) was diluted to 2 µg/ml in PBS and incubated on the plate at 24°C for 1 h.  The 
plate was washed again with PBST.  A Quanta Blue kit (Pierce; Rockford, IL) provided 
the substrate to react with the HRP enzyme.  The substrate was mixed together with the 
stabilizing solution provided in the kit according to manufacturer’s instructions.  The 
mixture was a combined 9 parts substrate solution to 1 part stable solution.  One hundred 
microliters per well of the substrate was incubated on the plate for 25 minutes.   After the 
incubation period, 100 µl per well of stop solution was added to each well and the plate 
was read on a Spectramax Gemini XS microplate reader (Molecular Devices; Sunnyvale, 
CA).    
Analyte 2000 Biosensor 
 The Analyte 2000 biosensor (Research International; Monroe, WA) was used to 
perform all biosensor experiments in this study (Figure 9).   
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 FIGURE 9.  Analyte 2000 biosensor (Research International; Monroe WA).  This 
instrument has four channels allowing for four samples to be processed at once. 
 
In this instrument, optical fibers act as waveguides carrying electromagnetic waves.  An 
evanescent wave sensing scheme is utilized where only fluorophores close to the surface 
of the fiber (~100 nm) will generate a signal (157).  This is achieved when a 635 nm 
diode laser sends light through the proximal end of a polystyrene waveguide propagating 
electromagnetic waves within the optical fiber which are reflected off its exposed surface.  
An electric field is generated and causes the excitation of fluorescent molecules at a 100-
1000 nm distance of the wave guide. The emission energy is recoupled through the 
waveguide.  The emitted light is collected and the photodiode allows for the quantitation 
of the emission at wavelengths above 650 nm.  The binding event is recorded as a 
numerical signal on a computer.     
Biosensor Sandwich Immunoassays 
 Sample preparation.  All samples assayed using a sandwich immunoassay format on 
the fiber optic biosensor were prepared by taking a sample of the test organism from the 
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freezer stock culture and growing the culture on TSA or TSB for 18-24 h at 36°C.    After 
this growth period, some of the culture was taken directly from the plate using either a 
sterile polyester fiber tipped plastic swab or a loop and resuspended in PBS to 
approximately 108 CFU /ml.  This starter sample was serially diluted 10-fold in PBS and 
plated onto TSA to obtain a viable count of cells.  Aliquots from this dilution set were 
assayed directly on the biosensor from lowest to highest concentration.  If TSB was used, 
the culture was centrifuged at 4,000 x g in an Allegra 6R centrifuge to pellet the cells.  
The supernatant fluid was decanted and the cells were resuspended in PBS.  These 
samples were assayed directly after serially diluting and plating on TSA for a viable 
count.   
 Preliminary experiments were performed on the biosensor using viable cells.  
Different sample preparations were used in an attempt to improve assay sensitivity.  In all 
experiments, a starter culture tube was made in PBS to 108 CFU/ml and then serially 
diluted in PBS.  A viable count was performed by plating onto TSA.  In heat killed cell 
experiments, the tubes to be analyzed were boiled for 20 minutes.  After cooling, the 
solutions were assayed directly on the biosensor.  Cell samples were also treated by 
freeze thawing.  Dry ice was combined with denatured ethanol in a Styrofoam cooler.  
The samples were then placed in the dry ice solution for 1 minute and then allowed to 
thaw in a 36°C waterbath.  This procedure was repeated three times to disrupt cells as 
much as possible.  Sonication was also performed as an alternative cell prep to disrupt the 
bacterial cells.  A 4 ml volume of bacteria resuspended in PBS was placed in a 50 ml 
plastic conical tube.  The tube was placed in a styrofoam cooler with ice to ensure that the 
tube did not become warm and sonicated at setting number 2 on the Dismembrator 100 
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(Fisher Scientific) for different time intervals.  These different sample preparations were 
compared through ELISA and those which gave the highest signals when reacted with the 
target specific antibody were assayed on the biosensor. 
 Waveguide preparation.  Polystyrene waveguides (Research International), 
approximately 4 cm in length, were cleaned by sonication for 30 seconds in 2-
isopropanol using an ultrasonic cleaner.  The waveguides were rinsed in deionized water 
and then black ink was placed on the tip of each waveguide to prevent the escape of laser 
light.   The waveguides were allowed to air dry completely and were then placed in a 
glass capillary tube approximately 4.5 cm in length which served as the reaction 
chamber.  The capillary was cut to hold approximately 100 µl of solution.  A solution of 
streptavidin was prepared in PBS (pH 7.4) at a concentration of 100 µg/ml.  One hundred 
microliters of solution was used to fill the reaction chamber and the waveguides were 
incubated for 18-24 hours at 4°C with this solution.   
 Sensitivity and specificity assays.  Following incubation with streptavidin, the 
waveguides were placed into the cuvettes made specifically to fit the instrument’s laser 
diode manifold.  Figure 10 shows the waveguide and the Analyte 2000 cuvette which 
holds the fiber during the assay.  Waveguides were secured with a cap that fits and 
secures the waveguide into the cuvette.  Two ports coming out of the cuvette were 
connected to lines of tygon tubing.  Wash solution and or antibody solutions were 
introduced into the cuvette through the proximal inlet.  The distal outlet at the top of the 
cuvette was connected to a waste line.  
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 FIGURE 10.  Waveguide and cuvette used for biosensor assay.  The polystyrene 
waveguide used in all biosensor assays was housed in the black cuvette above.  This 
cuvette was made specifically for the Analyte 2000 biosensor instrument. 
 
The waveguide was then washed with 3 ml of PBST injected into the cuvette using a 1 ml 
syringe to rinse out any unbound streptavidin.   
 Different capture molecules were tested throughout the course of the study.  
Concanavalin A (ConA) (Nordic Immunology; Tilburg, The Netherlands) and Wheat 
Germ Agglutinnin (WGA) (Vector Laboratories, Burlingham, CA) lectins were tested as 
potential capture molecules for the sandwich immunoassay based on their ability to bind 
surface carbohydrate groups on Enterococcus cells (27).  They were screened using 
ELISA as described above.  After screening the two lectins, it was observed that 
extensive cross-reactivity existed between ConA and the polyclonal anti-Strep Group D 
antibody (ARP) so this was not pursued.  WGA crossreacted to a lesser degree with the 
antibody and was tested on the biosensor.  Biotinylated WGA was diluted to10 µg/ml in 
PBS and then incubated on the streptavidin coated waveguide at 4°C for 18-24 h.   
 Polyclonal antibody labeled with biotin specific to the target being tested was 
prepared in PBS to a concentration of 100 µg/ml. Other concentrations of capture 
antibody were also tested. An initial reading was taken to observe the inherent 
Polystyrene 
Waveguide 
Cuvette Inlet 
Port for 
wasteline
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fluorescence of the waveguide.   In later experiments to reduce overall assay time, all 
antibody preparations were made in blocking buffer (2 mg/ml casein and bovine serum 
albumin in 0.01 M PBS (pH 7.4)).  One hundred microliters of capture antibody was 
allowed to react in the cuvette for 1 h.  Following incubation, the waveguide was rinsed 
with 1 ml of PBST.  In early experiments, a blocking step was included in the assay to 
block non-specific binding on the waveguide.  The waveguide was incubated with 100 µl 
of blocking buffer for 20 minutes.  In later experiments this step was removed and all 
antibody solutions were prepared in blocking buffer.   
 Background fluorescence caused by nonspecific binding of Cy5 labeled antibodies 
was determined by incubating the Cy5 labeled antibodies (10-20 µg/ml) at 5 minute 
intervals on the waveguides 4 times.  After each incubation, the waveguide was rinsed 
with 2 ml of PBST.  The signal recorded after the PBST rinse was considered the 
background signals.  These readings were analyzed later to determine limits of detection 
(LOD).  Cells were serially diluted in PBS for use in the assay.  One milliliter of each test 
sample was allowed to react with the capture antibody for 10 minutes.  Uncaptured 
bacteria were washed out with 1 ml PBST.  Cy5 labeled detection antibody specific for 
the target being tested was allowed to react with captured cells for 5 minutes.  Any 
unbound detection antibody was washed out of the cuvette with 2 ml PBST and a reading 
was taken.  The assay scheme is illustrated in Figure 11.           
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 FIGURE 11.  Sandwich immunoassay format for evanescent wave biosensor.  The 
standard assay time is 20 minutes excluding the attachment of capture antibody on the 
waveguide (1 h) and sample preparation (10-30 minutes depending on preparation 
method).   
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Biosensor Indirect Immunoassays for Enterococci 
 Sample Preparation.   The test organism was grown on TSA at 36°C for 18-24 h.  A 
starter tube was made by taking a sample from the TSA culture plate with a sterile 
polyester fiber tipped plastic swab or loop and resuspending the cells in 0.1M carbonate-
bicarbonate buffer (pH 9.3) to approximately 108 CFU /ml.  A 10-fold serial dilution of 
this sample was made in bicarbonate-carbonate buffer (pH 9.3).  Samples from the 
dilution set were plated onto TSA to obtain a viable count of bacteria.   
 Waveguide preparation.  Polystyrene waveguide fibers were cleaned and prepared as 
described previously with one exception, after the waveguides were dried from cleaning, 
they were placed in a glass capillary tube, but were not incubated with streptavidin.  
Bacterial cells resuspended in PBS or 0.1 M carbonate-bicarbonate buffer (pH 9.3) were 
used to fill the glass capillary tube.  The cells were allowed to passively adsorb to the 
waveguide at 36°C for a minimum of 30 minutes.  Experiments were performed to test 
the time requirements for adsorption of cells to the waveguide so at times, cells were 
incubated up to 18-24 hours. A negative control consisting of either 0.1M carbonate-
bicarbonate buffer or uninoculated enrichment broth was always included in each assay. 
 Sensitivity and specificity assays.  Following incubation with the bacterial cell 
suspension, the waveguides were placed in the Analyte 2000 cuvettes as described 
previously.  The waveguides were rinsed with 2 ml of PBST to wash out any unadsorbed 
sample.  An initial reading was taken to determine the inherent fluorescence of the 
waveguide and of the dirty sample.  Background fluorescence of the Cy5 labeled anti-
rabbit IgG was determined by first, allowing a polyclonal antibody non-specific to the 
target antigen (polyclonal anti-V. cholerae O1, Difco Laboratories) to react with the 
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sample on the waveguide for 5 minutes.  The waveguide was rinsed with 2 mls of PBST.  
Then a Cy5-labeled anti-IgG was incubated on the waveguide for 5 minutes.  Any 
unbound antibody was rinsed with 2 ml PBST and then a reading was taken.  This 
procedure was repeated four times and a limit of detection was calculated based on these 
readings.  Unlabeled polyclonal anti-Strep group D antibody (ARP) (American Research 
Products, Belmont, MA) was diluted as described previously to a concentration of  
10 µg/ml.  One hundred microliters of antibody was allowed to react with the attached 
cells for 5 minutes.  Any unbound antibody was rinsed away using 2 ml of PBST.  An 
anti-rabbit IgG labeled with Cy5 was diluted to1.5 µg/ml in PBS or blocking buffer.  One 
hundred microliters of the anti-IgG was allowed to react with the primary IgG already 
bound to the bacteria on the waveguide for 5 minutes.  Any unbound anti-IgG was rinsed 
away with 2 ml PBST and a reading was taken.  The assay scheme is illustrated in Figure 
12. 
 
 
 
 
 
 
 
 
 
 
 78 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 FIGURE 12. Indirect immunoassay format for evanescent wave biosensor.  The 
standard assay time for the indirect immunoassay for the evanescent wave biosensor is 10 
minutes excluding the sample preparation step (10 minutes for a pure culture) and 
adsorption of the sample to the polystyrene waveguide (at least 30 minutes).   
 
Data Analysis for Biosensor Assays 
   The data for the waveguides and bacterial concentrations tested were analyzed 
differently for the sandwich immunoassays and for the indirect immunoassays.  Data 
from each waveguide for the sandwich immunoassays were normalized to allow 
comparison of independent waveguides (266).  Values were normalized by setting the 
signals obtained at the highest concentration tested to 100.  The normalized values were 
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treated as ratios of 100%.  An average normalized signal was calculated for each bacterial 
concentration tested and the standard deviation between the normalized signals for a 
particular concentration was determined.  The limit of detection (LOD) for each 
waveguide was determined by calculating the standard deviation of the backgrounds and 
multiplying by three.  This was done after three background readings were taken.  In later 
experiments the amount of backgrounds performed was increased to four and LODs were 
calculated differently. The LOD was calculated by averaging the differences between 
each consecutive background reading. Then the standard deviation of the mean was 
calculated and multiplied by three. Those two values were added together and were 
considered the LOD for each waveguide.  Any signal over the LOD was considered a 
positive.   
 The data for the indirect immunoassays for enterococci could not be expressed as 
normalized signals because different waveguides were used to test various concentrations 
of bacteria.  The limit of detection for each waveguide was calculated in exactly the same 
fashion as described above in later experiments when four background readings were 
performed. A negative control was always tested along with test samples to assess the 
extent of non-specific binding of the antigen specific antibody (anti-Strep group D 
polyclonal antibody).  A sample was considered positive only if the signal generated was 
greater than the limit of detection and also greater than the signal generated by the 
negative control. 
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Seawater Sample Collection and Sample Preparations 
 Unspiked samples.  Twenty liter volumes of seawater were collected using a sterile 20 
liter carboy by the EPA Method 1600, American Public Health Standard Methods for the 
Examination of Water and Wastewater, and the methods described by Simmons and 
Francy (4, 88, 234, 263).   Water was collected from Courtney Campbell Causeway 
beach (Clearwater,FL).  Samples were collected three feet from shore and at a depth of 
approximately 6-12 inches below the water surface. Water samples were kept on ice for 
30 minutes during transit to the laboratory.  All samples were processed immediately 
upon arrival or within 6 hours of collection.  On Tuesdays when samples from this site 
were also collected by the Pinellas County Department of Health, counts were obtained 
from the Florida Department of Health, Tampa Branch Laboratory, which processed the 
samples collected by Pinellas County officials.  On all other days when samples were 
collected, initial Enterococcus counts were obtained by using standard EPA methods 
(263).  Fifty and 100 ml samples were filtered through a 0.45 µm filter.  After filtration, 
the filter and the unit was rinsed with buffered water [1.25 ml stock phosphate solution 
(34.0 g KH2PO4 in 500 ml reagent grade H2O) + 5.0 ml magnesium chloride solution 
(81.1 g MgCl2 6H2O/L)/L].  The filter was then placed with sterile forceps on mEI media 
and incubated at 41°C for 24 h.  The following day, any colonies with blue halos 
surrounding them indicating the presence of β-D-glucosidase positive enterococci and 
were counted.  Final concentrations were reported as CFU/100ml. 
 Spiked Samples.  Twenty liter volumes of water were sterilized and used to fill a 
sterile 20 liter carboy.  Test organisms were grown on TSA for 12-24 h at 36°C.  A 
sample was taken from the culture plate and resuspended in PBS to approximately  
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108 CFU/ml.  A serial dilution of the starter tube was made and viable counts were 
performed to determine the number of live bacteria in each tube.  Spiked assay samples 
were prepared by inoculating the carboy with 3 mls of a particular dilution of bacteria to 
obtain the desired CFU/100ml.  All assays performed in sterile water were also 
performed in Instant Ocean (Aquarium Sytems Inc.; Mentor OH) (3.5% in DI water) 
following the same procedure described above. 
Concentration of Seawater with a Hollow Fiber Filter 
 Twenty liter samples of spiked sterile water and unspiked sea water samples were 
concentrated by using an 80,000 molecular weight cutoff hollow fiber filter (Fresenius 
USA; Lexington, ME) (88, 234).  Initial experiments were carried out by the same 
method but in 20 liters of sterile deionized water. The day before the assay was 
performed, the filter was blocked with 0.1% Laureth-12 (PALL Corporation; East Hills, 
NY) elution buffer (blocking buffer) made in 0.01 M PBS (pH 7.4).  The filter was 
incubated at 4°C for 18 h.  Concentration was performed using a Masterflex 4S 
motorized pump (Model # 77201-62, Cole Parmer Instrument Company; Barrington IL).  
The filter was connected to the carboy using 36 gauge tygon tubing connected by plastic 
adaptors and secured with metal clamps.   The apparatus used to concentrate water is 
illustrated in Figure 13. 
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 FIGURE 13.  Concentration apparatus.  Twenty liter volumes of spiked and unspiked 
sterile water and seawater were concentrated using an 80 K MWCO hollow fiber filter.  
Water was continuosly recirculated through the system releasing partial volumes as 
permeate until the whole sample was filtered.  Bacteria were eluted from the filter using 
1% Laureth 12 solution.  
 
 
Following concentration, the filtrate was eluted with 250 ml of 1% Laureth-12 elution 
buffer made in PBS.  The elution was performed for 1 minute with a visual reduction in 
buffer volume.  A sample from the elution was either plated directly or diluted and then 
100 µl was plated on TSA, mEI and marine agar to obtain a viable count from the 
concentrated sample and to calculate a percent recovery.   This was also performed on the 
three types of media listed above to observe any background flora which may also be 
growing along with the enterococci.  The eluted sample was then filtered through a  
0.45 µm filter (Millipore).  This filter was rinsed with buffered water and then cut out of 
the filtration apparatus. Using sterile forceps, the filter was placed into a beaker 
containing mE enrichment broth prewarmed to 36°C.  One hundred microliters of this 
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sample were also plated on TSA, mEI and marine agar.  The beaker was then placed into 
a 36°C shaking water bath to enrich for 8-24 hours.  Figure 14 shows the procedure used 
to process and enrich concentrated seawater samples.  Following enrichment and 
concentration, a sample was removed and directly assayed on the biosensor. 
 
 
 FIGURE 14.  Processing steps for concentrated seawater samples. 
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Concentration, Enrichment and Biosensor Detection of Fecal Enterococci 
 Concentration with a hollow fiber filter was combined with biosensor detection to 
create a sensitive and specific method to detect fecal enterococci in sea water.  
Concentration was carried out as described above.  During the enrichment period, a  
100 µl sample was plated at strategic time periods, usually at the 8 h, 10 h, 12 h, 14 h and  
24 h marks.  Samples were plated on mEI, TSA, and marine agar to obtain a viable count 
at that time period.  An Enterococcus count of at least 106 CFU/ml was necessary to 
obtain positive detection on the fiber optic biosensor.  At those key time periods, a 1 ml 
sample was removed and incubated with the polystyrene waveguide as described 
previously.  The glass capillary reaction chamber was filled with the enriched sample and 
cells were allowed to adsorb to the waveguide at 36°C for a minimum of 30 minutes.  
The biosensor assay was performed according to the protocol described for the indirect 
immunoassay. 
SDS PAGE and Western Blot Analysis 
 Enterococcus faecalis cells were grown on TSA agar for 18-24 h at 36°C.  A sample 
of the cell culture was taken with a sterile loop or swab and the sample was resuspended 
in sterile H2O.  Samples were prepared by combining 13 µl of sample (whole cell 
samples of Ent. faecalis untreated or treated by sonication  for 20 minutes) with 5 µl 
NuPAGE LDS sample buffer (4x) (Invitrogen; Carlsbad,CA) and 2 µl H2O and heated at 
95°C for 5 minutes.  A 4-12% Bis-Tris polyaccrylamide gel (Invitrogen; Carlsbad, CA) 
was loaded with 10 µl of the prepared sample.   Running buffer used to run the gel was 
1x SDS-MES running buffer (Invitrogen; Carlsbad,CA).  The gel was run at 200 volts for 
30 minutes.  A protein color marker (Sigma; St. Louis, MO) with a molecular weight 
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range between 6,500-205,000 was used to run the gels.  The cells samples were 
transferred to a nitrocellulose membrane (Sigma) in Tobin buffer (pH 8.3) for up to 48 h 
at 20 volts. The following day, the membranes were removed from the transfer cell and 
blocked with 40 ml of blocking solution (5% non-fat dry milk made in PBST) for 30 
minutes with continuous agitation.  The membrane was washed with 40 ml of PBST. 
Target specific antibody (anti-Strep group D antibody) was added to the membrane at a 
1:1000 dilution in PBS and incubated for 30 minutes with continuous agitation.  The 
membrane was rinsed with 40 ml of PBST three times.  Anti-rabbit IgG conjugated to 
alkaline phosphatase was diluted 1:5000 and was incubated on the membrane for 30 
minutes with continuous agitation.  The membrane was washed with 10mM EDTA for 30 
seconds with agitation.  The membrane was then washed with 40 ml of PBST three times.  
Forty milliliters of substrate (50 ml borate buffer (pH 9.7) -13 mg o-dianisidine, 13 mg β-
naphthyl acid phosphate) was added to the membrane and the membrane was allowed to 
develop until bands appeared (59).   
Immunodot Analysis 
 Nitrocellulose membrane was cut into a 4 inch square.  Wells were embossed using a 
96-well ELISA plate (Nunc, Fisher Scientific).  Cells of Enterococcus faecalis were 
grown on TSA at 36°C for 18-24 h.  The cells were resuspended in PBS and a 10-fold 
serial dilution was made and plated on TSA to obtain a viable count. On some occasions, 
sonicated cells extracts (sonicated for 20-30 minutes) were analyzed.  Ten microliters of 
each dilution were dotted in the embossed wells and allowed to dry.  The membrane was 
incubated at 4°C for 10 minutes.  The rest of the immunodot procedure was as described 
above for Western blot analysis. 
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Scanning Electron Microscopy Analysis 
 Waveguides were prepared as described above for the biosensor assays.  After 
cleaning, incubation with streptavidin and biotin-labeled anti Strep group D capture 
antibody (ARP), the waveguides were incubated with 100 µl of an Ent. faecalis cell 
suspension (3.8 x 108 CFU/ml in PBS).  Two of the waveguides were incubated with 
untreated cells and the other two were incubated with cells which were sonicated for 
twenty minutes on setting number 2 using the Dismembrator 100 (Fisher Scientific).  The 
waveguides were washed with 2 ml of PBST and then the waveguides were taken to 
Betty Loramm, USF Department of Biology, to prepare the waveguides for SEM 
analysis.  Waveguides were prepared according to her instructions.  The waveguides were 
fixed in Trump fixative (Electron Microscopy Sciences; Ft. Washington, Pennsylvania).  
They were rinsed three times in 0.1M sodium cacodylate buffer (pH 7.4) for 10 minutes 
each rinse.  The waveguides were then placed into 2% osmium tetroxide in 0.1M sodium 
cacodylate buffer (pH 7.4) for 1 h.  Each waveguide was then rinsed three times again in 
0.1M sodium cacodylate buffer (pH 7.4) for 1 h.  The samples were then dehydrated 
according to the following sequence: 
                                               30% ethyl alcohol-10 minutes 
                                               60% ethyl alcohol-10 minutes 
                                               90% ethyl alcohol-10 minutes 
100% ethyl alcohol-15 minutes 
100% ethyl alcohol-15 minutes 
 
The waveguides were dried chemically with hexamethyldislazane (HMDS).  The whole 
procedure was repeated and then the waveguides were critical point dried with liquid 
CO2.  Double stick adhesive was used to mount dried waveguides onto SEM stubs 
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Hitachi S800 (Ernest F. Fullam Inc., Latham, NY).  The waveguides were then sputter 
coated and mounted with Gold-paladium target using a Pelco Model 3 sputter coater.  
Once sputter coated, the waveguides were ready for SEM analysis.  
Growth Curve Experiments for Enterococci 
 Cells of Ent. faecalis were grown in TSB broth at 36°C for 18-24 h.  A one percent 
inoculation was performed in the enrichment broth being tested (mE broth or bile esculin 
azide broth).   One hundred microliters of the enrichment culture was plated on either 
TSA or mEI or both every 30-60 minutes.  Absorbance (OD 540 nm) readings were also 
taken in growth curve experiments using a DU-64 spectrophotometer.  The growth 
experiments were performed over a 6 hour period. 
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RESULTS 
Development of Biosensor Sandwich Immunoassay for Enterococci 
 All initial experiments were performed on the Analyte 2000 biosensor using a 
sandwich immunoassay format.  Whole cells of Enterococcus faecalis were resuspended 
in PBS and serially diluted by 10-fold dilutions.  The samples were assayed from lowest 
to highest cell concentration.   
 Antibody specificity.  Several commercial and custom made antibodies were tested for 
use in the development of a sensitive and specific assay for the detection of fecal 
enterococci in seawater.  Seawater of high quality contains a very low concentration of 
enterococci in seawater (0.01 CFU/ml – 1 CFU/ml) and necessitates a method sensitive 
enough to enumaerate such a low concentration.  A high quality antibody was a very 
important part in developing such an assay using the Analyte 2000 biosensor.  Figure 15 
shows the results of an ELISA screening of all the antibodies tested.  Antibodies were 
diluted to 10 µg/ml except the monoclonal antibodies tested which were diluted 1:10 in 
PBS. 
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 FIGURE. 15. Enterococcus antibodies tested for biosensor assay optimization. All 
antibodies were tested against Ent. faecalis cells at 10 µg/ml except the monoclonal 
antibodies which were diluted 1:10 in PBS. 
 
The commercial polyclonal antibodies from American Research Products (ARP), Lee 
Laboratories, and the custom made Strategic Biosolutions (SBS) polyclonal antibodies 
showed the greatest affinity for the Enteroccoccus faecalis cells.   These antibodies were 
tested to evaluate their efficiency at detecting low levels of Ent. faecalis on the biosensor.  
Figure 16 shows the results of an ELISA used to determine the binding affinity of the 
selected antibodies to low concentrations of enterococci.  The custom made SBS 
antibody and the commercial ARP gave the highest signals when tested against low 
concentrations of Ent. faecalis. 
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 FIGURE 16.  Comparison of high affinity Enterococcus antibodies for use in assay 
development. Polyclonal antibodies from Lee Laboratories, American Research Products 
(ARP) and Strategic Biosolutions (SBS) were tested against Ent. faecalis cells at 10 
µg/ml. Both the ARP and the SBS had a higher affinity for Ent. faecalis than the 
polyclonal antibodies from Lee Laboratories did. 
 
ARP and SBS antibodies were assayed using Western blot analysis, as described in the 
Materials and Methods, to see which antibody showed the greatest affinity for different 
epitopes of Ent. faecalis cells.  The cells were tested sonicated and unsonicated with 
SDS-PAGE.  Part of each sample was centrifuged to assay the pellet and supernatant 
fluid to determine which fraction contained a greater amount of antigen to bind with the 
ARP antibody.  Subsequent Western blot analysis revealed that the SBS antibody showed 
greater affinity for a low molecular weight molecule, but the ARP antibody showed a 
higher affinity for more than one epitope on the Ent. faecalis cells (Figure 17)  Also, it 
was observed that after sonication, more soluble antigen was present in the supernatant 
fluid than in the pellet fraction. The ARP antibody was chosen for further assay 
development on the Analyte 2000 biosensor. 
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 FIGURE 17. Western blot analysis of polyclonal ARP and SBS antibodies for 
Enterococcus biosensor assay. 
Lane 1:  Marker 
Lane 2:  Unsonicated Ent. faecalis ATCC 19433 cells 
Lane 3:   Sonicated Ent. faecalis ATCC 19433 cells 
Lane 4:   Supernatant from sonicated cells after centrifugation 
Lane 5:   Pellet from sonicated cells after centrifugation 
Lane 6:   Supernatant unsonicated cells after centrifugation 
Lane 7:   Pellet unsonicated cells after centrifugation 
Lane 8:   N/A 
Lane 9:   100 µg/ml lipoteichoic acid from Ent. faecalis (Sigma) 
Lane 10:  50 µg/ml lipoteichoic acid from Ent. faecalis (Sigma) 
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Of note is the lack of a distinct bad for unsonicated cell preparations of Ent. faecalis.  
This is probably due to the in accessible location of the group D antigen (LTA) of 
enterococci.  The LTA is located under the cell surface where antibodies do not have 
binding access.   
 Crossreactivity assays.  The ARP polyclonal antibody was assayed for specificity 
against environmental isolates of enterococci and also other potentially cross-reactive 
species.  Positive samples were recorded as any fluorescence readings that gave a signal 
to noise ratio of 2 or greater.  Those microorganisms tested are listed in Table 11 along 
with the signal to noise ratio that was obtained at the concentration required to give a 
positive.  Several bacteria were shown to crossreact with the ARP antibody at the same 
concentrations as the enterococci tested.  Those species included Lactobacillus 
arabinosa, Leuconostoc, Pediococcous dextrinicus, Staphylococcus aureus.   
 TABLE 11. Specificity data for anti-Strep group D antibody (American Research 
Products) generated by ELISA. 
 
  Microorganism                Signal to noise ratioa             Concentration required for  
                                                                                               positive signal (CFU/ml) 
Aerococcus viridans N/Ab N/Ab 
(ATCC 700406) 
Ent. casseliflavus (USF 691) 2.6 3.2 x 107 
Ent. casseliflavus (USF 703) 3.6 1.0 x 108 
Ent. casseliflavus (USF 707) 3.1 2.3 x 107 
Ent. casseliflavus (USF 740) 2.0 2.7 x 107 
E. coli (USF 640) N/Ab N/Ab 
Ent. faecalis (ATCC 19433) 4.6 7.0 x 106 
Ent. faecalis (USF 693) 2.7 3.4 x 105 
Ent. faecalis (USF 696) 6.0 3.2 x 106  
Ent. faecalis (USF 709) 2.2 5.8 x 105 
Ent. faecalis (USF 710) 2.2 4.5 x 105 
Ent. faecalis (USF 711) 2.4 3.2 x 105  
Ent. faecalis (USF 713) 4.8 4.2 x 106 
Ent. faecalis (USF 715) 6.1 3.5 x 106 
Ent. faecalis (USF 719) 3.7                                          7.8 x 106 
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a A signal to noise ratio over 2.0 was required for a value to be considered positive. 
bN/A, no positives were observed 
 
S. aureus consistently showed crossreactivity with the ARP antibody.  While  
Ent. faecalis and S. aureus both contain a lipoteichoic acid antigen, S. aureus has a  
Ent. faecalis (USF 720) 6.5 7.6 x 106  
Ent. faecalis (USF 721) 2.0                                          1.0 x 106 
Ent. faecalis (USF 723) 4.1                                          1.3 x 107 
Ent. faecalis (USF 724) 2.1                                          1.3 x 106 
Ent. faecalis (USF 726) 5.4                                          1.2 x 107  
Ent. faecalis (USF 727) 4.9                                          7.9 x 106 
Ent. faecalis (USF 734) 2.1                                          1.0 x 106 
Ent. faecalis (USF 747) 3.2                                          1.4 x 106 
Ent. faecalis (USF 751) 2.4                                          4.3 x 105 
Ent. faecium (USF 692) 2.8                                           6.1 x 106 
Ent. faecium (USF 725) 3.9                                           7.0 x 106 
Ent. faecium (USF 730) 2.4                                           6.0 x 106 
Ent. faecium (USF 753) 3.6                                           1.6 x 107 
Ent. faecium (USF 754) 5.1                                           5.6 x 107 
Ent. faecium (USF 759) 3.9                                           6.0 x 106 
Ent. durans (USF 694) 2.4                                          1.8 x 106 
Ent. durans (USF 732) 2.0                                          1.9 x 107 
Ent. gallinarum (USF 767) 2.0                                           1.5 x 107 
Group A Streptococcus  4.1                                          1.8 x 108 
(8-R291 TGH) 
Group B Streptococcus N/Ab N/Ab 
(1215-RNSJ183V) 
Lactobaccillus arabinosa 2.0                                          2.0 x 106 
(USF 541) 
Lactococcus lactis (USF 690) N/Ab N/Ab 
Lactococcus lactis (USF 776) 3.0                                           6.2 x 107 
Leuconostoc (USF 706) 2.6                                           8.3 x 106 
Pediococcus dextrinicus 2.8                                           1.2 x 106 
(ATCC 33087) 
S. aureus (USF 645) 2.0                                           2.6 x 107 
Streptococcus bovis 4.5                                           2.7 x 108 
(ATCC15351) 
Streptococcus bovis 2.2                                           8.7 x 108 
(ATCC 49133) 
Vibrio alginolyticus (USF 516) 2.5                                           8.4 x 108 
Weissella confusa 3.2                                           2.9 x 107 
(ATCC 14434) 
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ribitol teichoic acid and Ent. faecalis has a glycerol teichoic acid.  The nature of this 
crossreactivity, however, was found to be predominantly due to the protein A molecules 
on the surface of S. aureus as this phenomenon has been reported in previous studies 
(100).  This characteristic was tested on ELISA by using an S. aureus strain mutated to 
not produce protein A (Figure 18).  This strain was tested against a Cowen I strain that 
had abundant protein A molecules on its surface.  In previous studies, it was found that 
protein A bound the Fc portion of antibody molecules with great affinity.  This was found 
to be the case with the ARP antibody as well.  There was still some degree of 
crossreactivity, however, even with the non-protein A S. aureus. 
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 FIGURE 18.  Crossreactivity between ARP antibody and S. aureus. Crossreactivity 
was assessed through ELISA using ARP at 10 µg/ml.    Non-protein A S. aureus ATCC 
10832 and USF 613 Cowen I S. aureus were tested to see if ARP antibody specifically 
bound epitopes on the cell surface of S. aureus or if crossreactivity was due to non-
specific binding of the Fc portion of the antibody to protein A on the cell surface. 
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 Affinity purification of ARP antibodies.  The ARP antibody was affinity purified to 
attempt to improve the sensitivity and specificity of the test assays.  The antibody was 
purified using an affinity column consisting of a gel bed that had oxidized teichoic acid 
from Ent. faecalis cells attached to it.  The column was made according to manufacturer’s 
instructions and the antibody was purified also according to manufacturer’s instructions.  
Figure 19 shows the mean signal to noise ratio obtained on ELISA at various  
Ent. faecalis concentrations.  Affinity purification did not improve the binding affinity of 
the ARP antibody to Ent. faecalis cells. 
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 FIGURE 19.  Affinity purification of ARP polyclonal antibody.  An affinity column 
kit from Pierce was used to create an affinity column conjugated with teichoic acid 
extracted from Ent. faecalis cells.  This column was used to affinity purify polyclonal 
ARP antibody.  A protein A column (Amersham Biosciences) was used to IgG purify the 
ARP antibody as well. 
 
 Varying capture antibody concentration. Various conditions were tested to develop a 
sensitive sandwich immunoassay on the Analyte 2000 biosensor.  Two different ARP 
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capture antibody concentrations of, 100 µg/ml and 200 µg/ml, were tested to determine 
which concentration resulted in optimum capture on the polystyrene waveguides.  The 
mean LOD for the 200 µg/ml assay was 5.1.  The mean LOD for the 100 µg/ml assay was 
16.3.  The mean fluorescence over background of those waveguides incubated with  
200 µg/ml of capture antibody went up with increased cell concentrations; however, the 
signals did not increase logarithmically as was expected in this type of immunoassay 
(Figure 20).  In fact, the signals were very low, even at 108 CFU/ml.  There also was no 
discernible pattern when normalized signals were graphed (Figure 21).   
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 FIGURE 20.  Various antibody capture concentrations for optimization of  
Enterococcus sandwich immunoassay.  Biotinylated ARP antibody was tested at 200 
µg/ml and 100 µg/ml to optimize the sandwich immunoassay.  The mean LODs were 5.1 
and 16.3, respectively. 
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 FIGURE 21.  Normalized values for the mean signals shown in Figure 20.  
Results in Figures 20 and 21 are data obtained from two experiments. 
  
 Varying  detection antibody concentration.  Two different concentrations of ARP 
detection antibody, 20 µg/ml and 40 µg/ml, were tested to try and optimize the biosensor 
immunoassay as well.  The 40 µg/ml detection antibody concentration showed improved 
detection of Ent. faecalis, but only at 108 CFU/ml (Figures 22 and 23).  This still, did not 
improve the sandwich assay sufficiently to develop the assay in this format for screening 
environmental sea water samples.   The mean LOD of the assays tested with 20 ug/ml of 
detection antibody was 26.1.  The mean LOD for the assays tested with 40 ug/ml 
detection antibody was 93. 
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 FIGURE 22.  Determining optimal detection antibody concentration for biosensor 
sandwich immunoassay.  Two concentrations of ARP Cy5 labeled polyclonal antibody 
were tested: 20 µg/ml and 40 µg/ml. Biotinylated capture antibody was used at 100 
µg/ml. Mean fluorescence signals over the limit of detection for each concentration tested 
are represented.  The mean LODs were 26.1 and 93, respectively. 
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 FIGURE 23.  Normalized values for the mean signals shown in Figure 22. 
Figures 22 and 23 are summarized data from two different experiments. 
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 Comparison of broth media and plate media.  Ent. faecalis cells were grown on plate 
media or in broth media and assayed directly on the biosensor to see if the culture 
medium would make a difference in the amount of antigen expressed by the cells that the 
antibody could bind.  The results suggested that the broth culture made a difference in the 
binding of the antibodies to antigenic determinants on the cells, but not significantly 
enough to improve the sensitivity of the sandwich immunoassay (Figure 24).  The cell 
signals were very low.  The mean LOD for the assay was 23.9. 
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 FIGURE 24.  Comparison of biosensor signals when Ent. faecalis cells were grown 
for 18 hours in trypticase soy broth (TSB) vs.trypticase soy agar (TSA).  These results 
were obtained from two replicate experiments. Mean  fluorescence signals over the limit 
of detection for each concentration tested are represented.  This assay was performed 
using a sandwich immunoassay and a polyclonal anti- Strep group D antibody (American 
Research Products) to capture and detect cells of Enterococcus faecalis.  The mean LOD 
was 23.9. 
 
  
 Different antigen preparations tested for assay development.  Various antigen preps 
were attempted to try to optimize the immunoassay and obtain detection of Ent. faecalis 
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within the limits required by the EPA for beach water quality.  Antigen preparations 
attempted included sonication, boiling and freeze-thawing.  The methods for these 
antigen preparations were described in the Materials and Methods.  Boiling the cells was 
the least efficient preparation for improving the immunoassay.  This was most likely due 
to the denaturation of some of the antigenic proteins by the heat (Figure 25).  Freeze-
thawing also showed an improvement, however, sonication showed a drastic 
improvement in sensitivity when screened with ELISA.  The ELISA, however, was not a 
sandwich assay.  The sandwich immunoassay format needed to be tested on the Analyte 
2000 biosensor. 
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 FIGURE 25.  Comparison of antigen preparations for immunoassay optimization.  An 
ELISA was performed to compare three different sample preparations: repeated freeze 
thawing with dry ice and denatured ethanol; boiling for 20 minutes; and sonication for 
10-30 minutes.  Samples were tested in duplicate.  Anti-Strep group D antibody (10 
µg/ml) (American Research Products) was used to test the effect of each sample 
preparation on assay sensitivity.  Sonication of Ent. faecalis cells proved to be the most 
efficient sample preparation. 
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 Sonication and boiling antigen preparation on biosensor sandwich immunoassay.  
Viable and dead cells were assayed on the biosensor to verify results obtained by ELISA.  
Cells were grown on TSA overnight as described in the Materials and Methods and 
resuspended in PBS.  After a 10-fold serial dilution was made, the cells were boiled and 
allowed to cool and then assayed on the biosensor instrument.  Mean signals and 
normalized signals are shown in Figures 26 and 27.  The mean LOD was 48.4.  There 
were minor increases in mean signals over background and the normalized signals, but 
not logarithmic as would be expected with the addition of higher cell concentrations.  
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 FIGURE 26.  Comparison of boiled cells and viable cells for biosensor detection 
using a sandwich immunoassay.  Mean  fluorescence signals over the limit of detection 
for each concentration tested are represented.  Biotinylated polyclonal anti-Strep group D 
antibody (ARP) was used for capture (100 µg/ml) and Cy5 labeled ARP was used for 
detection (20 µg/ml) of Ent. faecalis cells in PBS. The mean LOD was 48.4. 
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 FIGURE 27.  Normalized values for the mean signals shown in Figure 26. 
Figures 26 and 27 are summarized data from four different experiments. 
 
Sonication of Ent. faecalis cells showed improvements in assay sensitivity on ELISA and 
was tested on the biosensor using the sandwich immunoassay.  Sonication showed a 
marked increase in mean fluorescence over the previous signal (Figures 28 and 29).  The 
mean LOD was 15.1.  The sensitivity of the sandwich immunoassay on the biosensor was 
improved by one log concentrations to 107 CFU/ml.  This sensitivity was still not low 
enough for the development of an assay to comply with EPA water quality standards 
using the biosensor alone.  Figures 28 and 29 are summarized data from two different 
experiments. 
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 FIGURE 28.  Sonicated cell preparation used for optimization of biosensor sandwich 
immunoassay.  Mean fluorescence values over the limit of detection for each 
concentration tested are represented.  Biotinylated polyclonal anti-Strep group D 
antibody (ARP) was used for capture (100 µg/ml) and Cy5 labeled ARP was used for 
detection (20 µg/ml) of Ent. faecalis cells in PBS.  The mean LOD was 15.1. 
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 FIGURE 29.  Normalized values for the mean signals shown in Figure 28. 
Figures 28 and 29 are summarized data from three different experiments.  
 Immunodot analysis of sonicated vs. unsonicated cells.  An immunodot was 
performed to verify results obtained from biosensor assays testing the efficacy of 
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sonicating Ent. faecalis cells.  The immunodot showed a distinct difference in antibody 
binding to cells that were sonicated and not sonicated (Figure 30).  The ARP antibody 
binds with greater affinity to sonicated cells, suggesting that the antibody has better 
access to those epitopes such as the group D antigen which is located beneath the cell 
surface. 
 
 
           
 FIGURE 30.  Immunodot analysis of sonicated and unsonicated preparations of  
Ent. faecalis cells in PBS.  Ent. faecalis cells were sonicated for 30 minutes at setting #2 
on the Dismembrator (Fisher Scientific).  Polyclonal ARP antibody was diluted 1:1000 in 
PBS was used for detection. 
 
 SEM analysis.  All SEM analysis was performed by Jay Bieber at the USF College of 
Engineering. Waveguides were prepared as described in Materials and Methods.  The 
waveguides were prepared for SEM by Betty Loramm, USF Department of Biology as 
described in Materials and Methods.  The comparison of sonicated captured cells and 
unsonicated captured cells is obvious.  There are scattered debris and salt deposits on the 
waveguide analyzed with cells that were unsonicated (Figures 31 and 32).  This debris is 
         108            107            106             105           104            103 
 
Sonicated  
 
 
 
 
 
 
 
 
Unsonicated 
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more evident on the waveguide exposed to unsonicated cells, than on the other 
waveguide analyzed.  More efficient capture is obtained on the waveguide allowed to 
react with sonicated cells and further explains the improved assay sensitivity when 
sonication is used for sample preparation  
 
          
 FIGURE 31.  Unsonicated Ent. faecalis cells captured on polystyrene waveguide. 
Biotinylated ARP antibody was used to capture the cells.   
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 FIGURE  32. Sonicated Ent. faecalis cells captured on polystyrene waveguide. 
Biotinylated ARP antibody was used to capture the cells.   
 
 Lectins as capture molecules.  Lectins were tested as capture molecules for 
enterococci on the fiber optic waveguide surface because of their known abilities to 
agglutinate carbohydrate groups on the surface of gram positive cells.  ConA and WGA 
have been observed to agglutinate enterococci and group D streptococci so they were 
chosen as test molecules.  Initial screening with ELISA revealed that ConA cross-reacted 
extensively with the polyclonal anti-strep group D antibody used as the detection 
molecule in the assay.  Antibodies are glycoproteins so this crossreactivity was not 
surprising.  WGA crossreacted to a lesser degree with the ARP antibody and so WGA 
was pursued for use on the biosensor sandwich immunoassay.  Because some cross 
reactivity was also observed between WGA and the Enterococcus antibody, backgrounds 
were performed by running negative samples (sterile PBS) and then the labeled detection 
molecules.  Cy5 labeled primary antibody did not directly detect captured Ent. faecalis 
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cells, so an anti-IgG labeled with Cy5 was used to amplify the signal of antibodies bound 
to cells.  This antibody was diluted 1:1000 in 0.1M PBS.  LODs were calculated as 
described in Materials and Methods.  Using WGA as a capture molecule was successful, 
but not sensitive enough, to improve the efficiency of the sandwich assay.  Sensitivity 
was 2.1 x 108 CFU/ml.  Figures 33 and 34 show the results of four experiments testing 
this WGA as an alternative capture in the sandwich assay.  The mean LOD was 12.5. 
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 FIGURE 33.  WGA as capture molecule for Enterococcus sandwich immunoassay.  
Biotinylated WGA diluted 1:50 was used to capture Ent. faecalis cells.  Mean LOD was 
12.5. 
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 FIGURE 34.  Normalized values for the mean signals shown in Figure 33. 
Figures 33 and 34 are summarized data from four experiments. 
Optimization of Biosensor Indirect Immunoassays for Enterococci 
 EPA standards for recreational water quality require a very sensitive assay for proper 
water quality assessment.  The sandwich immunoassay was optimized, but the sensitivity 
was not adequate to be a feasible test for enumerating indicator organism density in beach 
water.  An indirect assay format (illustrated in Materials and Methods) was optimized as 
an alternative to increase assay sensitivity.  In preliminary experiments, Ent. faecalis cells 
suspended in 0.1M carbonate-bicarbonate buffer (pH 9.3) were assayed to ascertain the 
sensitivity of this type of assay (Figure 35). This format of immunoassay was used to 
screen antibodies using ELISA and the sensitivity of the ARP antibody was found to be 
106 CFU/ml.  Using the same assay principles, this format was tested on a polystyrene 
waveguide on the Analyte 2000 biosensor.  Two polyclonal antibodies were used in the 
assay, one specific to group D streptococci (ARP), and one used for determining 
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background signals which was specific for V. cholerae O1 (Difco Laboratories).  Anti-
rabbit IgG labeled with Cy5 was used to generate a specific signal when excited at  
635 nm.   Figure 35 was generated with data from five experiments and the mean LOD 
was 12.2.   The sensitivity of this indirect immunoassay was 105-106 CFU/ml. 
-1000
0
1000
2000
3000
4000
5000
6000
Neg.
control
10 8^ 10 7^ 10 6^ 10 5^ 10 4^ 10 3^ 10 2^
Ent. faecalis concentration (CFU/ml)
Ent. faecalis cells
in carbonate buffer
(pH 9.3)
   
   
   
 M
ea
n 
si
gn
al
 o
ve
r
   
ba
ck
gr
ou
nd
 (p
A
m
ps
)
 
 FIGURE 35.  Directly adsorbed Ent. faecalis cells in 0.1 M carbonate buffer (pH 9.3).  
Polyclonal ARP antibody (10 µg/ml) was used to detect Ent. faecalis cells in carbonate-
bicarbonate buffer.  Anti-IgG labeled with Cy5 was used to detect ARP antibody bound 
to the target antigen.  Mean LOD was 12.2. 
 
Ent. faecalis cells were also tested in filter-sterilized seawater (Figure 36).  A negative 
control was tested to assure that there was no inherent or background fluorescence from 
the seawater.   Figure 36 is summarized data from three different experiments and the 
mean LOD was 13.6.  The sensitivity in seawater, detection of 106 CFU/ml, was 
comparable to that in sterile carbonate-bicarbonate buffer (pH 9.3). 
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 FIGURE 36.  Directly adsorbed Ent. faecalis cells in seawater.  Polyclonal ARP 
antibody (10 µg/ml) was used to detect Ent. faecalis cells in carbonate-bicarbonate 
buffer.  Anti-IgG labeled with Cy5 was used to detect ARP antibody bound to the target 
antigen.  Mean LOD was 13.6. 
  
Table 12 shows the mean signals from five experiments where Ent. faecalis cells in 
seawater were directly adsorbed to the waveguide.  In four out of four experiments, 
positives signals were seen when negative samples were assayed on the biosensor. This 
was probably due to nonspecific binding of the detection antibody to the waveuide.  
These false positives were very close to signals generated by the 105 concentrations 
tested so positive signals were not significant until 106 CFU/ml.   
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 TABLE  12.  Comparison of mean signals from five biosensor experiments. 
 
 
aStandard deviation 
 Incubation times were also tested to try and shorten the time required for cells in 
carbonate-bicarbonate buffer (pH 9.3) to adsorb to the polystyrene waveguides.  Figure 
37 shows summarized data obtained from four experiments and the mean LOD was 33.6.  
High concentrations still gave strong positive signals with as short an incubation time as 
30 minutes (Figure 37).   Table 13 shows the mean signals from those 4 experiments. 
False positive were seen in three out of four control samples and because the mean 
signals at 105 were so close to the false positives, the sensitivity of this assay was 106 
CFU/ml.  This assay improved the overall sensitivity of the Enterococcus assay by one 
log concentration, however, the assay was still not sensitive enough to detect enterococci 
from the environment directly.  The sensitivity, detection of 106 CFU/ml, in both matrices 
was comparable to that on ELISA. 
 
 Avg. CFU/ml Mean signal         SDa                        Number of  
          (pAmps)     positive  
        samples/ 
                                                                                                                      total number
                                                                                                                         of samples 
        0 56.6 50.5 4/4 
  3.1 x 105 23.8 22.1 0/5 
  3.1 x 106 162.4 73.3 2/2 
  3.0 x 107 395.2 131.1 2/2 
  4.7 x 108 7053.9 4121.4 5/5  
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 FIGURE 37.  Ent. faecalis cells directly adsorbed to a polystyrene waveguide after a 
30 minute incubation at 36°C.  Polyclonal ARP antibody (10 µg/ml) was used to detect  
Ent. faecalis cells in carbonate-bicarbonate buffer.  Anti-IgG labeled with Cy5 was used 
to detect ARP antibody bound to the target antigen. 
 
Table 13 shows the mean signals from four experiments where Ent. faecalis cells in 
carbonate- bicarbonate buffer (pH 9.3) were incubated at 36°C for 30 minutes.  The same 
results were observed in these assays that were observed in the seawater assays.  Signals 
at 105 CFU/ml were very close to the false positives which were observed.  Positive 
detection was obtained at 106 CFU/ml. 
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 TABLE  13.  Mean signals from four experiments where Ent. faecalis cells were 
incubated at 36°C for 30 minutes. 
 
a Standard deviation 
Concentration of 20 Liter Volumes of Water 
 Twenty liter water samples were concentrated according to the method of Simmons  
et al (234).  Hollow fiber filter concentration was used to enhance the sensitivity of the 
bioassay.  Preliminary experiments were performed in 20 liter volumes of sterile water to 
assess the recovery efficiency of the filter and also to see if samples could be 
concentrated sufficiently to detect enterococci directly on the biosensor following 
filtration (Table 14). 
 
 
 
 
 
 
 
 
 
 Avg. CFU/ml Mean signal          SDa          Number of positive   
           (pAmps)                                    samples/ total  
                                                                                                          number of samples  
     0 74.5 59.5 3/4 
  5.6 x 105 128.6 75.7 4/4 
  5.6 x 106 994.0 358.6 4/4 
  5.6 x 107 3695.7 2257.7 4/4 
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 TABLE 14.  Recovery of Ent. faecalis cells when concentrated with hollow fiber 
filter. 
 
a. Experiment was performed with an environmental seawater sample.  Counts were 
obtained from the Florida Department of Health Tampa Branch Laboratory.    
 
The mean recovery using the Fresensius hollow fiber filter was 89.6%.  The lower the 
cell concentration, the more erratic the recovery became.  This was especially the case 
when a concentration of ~ 1 CFU/ml was filtered.  Overall, this process concentrated 
water samples 100-fold.  This improved assay sensitivity, but an enrichment step was 
needed to further enhance assay sensitivity. 
Growth Curve Experiments and Enrichment of Enterococci 
 To enhance the sensitivity of the biosensor assay, an enrichment step was added to 
the method along with concentration.  Initial experiments for enrichment of Ent. faecalis 
were performed in bile esculin azide broth.  This selective enrichment broth, however, 
did not prove sufficiently selective for use with actual beach water samples.  mE broth 
Concentration Concentration  Eluted volume % Recovery
in 20 L (CFU/ml)  after filtration  (mls) 
      (CFU/ml)  
 2.6 x 104 2.6 x 106 225 109 
 3.6 x 104 3.0 x 106 185 76.4 
 3.3 x 104 3.3 x 106 210 105 
 3.0 x 104 2.0 x 106 230 76.7 
 2.3 x 104 1.3 x 106 208 60 
 2.7 x 104 2.7 x 106 268 133 
 255 3.0 x 104 198 116 
 225 1.7 x 104 230 86.9 
 210 2.0 x 104 182 86.7 
 375 2.3 x 104 105 32 
 269 1.6 x 104 230 72.5 
 480 6.0 x 104 170 106 
 2.1  32 180 13 
 1.8  200 226 125 
 1  200 226 214 
 4.8  100 244 25 
 .08  10 138 86a 
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was used to perform the rest of the enrichment experiments.  The mean generation time 
of Ent. faecalis in mE broth was 40.5 minutes.  The growth curve was performed as 
described in the Materials and Methods and the results appear in Figure 38. 
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 FIGURE 38.  Growth curve of Ent. faecalis in mE enrichment broth.  Based on this 
growth curve, the mean generation time for Ent. faecalis in mE broth was 40.5 minutes. 
 
Concentration, Enrichment, and Biosensor Detection 
 Seawater samples were processed in 20 liter volumes on Tuesdays when the Pinellas 
County Department of Health (DOH) also tested water from this same beach (Courtney 
Campbell Causeway beach, Clearwater, FL).  Initial counts were obtained from David 
Wingfield at the Florida Department of Health Tampa Branch Laboratory.   A guide was 
developed similar to what is used in Pinellas County for gauging the quality of beach 
water based on established EPA guidelines.  The Pinellas county guidelines are listed in 
Table 15. 
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 TABLE 15.  Pinellas County Health Department/EPA water quality criteria. 
a These criteria were derived from standard set by the U.S. Environmental Protection  
   Agency. 
 
A similar guideline to that described above was created to gauge water quality based on 
enrichment times and biosensor detection.  Seawater samples were processed as 
described in the Materials and Methods.  Following concentration with a hollow fiber 
filter, samples were enriched in 50 ml of mE broth.  Samples were taken at key time 
intervals for detection on the biosensor and also to perform a viable count.  Based on 
these data a guide was developed to determine the water quality of unspiked samples.  
The guide consisted of three parts, Good quality water, Moderate quality water, and Poor 
quality water, similar to the Pinellas County method.  These categories were established 
based on the time it took for a sample to enrich to 106 CFU/ml (the limit of detection for 
the indirect immunoassay on the biosensor) where there should also be positive detection 
on the biosensor.  That general guideline is listed in Table 16 for this integrated method 
for determining water quality. 
 
 
 
 
 
                      Pinnellas County Water Quality Guidelines for Enterococcia 
Good   0-34 CFU/100 ml 
Moderate  35-104 CFU/100ml 
Poor  > 105 CFU / 100 ml 
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 TABLE 16.  Biosensor/ enrichment criteria for determining water quality. 
 a In two out of three experiments, positive detection was observed after 14 h of    
        enrichment in mE broth.  In one of the replicate experiments, detection was  
        observed at 14 h. 
 b In two out of three experiments, positive detection was observed between 12-14 h of    
  enrichment in mE broth. One of the replicate experiments, detection was not     
  observed until14 h of enrichment. 
 c In three out of three experiments, positive detection was observed between 8-10 h  
       of enrichment in mE broth.  
 
All experiments to create these guidelines were performed in triplicate in sterile water 
and in simulated sea water (Instant Ocean, 3.5% in DI H2O).  Results were the same in 
both matrices. 
 Experiments for determining criteria for Good quality water samples.  Sterile water 
was spiked with a concentration of Ent. faecalis cells that would give an approximate 
count equal to what the Pinellas County Health Department considers good quality water 
(0-34 CFU/100 ml of enterococci).  The process was performed as described in Materials 
and Methods.  Three experiments were performed and the results of those experiments 
are listed in Table 17.      
 
 
 
 
 
Category Viable counts                    Enrichment time needed  
                                                                                        for positive biosensor detection
 
Good  106 CFU/ml over 14 hoursa 
Moderate 106 CFU/ml 12-14 hoursb 
Poor 106 CFU/ml 8-10 hoursc 
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 TABLE 17.  Experiments for the development of criteria to measure Good quality 
water.           
     
a Limit of Detection 
b N/A= samples were not assayed on the biosensor. 
c Negative control consisted of uninoculated mE broth which was allowed to react 
with the polystyrene waveguides at 36°C for the same amount of time as the samples. 
d False positives were seen for negative controls.  Positives had to be higher than the  
   LOD and higher than the negative control. 
 
Time points were judged based on viable counts and if positive detection was observed 
when counts reached the biosensor’s limit of detection (106 CFU/ml).  Those points are 
boldfaced in the Table 17.  To be considered a positive result, not only did the signal 
have to be higher than the LOD, but it also had to be higher than the false positive 
observed for the negative control.  The mean LOD was 20.8 + 15.2.  The mean recovery 
was 72%.  Two times out of three, it required over 14 hours to enrich a concentration this 
low (~0.01 CFU/ml) to obtain the minimum CFU/ml (106 CFU/ml) required for positive 
Experiment Time point       Viable count LODa     Biosensor signal 
       (hrs)             (CFU/ml)     (pAmps)                (pAmps) 
  
 1 8 2.3 x 103 N/Ab N/Ab 
 (5 CFU/ 10 7.8 x 103  12.6 8.0 
 100 ml) 12 2.4 x 104 N/Ab N/Ab 
  14 2.0 x 105 16.4 68.3 
  72 1.6 x 108 21.4 3579.9 
   Neg. controlc 53.1 179.3d 
  
 2 10 2.8 x 103 4.2 24.7 
(3 CFU/ 12 5.0 x 103 N/Ab N/Ab 
100 ml) 14 6.1 x 104 18.7 23.2 
  24 1.7 x 107 13.6 573.3 
   Neg. Controlc 5.5 48.7 d 
  
 3 10 7.2 x 104 12.4 35.8 
(3 CFU/ 12 1.6 x 106 N/Ab N/Ab 
100 ml) 14 9.6 x 106 14.3 379.4 
  24 2.6 x 109 32.8 5512.8 
   Neg. controlc 44.9 139.1 d 
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detection on the Analyte 2000 biosensor.  The growth rate for Ent. faecalis was 
calculated to observe any discrepancies in growth due to differences in initial inoculum 
between the three categories.  The mean growth rate for these experiments was calculated 
to be 43.6 + 2.6 minutes.  All of these data were used to establish criteria for the Good 
category of water quality developed in this method. 
 Experiments for determining criteria for Moderate quality water samples.  Sterile 
water was spiked with a concentration of Ent. faecalis cells that would give an 
approximate count equal to what Pinellas County Health Department considers moderate 
quality water (35-104 CFU/100 ml of enterococci).  The process was performed as 
described in Materials and Methods.  Three experiments were performed and the results 
of those experiments are listed in Table 18.       
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 TABLE 18.  Experiments for the development of criteria to measure Moderate quality  
water.               
 
     a Limit of Detection 
    b Negative control consisted of uninoculated mE broth which was allowed to react     
      with the polystyrene waveguides at 36°C for the same amount of time as the samples. 
     c  False positives were seen for negative controls.  Positives had to be higher than the     
       LOD and higher than the negative control. 
   d   N/A= samples were not assayed on the biosensor. 
   e Results fit into Good category, but this experiment was done as part of moderate 
quality experiments. 
 
When an initial inoculum of ~0.1 CFU /ml was tested, two out of three experiments 
showed that 12-14 hours of enrichment was required to obtain the minimum 
concentration of Ent. faecalis (106 CFU/ml) to get positive detection on the Analyte 2000 
biosensor.  Those time points are boldfaced in Table 18.   Again, to be considered a 
positive result, the signal had to be higher than the LOD and higher than the false positive 
observed for the negative control.  The mean LOD was 30.9 + 16.6.  The mean recovery 
was over 100%.  The mean growth rate of Ent. faecalis in this set of three experiments 
Experiment Time point       Viable count LODa Biosensor signal  
       (hrs)             (CFU/ml)     (pAmps)           (pAmps) 
  
 1 10 5.1 x 105 9.8 33.9 
 (71 CFU/ 12 2.9 x 106 42.5 308.6
 100 ml) 14 1.6 x 107 24.9 781.9 
  24 2.5 x 109 31.2 5280.2 
   Neg. controlb 50.2 135.9c 
  
 2 10 1.1 x 105 8.9 24.9
 (48 CFU/ 12 4.9 x 105 N/Ad N/Ad 
 100 ml) 14 4.4 x 106 7.0 167.5 
  36 2.0 x 107 34.6 5595.2 
   Neg. controlb 47.3 136.2c 
  
 3 10 2.0 x 103 13.0 11.5 
 (32 CFU/ 12 6.4 x 104 N/Ad N/Ad 
 100 ml)e 14 1.1 x 105 33.9 32.1 
  36 1.7 x 108 52.2 3950.9 
   Neg. controlb 46.1 158.7 c 
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was calculated as 46.9 + 3.2 minutes.  This data was used to establish criteria for samples 
of moderate quality using concentration, enrichment and biosensor detection. 
 Experiments for determining criteria for Poor quality water samples.  Sterile water 
was spiked with a concentration of Ent. faecalis cells that would give an approximate 
count equal to what Pinellas County Health Department considers poor quality water 
(>105 CFU/100 ml of enterococci).  The process was performed as described in Materials 
and Methods.  Three experiments were performed and the results of those experiments 
are listed in Table 19.        
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 TABLE 19.  Experiments for the development of criteria to measure Poor quality 
water.               
 
a  Limit of Detection 
b  N/A= samples were not assayed on the biosensor. 
      c   Negative control consisted of uninoculated mE broth which was allowed to react     
         with the polystyrene waveguides at 36°C for the same amount of time as the      
         samples. 
d  False positives were seen for negative controls.  Positives had to be higher than the  
    LOD and higher than the negative control. 
 
When an initial inoculum of ~1 CFU/ml was tested, three out of three experiments 
showed that 8-10 hours of enrichment was required to obtain the minimum concentration 
of Ent. faecalis (106 CFU/ml) to get positive detection on the Analyte 2000 biosensor.  
Those time points are boldfaced in Table 19.   To be considered a positive result, the 
signal had to be higher than the LOD and higher than the false positive observed for the 
Experiment Time point       Viable count LODa Biosensor signal  
       (hrs)             (CFU/ml)      (pAmps)                 (pAmps) 
  
 1 5 1.4 x 104 N/Ab N/Ab 
 (180 CFU/ 6 4.5 x 104 N/Ab N/Ab
 100 ml) 7 1.1 x 105 N/Ab N/Ab 
  8 3.7 x 105 N/Ab N/Ab 
  9 6.1 x 105 N/Ab N/Ab 
  10 1.7 x 106 14.1 268.1 
  24 3.9 x 108 39.3 4185.5 
   Neg. control c 36.3 107.4 d 
  
 2 8 2.2 x 106 41.6 318.8 
 (600 CFU/ 10 2.6 x 107 40.8 2993.8 
 100 ml) 24 1.1 x 109 46.3 4923.3 
   Neg. control c 20.3 104.6 d 
  
 3 8 1.0 x 106 13.1 66.7 
 (330 CFU/ 10 5.4 x 106 11.2 191.6 
 100 ml) 36 3.0 x 107 74.6 4698 
   Neg. control c 50.1 97.9 d 
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negative control. The mean recovery was 148% and the mean LOD was 35.3 + 19.3.  The 
mean growth rate of Ent. faecalis in this set of three experiments was calculated as  
43.3 + 8.4 minutes.  These data were used to establish criteria for samples of poor quality 
using concentration, enrichment and biosensor detection.  In all the experiments 
performed, the growth rates were similar.  Of note is the false positives seen with the 
negative control waveguides.  The backgrounds were taken using a primary antibody 
other than the anti-Strep group D polyclonal antibody.  A Difco anti-V. cholerae O1 
polyclonal antibody was used to ascertain all background noise which the Cy5 labeled 
anti-IgG would give due to non-specific binding. While the anti-V. cholerae antibody did 
not seem to show affinity to any of the media components or non-specifically adhere to 
the polystyrene waveguide, the anti-Strep group D antibody did show some nonspecific 
activity leading to higher background signals and false positive when allowed to react 
with the secondary antibody.   
 While this water quality guide is only semi-quantitative, it definitively distinguishes 
between Good and Poor quality of water very well.  A draw back to the method is that the 
geometric mean, which is routinely calculated by the Pinellas County Department of 
Health, cannot be calculated based solely on this method because it is semi-quantitative.  
Initial counts for all these experiments were obtained from viable counts on TSA before 
spiking 20 L of sterile water in a carboy, but in blind samples, the water would just be 
processed to observe in what category the water would fall into (23).  This category as 
explained previously would be an estimate of the counts that are truly present in the 
water.  Criteria for closing a beach not only rely on the three categories mentioned 
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previously, but also on the calculated geometric mean which takes into account specific 
counts from the previous five sampling weeks.  If the geometric mean exceeds  
35 CFU/100 ml, than the beach is posted and warnings are sent out to the news media and 
posted on the county website and at the beach.  This method would be a very good 
preliminary screening tool and results would be obtained faster than the standard methods 
which can require biochemical confirmation to assert the presence of fecal enterococci. 
 Unspiked 20 liter volumes of seawater. Samples of unspiked seawater were assayed 
as described in Materials and Methods.  Table 20 shows the results of three 
environmental seawater samples which were processed using the integrated 
biosensor/concentration/enrichment method. 
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 TABLE 20.  Results from environmental samples tested using integrated biosensor 
method. 
 
a  Limit of Detection 
b  N/A= samples were not assayed on the biosensor. 
      c   Negative control consisted of uninoculated mE broth which was allowed to react   
         with the   polystyrene waveguides at 36°C for the same amount of time as the  
         samples. 
d   False positives were seen for negative controls.  Positives had to be higher than the  
    LOD and higher than the negative control. 
 e Water sample falls into good category according to counts and biosensor        
        detection.  Also matches good category in Pinellas county guidelines. 
 f Water sample falls into good category according to Pinellas county guidelines.    
        According to counts and biosensor data, it falls into the moderate water quality   
        category. 
 g  Water sample falls in moderate category for both Pinellas county guidelines and   
         biosensor detection. 
 h Counts obtained from the Department of Health 
 i   Filtration counts on mEI performed in the lab. 
Experiment Time point      Viable count LODa Biosensor signal  
       (hrs)             (CFU/ml)     (pAmps)           (pAmps) 
  
 1e 8    N/Ab N/Ab N/Ab 
 (6 CFU/ 10 6.0 x 103 N/Ab N/Ab
 100 ml)h 12 3.0 x 104 35.0 -2.2 
   (9 CFU/ 14 4.8 x 105 35.4 -3.3 
    100 ml)i 16 2.3 x 106 N/A N/A 
  24 6.1 x 108 58.0 777.5 
    
 2f 8     N/Ab N/Ab N/Ab 
 (4 CFU/ 10 2.4 x 105 N/Ab N/Ab 
 100 ml)h 12 1.2 x 106 75.0 37.7 
 (69 CFU/ 14 1.0 x 107 218.9 403.3 
  100 ml)i 16 2.6 x 108 -39.1 4028 
   Neg. controlc 13.7 104 d 
  
 3g 10 2.6 x 105 -26.5 -28.7 
 (60 CFU/ 12 6.4 x 106 422.9 282.2 
 100 ml)h 14 7.0 x 106 79.0 138.5 
   (43 CFU/ 16 3.9 x 197 N/Ab N/Ab 
 100 ml)i 18 1.4 x 108 N/Ab N/Ab 
   Neg. control c 15.5 29.7 d 
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Two out of three times, the method correctly correlated the growth of fecal enterococci in 
mE enrichment broth to the actual density of the organisms in beach water.   The mean 
recovery was 71.5% and the mean LOD was 80.7 + 132.5.  The mean growth rate was 
46.3 + 1.1.  The increased growth rate is expected as the cells from environmental 
samples are stressed and then undergo further stress through filtration with the hollow 
fiber filter.  In all unspiked samples, representative colonies with blue halos on mEI were 
confirmed by inoculating into brain heart infusion broth with 6.5% NaCl and streaking 
onto bile esculin azide agar.  These isolates were identified using API Strep and a 
biochemical key that was put together by Manero (171).  The predominating species 
identified were Ent. faecium and Ent. faecalis. The yellow bacterium Ent. casseliflavus 
was found only occasionally.  Two red colonies which resulted on mEI in one of the 
experiments were not able to be identified through API Strep and these results remained 
inconclusive.  In one of the experiments, one red colony was found to grow which had no 
blue halo on mEI.  This isolate was identified as Aerococcus viridans.  In experiment 3, 
Vibrio alginolyticus thrived in the mE enrichment broth along with the enterococci.  This 
was only found to happen in this experiment.  V. alginolyticus was assayed on the 
biosensor and with ELISA to check for crossreactivity with the anti-Strep group D 
antibody.  This organism was not found to crossreact significantly.  The fact that this 
organism grew in the mE broth which contained nalidixic acid was surprising considering 
that this organism is very susceptible to this antibiotic.  An experiment performed on 
isolates of V. alginolyticus isolated from marine water from Indonesia showed that 1.3 % 
of the strains recovered were resistant to nalidixic acid (183).  The high pH (9.3) of the 
medium did not present an obstacle as vibrios are known to thrive in alkaline 
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environments.  The recovery from the filtration of the water sample was erratic between 
experiments including those used to create this water quality guideline.  While unusual, 
preliminary experiments where low concentrations of enterococci were concentrated also 
showed these fluctuations.  At higher concentrations, the loss is less evident and may 
account for the greater and more consistent recovery.  This unusual recovery was seen in 
all concentrations with a low starting bacterial concentration.   
Isolation of E. coli O157:H7 in seawater.   
 Seawater samples were analyzed and enriched for E. coli O157:H7 as described in 
Materials and Methods.  Samples were analyzed from two beaches and no isolates were 
found to be E. coli O157:H7.  Any suspect isolates of E. coli O157:H7 which were 
sucrose negative on CT-SMAC were identified through API.  These isolates were found 
to be either non- O157:H7 E. coli or Klebsiella spp. 
Biosensor Immunoassays for the Detection of E. coli O157:H7 in Seawater. 
 Previous work by DeMarco and Lim showed that the KPL affinity purified polyclonal 
antibody against E. coli O157:H7 was only mildly crossreactive with one other organism, 
Escherichia hermanii (63, 64).   Assays were performed as described in Materials and 
Methods using the sandwich immunoassay.  The data in Figures 39 and 40 are results 
from seven different experiments.  The mean LOD was 69.5.  Detection in seawater was 
comparable to detection in 0.01M PBS (pH 7.4).  Sensitivity in PBS and seawater was 
3.6 x 105 CFU/100 ml.   
 
 
 
 128 
 
-200
0
200
400
600
800
1000
1200
1400
1600
Neg
control
10 6^ 10 5^ 10 4^ 10 3^ 10 2^
E. coli  O157:H7 concentration (CFU/ml)
E.coli O157:H7 in
PBS
E. coli O157:H7 in
seawater
M
ea
n 
si
gn
al
s 
ov
er
 b
ac
kg
ro
un
d
   
   
   
   
   
  (
pA
m
ps
)
 
 FIGURE 39. Detection of E. coli O157:H7 in PBS vs. seawater.  A sandwich 
immunoassay format was used to detect E. coli O157:H7 in seawater.  Biotinylated KPL 
polyclonal antibody (100 µg/ml) was used to capture.  Cy5 labeled KPL (10 µg/ml).   
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 FIGURE 40.  Normalized values for the mean signals shown in Figure 39. 
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Isolation of V.cholerae from Seawater 
 A total of 128 isolates were recovered from seawater by isolation on TCBS agar as 
described in Materials and Methods.  Any organisms that were yellow and 2-3 mm in 
diameter on TCBS agar were restreaked onto TSA and further analyzed.  After gram stain 
and oxidase test, the organisms were examined using the two test method developed by 
Chopun et al. (46).  The organisms were inoculated into iron esculin medium and 
arginine dihydrolase broth.  One drawback to the two test method was the difficulty in 
interpreting the iron esculin hydrolysis test as described by Chopun et al.  The black 
precipitate which formed from esculin hydrolysis could also be the result of melanin 
production.  This was sidetstepped by checking for fluorescence of esculin under UV 
light which resulted from hydrolysis.   While this made interpretation easier, it was still 
difficult to interpret tubes which were completely black.  Negative results in both of these 
test lead to further identification through the API test.  Table 21 compares the three 
methods used to identify V. cholerae in this study. 
 TABLE 21.  Comparison of three methods for the identification of V. cholerae 
isolates. 
 
 a Using the 2-test method, 121 out of 127 isolates obtained from environmental samples 
were identified as V. cholerae. 
b  87 out of 127 isolates obtained from environmental samples were identified as V. 
cholerae  through API. 
c  67 out of 127 isolates obtained from environmental samples were identified as V. 
cholera. 
   Two-test method a  API ID b PCR c 
______________________________________________________________________
Number of        Number other/        Number            Number other/        Number of 
V. cholerae /      total number          V. cholerae/       total number           V. cholerae/
total number     of isolates               number of         of isolates                 number of  
of isolates                                          total isolates                                       total isolates
 121/127 6/127 87/127 40/127 67/127 
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Some of the isolates identified which were sucrose negative included V. vulnificus and V. 
parahaemolytcus.  These isolates were included in the final count of isolates and were 
API identified, but were not assayed through PCR or the two-test method.  All sucrose 
positive isolates were identified through API even if the two-test method results 
suggested a microorganism other than V. cholerae.  Many of the isolates which may have 
been considered V. cholerae from using just the two-method test were, in fact, identified 
as Vibrio alginolyticus when assayed using an API test strip.  V. alginolyticus is sucrose 
positive and also negative for arginine dihydrolase and iron esculin hydrolysis.  Another 
sucrose positive organism isolated was identified as Aeromonas hydrophila through API.  
This isolate, however, gave the expected results for arginine dihydrolase (+) and iron 
esculin hydrolysis (+) in the two test method.  In some instances the API results 
suggested A. hydrophila Group II and V. alginolyticus as alternatives if the isolate 
assayed was not V. cholerae.  In these cases, the isolate was identified through PCR along 
with other isolates which were identified as V. cholerae at greater confidence levels (95% 
and greater) through API.   When assayed through PCR by amplifying the ITS region of 
the 16S-23S rRNA sequence of V. cholerae, a total of 67 isolates from the 127 isolated 
from the two beaches tested resulted as being V. cholerae (Table 21).  This result was 
confirmed by the presence of the 300 bp fragment upon gel electrophoresis.  Figure 41 
shows the typical results of five isolates assayed by PCR and gel electrophoresis.  Four 
out of the five isolates assayed were confirmed as V. cholerae.  All other isolates were 
assayed the same way.  All confirmed V. cholerae isolates were non-O1 strains of V. 
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cholerae as confirmed through slide agglutination with Difco polyclonal anti-V. cholerae 
O1 polyclonal serum. 
                                      1        2         3        4        5        6        7         8 
              
 
 
 
 
 
 
  
 FIGURE 41. Summary of PCR results for the identification of V. cholerae  
environmental isolates obtained from two Tampa Bay beaches. 
 
Specificity Studies for V.cholerae Detection 
 Five different antibodies were tested for purposes of biosensor assay development.  
One monoclonal and four polyclonal were tested against V. cholerae O1 whole cells 
(Figure 42).  The Austral Biologicals monoclonal and the Difco polyclonal outperformed 
all the other antibodies tested.  The Difco polyclonal was chosen for use on the biosensor 
Lane 1- 1 Kb Marker (Bench Top PCR marker) 
Lane 2 - Negative control, sterile H2O 
Lane 3 – Positive V. cholerae O1 (CDC E5906-1018) 
Lane 4 – Isolate USF 877 from N. Shore beach 
Lane 5 – Isolate USF 878 from N. Shore beach 
Lane 6 – Isolate USF 879 from N. Shore beach  
Lane 7 – Isolate USF 880 from N. Shore beach 
Lane 8 – Isolate USF 883 from Courtney Campbell beach 
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due to its higher affinity for lower concentrations of V. cholerae O1 cells and the lower 
cost.   
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 FIGURE 42. Comparison of commercial polyclonal antibodies for V. cholerae 
detection on ELISA.  All antibodies were assayed as whole serum diluted 1:500 in PBS.  
A signal to noise ratio above 2.0 was necessary for a value to be considered positive. 
 
Several organisms were assayed for specificity against the Difco polyclonal antibody 
against V. cholerae O1 using ELISA (Table 22).   
 
 TABLE 22.  Organisms tested for crossreactivity with Difco polyclonal V. cholerae 
antibody through ELISA. 
 
 
a A signal to noise ratio above 2.0 was required for the ELISA to be considered positive. 
  Microorganism                   Signal to noise ratioa       Concentration needed  
       for (+) signal 
                                                                                                             (CFU/ml) 
Aeromonas hydrophila (USF 530) 2.0  2.2 x 107 
E.coli ATCC  29417  2.8  2.6 x 108 
Salmonella typhimurium (USF 515)  4.8   4.3 x 108 
V. cholerae O1  (CDC E5906-1018)  2.0   2.2 x 105 
Pseudomonas aeruginosa (USF 620)  N/A      N/A 
Vibrio alginolyticus (USF 516)   3.5   8.4 x 106 
V. cholerae O139 (CDC 2412-93)  3.3   3.7 x 109 
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Several of the organisms tested did crossreact with the Difco polyclonal.  The majority of 
the organisms only crossreacted at high concentrations.  Vibrio alginolyticus crossreacted 
to a greater degree.  This crossreactivity could be problematic considering how prevalent 
V. alginolyticus is in marine waters. 
Different Sample Preparations for V. cholerae Immunoassay Optimization  
 Different sample preparations were also tested for assay optimization.  Cells of 
V.cholerae were tested untreated, boiled for 20 minutes, or sonicated for 10-20 minutes.  
Boiled cells suspensions were compared to untreated cell suspensions using ELISA 
(Figure 43). 
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 FIGURE 43. Detection of viable V. cholerae cells and boiled V. cholerae cells.  Cells 
were boiled for 20 minutes and allowed to cool before assaying through ELISA. Difco 
polyclonal anti-V. cholerae O1 antibody (10 µg/ml) was used to test the different cell 
preparations. 
 
Boiled cells showed much stronger fluorescence readings than untreated cells.  
Sonication was compared to boiling on the biosensor to see if sensitivity could further be 
enhanced (Figure 44 and 45).  These data are results from 3 experiments.  Boiling still 
appeared to be the best sample preparation method for V. cholerae O1 assay 
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development. The mean LOD was 30.8.  The assay sensitivity for this assay was 1.6 x 109 
CFU/ml. 
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 FIGURE 44.  Detection of boiled and sonicated V. cholerae cells.  A sandwich 
immunoassay format was used to detect V. cholerae O1 cells on the biosensor.  Mean 
fluorescence over the limit of detection for each concentration tested is represented.  
Biotinylated Difco polyclonal antibody (100 µg/ml) was used to capture cells.  Cy5 
labeled Difco polyclonal antibody (10 µg/ml) was used to detect the captured cells.  Mean 
LOD was 30.8. 
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 FIGURE 45.  Normalized values for the mean signals shown in figure 44. 
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Isolation of S. aureus  from Seawater 
 Samples of seawater from North Shore beach and Courtney Campbell Causeway 
beach were collected, filtered and enriched for the presence of S. aureus as described in 
Materials and Methods.  Briefly, 100 ml samples (diluted and undiluted) were filtered 
through a 0.45 µm filter and the filter was placed onto Baird Parker agar.  Any black 
colonies were gram stained and then further tests were performed to identify any 
potential S. aureus isolates.  Only 12 isolates were identified as S. aureus and stored in 
glycerol and TSB at -80 °C. 
Specificity Assays for S. aureus Detection 
 Two antibodies were tested for purposes of assay development.  A polyclonal rabbit-
anti-S. aureus antibody from Maine Biotechnology Services Inc and a monoclonal 
antibody against peptidoglycan from Chemicon International, Temecula CA were tested 
against viable and dead cells of S. aureus (Figure 46).  These tests were performed by Dr. 
Marianne Kramer, University of South Florida, Tampa, FL.  The monoclonal antibody 
did not show good affinity for S. aureus.  Based on these results, further specificity 
studies were performed using the Maine Biotechnology polyclonal antibody. 
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 FIGURE 46.  Screening of S. aureus commercial antibodies.  Cells were boiled for 20 
minutes and allowed to cool before assaying with ELISA. All antibodies were assayed at 
10 µg/ml. 
 
The Maine Biotechnology polyclonal antibody was tested for crossreactivity with other 
species of Staphylocococcus (Figure 47) using ELISA.  A signal to noise ratio over 2 was 
considered a positive result.  All the organisms tested were crossreactive with this 
polyclonal antibody; however, S. aureus gave much stronger signals.  This antibody was 
used to develop the biosensor assay for S. aureus. 
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 FIGURE 47.  Crossreactivity studies with other Staphylococcus species.  The Maine 
Biotechnology polyclonal aantibody was tested at 10 µg/ml on ELISA.  A signal to noise 
ratio over 2.0 was required for a value to be considered positive. 
 
Biosensor Sandwich Immunoassays for S. aureus.   
 Waveguides were prepared as described in Materials and Methods.  The Maine 
Biotechnology polyclonal antibody used in the biosensor assay for S. aureus failed to 
detect S. aureus to any degree.  Figure 48 and 49 is data from three different experiments.  
The mean signals did not increase in proportion to the increase in cell concentrations 
assayed and no detection of S. aureus was observed at any concentration (Figure 48).  
The mean LOD was 68.2.  Normalized signals failed to show any distinctive pattern of 
detection either (Figure 49).  This assay was not pursued any further due to the lack of a 
high affinity antibody. 
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 FIGURE 48. Detection of S. aureus using biosensor sandwich immunoassay.  Mean  
fluorescence (pAmps) over the limit of detection for each concentration tested are 
represented.   
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 FIGURE 49.  Normalized values for the mean signals shown in figure 48. 
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DISCUSSION 
 The U.S. Environmental Protection Agency has set forth strict guidelines with respect 
to recreational water quality and the degree of contamination which is permissible.  Fecal 
indicator bacteria provide an estimation of the amount of feces in the water, and 
indirectly, the presence and quantity of fecal pathogens in the water. Enterococci have 
been recommended as one of the most accurate indicators of seawater quality.  In 
accordance with EPA regulations, a single sample containing >105 CFU/100ml  
(~1 CFU/ml) of enterococci is indicative of a high degree of fecal contamination and, 
therefore, could pose a dangerous threat to the health of the swimming public (261).  This 
danger is not due to the presence of enterococci, which can be pathogenic themselves, but 
more so because the presence of this particular bacterium indicates the possibility that 
other, more pathogenic bacteria and viruses of fecal origin could be present in the water 
as well.   
 Indicator organisms, particularly E. coli, have been assayed for over a century to 
assess water quality because these organisms are consistently found in the feces of 
warmblooded animals.  In the infancy of the science of waterborne diseases, a test for 
specific pathogens such as V. cholerae did not exist. Since Escherich’s discovery of the 
abundance of E. coli in fecal matter, contaminated water has been analyzed by assessing 
concentrations of fecal indicator bacteria (79).  Presently, assays for indicator organisms 
are routinely performed and preferred to assays for pathogenic microorganisms because 
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they are easy, inexpensive, do not require skilled personnel and depending on the 
indicator, and indicator bacteria densities have been found to correlate with the incidence 
of bather illness.  There are several emerging and reemerging waterborne pathogens that 
are becoming of increasing public health concern.  Many of those bacteria, viruses, and 
protozoans were listed in Table 4.  While assays for indicator organisms are convenient 
and easy, they are a preventative measure and tests for pathogenic microorganisms are 
also necessary, especially when a waterborne disease outbreak occurs. Such was the case 
in New Orleans during recent Hurricane Katrina where cases of Vibrio vulnificus 
infections were reported to the CDC (34).     
 Conventional methods for the detection and enumeration of enterococci and other 
pathogenic bacteria have largely been culture based.  Methods for detecting enterococci 
include membrane filtration and enrichment on mEI agar and the Enterolert most 
probable number system.  As explained previously, these methods are simple, user 
friendly, do not require highly skilled personnel and give results within 24-48 hours.  
However, colonies obtained from the membrane filtration technique are routinely 
confirmed through biochemical tests which add an extra day or longer for final results.  
The Enterolert system is unable to detect very low levels of enterococci since all samples 
need to be diluted 10-fold before testing (71).   Special equipment is also needed to run 
this test.  In spite of the advantages and disadvantages of culture methods, bacteria have 
evolved in such a way that culture based methods may not accurately depict the extent of 
contamination by these bacteria in the environment.  Research is now revealing that any 
method developed for the detection of bacteria in the environment needs to be designed 
to take into account conditions in the environment and how these conditions affect the 
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organism.  The viable but non-culturable (VBNC) phenomenon, for example, has been 
observed in many bacteria including the enterococci, E. coli O157:H7, and Vibrio 
cholerae (37, 106, 233).  The VBNC phenomenon results from a drastic change in 
environmental conditions such as changes in temperature or nutrients which stresses the 
bacteria and renders them unculturable.  Conventional culture techniques cannot account 
for these VBNC bacteria.  Furthermore, these bacteria while unculturable still can be 
capable of causing disease if they find the right host. 
 Due to the limitations of culture methods, molecular and immunological methods are 
being increasingly researched.  Immunomagnetic separation (IMS) has been used to 
rapidly detect low levels of E. coli O157:H7 and Salmonella typhimurium in food, water 
and feces (15, 40, 257, 282).  This method is simple and requires little expertise.  Rapid 
immunodiagnostic test kits using monoclonal antibodies to V. cholerae O1 such as the 
Cholera-Screen coagglutination test (52) and Cholera SMART from New Horizons 
Diagnostics, a colloidal gold based colorimetric test (109), have proved highly specific 
and sensitive when compared to culture methods.  A direct fluorescent antibody 
technique using monoclonal antibodies labeled with fluorescein isothiocyanate is able to 
detect 1.5 x 102 CFU/ml of V. cholerae O139 in water when combined with filtration 
(108).  
 Molecular methods such as PCR have been used to detect V. cholerae and 
Enterococcus faecalis in seawater and simulated seawater (111, 169, 220).  PCR has been 
used to detect V. cholerae cells and toxin genes in raw oysters and in synthetic seawater 
with much success (6 to 8 CFU per gram in oysters and 10 CFU per gram in seawater) 
(169, 211). Some studies have even shown the ability to detect 10 CFU per gram of 
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oyster homogenate (139).  PCR has obvious advantages such as sensitivity, specificity 
and rapidity of results however, there are limitations to the technique. The presence of 
inhibitors in the environment, which can interfere with the assay, is a large problem when 
rapid results from a dirty sample are desired. Additional steps to clean up and purify a 
sample add extra time to the assay. More importantly, the fact that PCR cannot 
distinguish between live and dead cells is one of the biggest disadvantages of this 
technique. Nonpathogenic dead cells would be detected along with viable cells and could 
lead to an inaccurate assessment of a particular sample.  If those bacteria are nonviable 
cells from a previous contamination event, results could lead to unsubstantiated beach 
closings.  Other nucleic acid techniques are finding a place in the field of rapid detection.  
Fluorescent in situ hybridization (FISH) is a method used to identify bacteria with a high 
degree of specificity.   FISH uses fluorophore-labeled nucleic acid probes complementary 
to a specific rRNA sequence in a particular bacterium to visibly identify the organism.  
This method has been used in combination with membrane filtration in a technique called 
microcolony filter hybridization to more rapidly identify indicator bacteria such as E. 
coli, S. aureus and enterococci (156, 177, 178, 198). In this method, a volume of water is 
filtered through a 0.45 µm filter and pre-enriched on selective media.  Cells are then fixed 
with formaldehyde and nucleic acid probes are introduced to hybridize with a target 
sequence.  The membranes are then visualized using a fluorescent microscope.  An 
advantage to using probes targeted to rRNA sequences is the flexibility of probe 
specificity.  By targeting regions of greater or lesser conservation, probes can be designed 
to be specific at a kingdom, genus, or species specific level (156).  While novel, this 
technique differs in efficiency between gram positive and gram negative cells.  Due to the 
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thicker cell wall of gram positive bacteria, added steps are required to allow the probe to 
enter the cell in these organisms.  This adds time to the overall procedure. The sensitivity 
of this assay is high and 102-105 cells/membrane are usually necessary (245).  FISH using 
peptide nucleic acid probes has been used to detect 104 CFU of E. coli with high 
specificity (245).   This technique also offers the added benefit that if multiple probes are 
used with different conjugated fluorophores, multiplexing can be achieved (198).  While 
molecular and immunological methods have proven to be comparable in sensitivity and 
specificity to culture methods, they often require preenrichment of up to 24 hours for 
positive detection. The method developed in this study was no exception.  
 Very low levels of enterococci in water can be indicative of larger amounts of fecal 
contamination in beachwater. With the many epidemiological studies and reviews which 
have been published correlating the incidence of disease in bathers to the levels of 
enterococci in seawater, the development of rapid and specific methods to detect low 
levels of enterococci in environmental samples has become more important and 
necessary (25, 72, 95, 259, 265).  Few if any immunoassays have been described for the 
detection of enterococci in seawater.  The primary goal of this study was to detect the low 
levels of enterococci required by EPA guidelines using an immunoassay format and an 
evanescent wave fiber optice biosensor.  This could not be achieved using the biosensor 
alone and, therefore, sample concentration and enrichment were required.  
 An evanescent wave fiber optic biosensor, the Analyte 2000, was used to detect 
enterococci in unspiked samples of seawater.  The limit of detection of the sandwich 
assay was 1.5 x 107 CFU/ml when Enterococcus cells were sonicated for a minimum of 
10 minutes.  An indirect assay format was developed where by Enterococcus cells were 
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adsorbed directly onto the polystyrene waveguide and detected using a specific antibody 
and a Cy5 labeled anti-IgG.  Using this method, 1 x 106 CFU/ ml of enterococci could be 
consistently detected in PBS (pH 7.4) and in environmental seawater samples.  Neither 
method alone was successful in detecting the low levels of enterococci required by the 
U.S. Environmental Protection Agency.  Sample concentration methods and enrichment 
were used to improve the assay sensitivity. 
 A guideline was developed to assess environmental samples for water quality based 
on enrichment times in mE broth and biosensor detection.  In accordance with this 
guideline, environmental water samples were assayed through concentration, enrichment 
and biosensor detection.  Environmental water samples were collected in 20 liter volumes 
from two Gulf Coast beaches known to consistently yield samples of poor quality. When 
concentrated with a hollow fiber filter and subsequent enriched in mE broth, water 
samples containing as few as 6 CFU/100ml of enterococci could be detected with the 
Analyte 2000 biosensor in 16-24 hours and determined to be water of good quality.  This 
result was found to correlate with the criteria set forth in the guideline developed in 
simulated water quality experiments.  The biosensor assay alone, excluding enrichment 
and sample preparation, took only 10 minutes total.  The anti-Strep group D antibody 
(American Research Products) was found to crossreact significantly with only S. aureus 
cells.  The nature of this crossreactivity was attributed mainly to nonspecific binding of 
the primary antibody used to the protein A molecules found on the surface of S. aureus.  
This crossreativity has been noted in other immunoassays developed to specifically detect 
S. aureus (100).  Crossreactivity could be eliminated to an extent by blocking the protein 
A binding sites on S. aureus cells with another species of IgG.  In this study, horse serum 
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was used as a blocking agent.  Crossreactivity could not be completely eliminated using 
this method. 
 Studies were also conducted to test the efficiency of the hollow fiber filtration step of 
the assay.  This process consistently concentrated water 100-fold and recovery was found 
to vary between 13% and greater than 100% depending on the concentration of the initial 
inoculum.  Lower recoveries were observed for lower concentrations of cells where the 
loss was more evident due precisely to the fact that lower cells are present and loss is 
more evident in this realm.  Only one non-target bacterium, Vibrio alginolyticus, was 
found to enrich along with the enterococci in mE enrichment broth.  This organism was 
assayed on ELISA with the anti-Strep group D antibody to check for cross-reactivity and 
no significant cross reaction was found.  
  While this integrated method was successful at detecting low levels of enterococci 
directly from seawater, this method could not be used alone without confirmatory 
biochemical tests.  This is because of the cross-reactivity that was found to exist between 
the anti-Strep group D antibody and other organisms such as S. aureus.   Five percent of 
the colonies obtained from viable counts on mEI agar were inoculated on bile esculin 
agar and into Brain Heart Infusion broth with 6.5 % Nacl to confirm that they were 
enterococci.  This type of confirmation must be done in all immunoassays not just the one 
developed in this study because of antibody crossreactivity. 
 A secondary goal of this project was to analyze water samples collected from two of 
the most highly contaminated beaches around Tampa Bay for the presence of Vibrio 
cholerae, E. coli O157:H7, and Staphylococcus aureus.  Furthermore, biosensor assays 
were developed to detect these pathogens which could be potentially shed in the water 
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simultaneously with enterococci.   Standard assay methods for total coliforms in seawater 
could not be used to isolate E. coli O157:H7 from seawater as the common temperature 
to isolate these organisms is 44.5°C.  This temperature was too high for the growth of  
E. coli O157:H7.  Maximum growth temperature for E. coli O157:H7 is 41.5- 42.5 °C 
(96, 208).  Ultimately, methods were modified to optimize chances of isolating E. coli 
O157:H7.  Immunomagnetic separation has been used to recover E. coli O157:H7 with 
great success from food, fecal samples, and water, so this method was employed to try 
and recover the organism from seawater (15, 40, 257, 282).   No isolates of E. coli 
O157:H7 were found in the waters from Courtney Campbell Causeway beach and North 
Shore Beach.  
 The Analyte 2000, evanescent wave fiber optic biosensor was used to detect the 
pathogenic E. coli O157:H7, Vibrio cholerae O1 and S. aureus in PBS and seawater.    A 
sandwich immunoassay format was used to detect E. coli O157:H7 in seawater and was 
able to detect the organism at 105 CFU/ml.  The zero tolerance policy of the FDA for  
E. coli O157:H7 in food matrices necessitates the improvement of assay sensitivity for 
rapid detection in food.  Similar low detection limits are required for water contaminated 
with E. coli O157:H7 because the infectious dose of E. coli O157:H7 is thought to be 
very low (50 CFU>) (254).     
 Isolates of V. cholerae and S. aureus were obtained from environmental water 
samples taken from Courtney Campbell Causeway beach in Clearwater, FL and North 
Port beach in St. Petersburg FL.  Sixty seven isolates were confirmed as V. cholerae 
through PCR.   None of the isolates were V. cholerae O1 strains as determined by slide 
aggluntination with V. cholerae O1 antiserum.    Twelve isolates of  
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S. aureus were also recovered from the two Gulf beaches using culture methods.  A 
suggested direction for this part of the project would be to further characterize the 
presence or absence of toxin genes in the 67 Vibrio cholerae isolates and to test the  
S. aureus isolates for methicillin resistance.  The presence of these pathogens in marine 
waters further substantiated the development of rapid assays for the detection and 
monitoring of these organisms in seawater.  The sensitivity of the biosensor sandwich 
immunoassay for V. cholerae O1 was 1.6 x 109 CFU/ml.    The evanescent wave fiber 
optic biosensor was evaluated for detection of S. aureus in seawater as well.  This attempt 
was not successful in PBS and was not pursued further because a high quality antibody 
was not available.   
 Many limitations to the developed biosensor assays were observed in this study.  For 
instance, inherent variability exists between polystyrene waveguides made by the 
manufacturer for the Analyte 2000 biosensor. This however, was not the root of the 
sensitivity issues for the biosensor assay for enterococci and the other organisms tested.  
One factor was the evanescent wave biosensor itself.  Any assay based on evanescent 
wave principles is limited by the distance of that evanescent wave.  The evanescent wave 
of the Analyte 2000 biosensor extended ~100 nm from the surface of the waveguide so 
anything outside of that evanescent wave was not detected.  Bacteria are large in size 
(enterococci are approximately 1.5 µm in length) and any antibodies attached to the cells 
that are outside the evanescent wave could not be detected (216).  In an assay format 
where capture and detection antibodies already compete for epitopes on the target 
antigen, the potential area for antibody binding is reduced greatly by the limitations of the 
evanescent wave. This handicap was overcome to some extent by using the indirect assay 
 148 
 
format with signal amplification to detect enterococci.  Signal amplification could bypass 
the effects of the evanescent wave phenomenon by increasing the signal of those 
antibodies which are bound to the target within the evanescent wave.  This was done in 
this study by using a fluorophore labeled anti-IgG.  
 The biggest limiting factor in the Enterococcus, Vibrio cholerae O1, and S. aureus 
assays was the lack of high quality antibodies.  As with all immunoassays, the test is only 
as good as the antibody and antigen.  If either one is less than optimal, than the success of 
the assay is compromised.  The antibody used in assays for V. cholerae O1 was found to 
be very crossreactive with several other organisms, especially Vibrio alginolyticus, and, 
in previous studies, it has been found that the KPL polyclonal anti-E. coli O157:H7 
antibody minimally crossreacted with E. hermanii (63). A high quality antibody to  
S. aureus cells could not be found and, therefore, the assay was unsuccessful.  
Compounding this problem is that any antibody used in an immunoassay for S.aureus 
would be problematic due to non-specific binding of the Fc portion of the antibody to 
protein A on the surface of S. aureus cells.  Specificity in any immunoassay for S. aureus 
would be compromised and methods to overcome this would need to be developed.  This 
would include finding a way to block those protein A binding sites.     
 As for the enterococci, two antibodies were commissioned for use in optimizing the 
biosensor assay for enterococci.  They were made by immunizing mice and rabbits with 
boiled cell preparations of Ent. faecalis and Ent. faecium. The first antibody created was 
a monoclonal antibody made by the Hybridoma Core Laboratory at the University of  
Florida, Gainesville, FL.  This process failed to yield a high affinity IgG for use on the 
biosensor assay.  IgM produced from this process was tested on the biosensor using the 
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sandwich immunoassay format and detection was not improved.  The other antibody was 
a polyclonal antibody made by a commercial source (Strategic Biosolutions) which 
showed high affinity for cells of Ent. faecalis when screened through ELISA.  On further 
analysis through Western blot, it was found that this antibody was specific for one 
primary target on the Ent. faecalis cells.  When compared to the American Research 
Products (ARP), polyclonal anti-Strep group D antibody, the custom-made antibody was 
found to be inferior.  The ARP antibody showed high affinity for several targets on the 
Enterococcus cells.  In theory, this antibody would allow for the maximum capture of 
cells and would minimize competition between capture and detection antibodies for the 
same epitopes (Figure 13).    One future direction for this part of the Enterococcus project 
would be to further research and characterize all the epitopes for which the ARP 
antibodies showed highest affinity.  Those proteins or carbohydrates could then be 
isolated and used to create several monoclonal antibodies to be combined later on to 
make a custom prepared polyclonal antibody.  The success of this procedure could yield a 
more specific and higher affinity antibody which could improve the sensitivity of the 
Enterococcus assay. 
 Within the past decade, research has revealed many new characteristics about the 
enterococci.  First, the enterococci have been found to subsist embedded in sediments and 
sand which would make counts obtained from water underestimates of the actual counts 
that are in the environment (92).  Second, enterococci have been known to enter a viable 
but non culturable state and attach to copepods much like V. cholerae does to enhance 
their survival under nutrient limiting conditions (164, 173, 231-233)  These findings drive 
the need to move away from or at least add to culture based methods of detection which 
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probably underestimate Enterococcus concentrations in the water.  This of course is a 
double edged sword with detection of indicators.  While it is desirable to be able to 
completely enumerate enterococci in seawater at any given time, if VBNC enterococci 
are present in the environment, their detection could compromise risk assessment.  The 
inability to distinguish the presence of enterococi due to current contamination event 
from those presnt from a previous contamination event could lead to unnecessary beach 
closings.  These are all factors which must be considered when developing methods for 
the detection of indicators of fecal pollution.   
 Viable but nonculturable cells present a unique problem for the biosensor and any 
immunoassay geared toward the detection of bacteria.  Antibodies for these assays are 
made to specific epitopes and antigens on the surface of a bacterial cell.  Many bacteria 
undergo physiological changes when in the viable but non culturable state which can lead 
to changes in antigenicity and cell surface structure.  However, an immunoassay format 
for detection of enterococci in seawater is feasible even when cells are in a VBNC state. 
The group D antigen is consistently produced by Enterococcus cells, even when the cells 
go VBNC.  In fact, it has been observed that teichoic acid production in these cells 
increases when they are in the VBNC state (86, 233).  This would certainly work to the 
benefit of an immunoassay as antibodies could bind cells even in times of stress. E. coli 
O157:H7, has been found to undergo structural changes that could interfere with an 
immunoassay.  The antibody used in assay development is directed against the O antigen 
of the cells.  This antigen has been found to be shed and not produced when these cells 
are in the VBNC state, however, verotoxin can still be produced (106). This structural 
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change presents a problem because the immunoassay would not be able to detect the cells 
that are still virulent.  
 VBNC V. cholerae is less of a concern in immunoassay development.  As described 
previously, this state has been shown to affect the production of O antigen in E. coli 
O157:H7 affecting the ability of an antibody to bind to the target cell.  The antiserum 
used in this study was created against the O antigen of V. cholerae, calling into question 
whether these VBNC cells may not be detected when assayed by immunological 
methods.  Research has shown that the loss of O antigen is not a problem with V.cholerae 
in the VBNC state as these cells do not lose O antigenicity when they are under these 
stressed conditions (37).  However, a limitation of the biosensor assay for V. cholerae 
would be the inability to detect nonagglutinable V. cholerae which does not react with O1 
antiserum.  While these vibrios are not as highly pathogenic as O1 V. cholerae, they have 
been found to cause disease.  This is a limitation for any immunoassay for V. cholerae, 
not just the biosensor assay.  Other supplemental methods such as culture or molecular 
methods would be needed to detect these vibrios. 
  There are several ways that the fiber optic biosensor assay could be improved in 
order to make this method more feasible for field use. The most important factor would 
be to improve the sensitivity of the assays by several log concentrations.  One way to 
address this problem would be to search for alternative capture and detection molecules 
besides antibodies.  One such alternative would be to model the fluorescent in situ 
hybridization technique (FISH) described above and use DNA or PNA probes specific for 
the 16S rRNA region of the enterococci labeled with a fluorescent molecule (120, 177, 
178, 255).  Advandx Inc. (Woburn, MA) has developed such a system for detecting  
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Ent. faecalis using a fluorescein isothiocyanate (FITC) labeled PNA probe.  The system 
is intended for use in blood culture however, it could be tested for use in other matrices.  
Although this system has been developed for use on a microscope slide, it could be 
adapted for use in cell suspension and ultimately, for use on the biosensor.  Aptamers 
which are unique antibody-like nucleic acids are also promising nucleic acid alternatives 
which could be used to improve biosensor assays. 
 Several molecules could be suggested as specific alternative capture and detection 
molecules for enterococci.  For example, enterococci have been found in clinical studies 
to bind biological molecules (extracellular matrix proteins) found in the human body such 
as collagen, fibronectin, fibrinogen, and vitronectin (186, 217, 278).  Bacterial surface 
adhesions called MSCRAMMs (microbial surface components recognizing adhesive 
matrix molecules) have been found in isolates of Ent. faecalis and Ent. faecium.  One 
such molecule, Ace, in Ent. faecalis binds collagen (206).  One of these molecules could 
potentially be used as a capture molecule much like lectins were used in this study.  A 
specific antibody could then be used for the detection step.  Also, human mannose 
binding protein has been found to bind the liptoeichoic acid of gram positive bacteria 
including enterococci, so this molecule is also an alternative for capture and detection of 
enterococci (205).  Lectins could also be tested as alternative capture molecules in the 
assays for V. cholerae, E. coli O157:H7 and S. aureus since they were not done so in this 
study.   
 Another way to improve assay sensitivity would be to add the sensitivity of PCR to 
the immunoassay.  One way to accomplish this would be to employ the use of a more 
novel technique, immuno polymerase chain reaction (immuno-PCR).  This method 
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developed by Sano et al. combines the specificity of both nucleic acids and antibodies 
into a versatile ELISA (219).  In immuno-PCR, antibodies are linked to specific nucleic 
acid sequences.  Using a standard sandwich immunoassay format, target antigen is 
captured by an antibody.  An antibody tagged with a specific nucleic acid sequence is 
used to detect the captured target.  Then nucleotides, primer, and polymerase are added to 
the mix and the specific DNA sequence attached to the detection antibody is amplified 
and used to generate a fluorescent signal using a real time PCR machine.  Immuno-PCR 
has been used to detect protein A of S. aureus with much success (113).  This 
methodology could be applied to the biosensor assay described in this study as a 
confirmatory method and a method of signal amplification.  It has been shown in our 
laboratory by Dr. Joyce Simpson, a postdoctoral fellow, that PCR can be performed on 
captured cells on the waveguide when the waveguide is cut into pieces (235).  This 
method could be used to try immuno-PCR on captured cells as well.   
 Novel methods are being studied and developed everyday for the detection and 
recovery of enterococci in water and these methods could potentially be adapted for 
biosensor detection.  Chemiluminescence has been discovered in enterococci when the 
bacteria are grown in the presence of a fermentable sugar and this property is now being 
developed as a method to try and detect fecal contamination in water (7).  
Chemiluminescence is based on the detection of photon emission produced by a chemical 
such a luminol in response to oxygen metabolites.  In the case of the enterococci, it was 
found that when the respiratory chain is impaired, extracellular superoxide is generated 
and can react with luminol to generate a chemiluminescent signal (7).  This property 
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could be used in an array type biosensor format using a camera which could detect the 
chemiluminescent signal.   
 Emerging biosensor technologies offer the opportunity to further expand detection 
assays.  DNA microarrays have been developed as a way to detect multiple targets at 
once.  The principle behind microarray technology is that DNA probes can be 
synthesized and patterned onto a glass slide for the detection of a specific cDNA 
sequence.  The patterned slide is exposed to the test sample labeled with either a 
radioactive label or a fluorescent tag and a signal is generated or not based on the 
hybridization event.  This technique has been used for years to monitor and record gene 
expression in different types of clinical research and now is being applied to pathogen 
detection in environmental samples (28, 197).  This technology has already been used to 
detect disease agents, but instead of DNA, antibodies were patterned onto a slide (216, 
249).  Multiplex methods such as a microarray would allow for the simultaneous 
monitoring of all suggested indicator organisms not just enterococci, and specific agents 
of waterborne disease such as V. cholerae O1, E. coli O157:H7, and S. aureus.  It has 
already been done to detect Staphylococcus enterotoxin B, ricin, Francisella tularensis, 
and Bacillus globigii using a portable version of the biosensor used in this study, the 
RAPTOR (5).  An approach like this would also be very helpful for epidemiological 
studies because they are always being conducted to try and correlate the incidence of 
disease caused by specific pathogens to the densities of indicator organisms in water.     
 There are many future directions for this project.  The first would be to attempt a 
study to determine the origin of fecal contamination at the Courtney Campbell beach in 
Clearwater.  Scott etal. recently reported the use of a host associated molecular marker 
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(esp; enterococcal surface protein) in Ent. faecium which could be used as an index of 
human fecal pollution (222).  This could be a way in which to ascertain if indicator 
bacteria are present in the water due to human fecal contamination.  Another recent study 
of Pensacola beach, addressed not only source-tracking of contamination at the beach, but 
also the survival of enterococci in the swash zone interstitial waters (92).  The swash 
zone is described as the area on shore where the waves continuously wash up on the sand.   
This swash zone is known to harbor generally higher densities of organisms than the 
actual water (85, 122, 227).  This becomes a problem because people spend more time on 
the beach rather than in the actual water.  Analyzing the swash zone for higher densities 
of enterococci at Courtney Campbell beach would be a worthy direction to pursue, as this 
beach is lacking in restrooms and pets are allowed on the beach at all times.  While it has 
been shown in this study that V. cholerae and S. aureus can be isolated from the seawater 
in Tampa Bay, these data should be followed up with a study to track the abundance of 
these organisms in the water.    
 A rapid assay for the detection of S. aureus and E. coli O157:H7 in seawater is both 
desirable and necessary for the prevention of illness.  The swimming public is exposed to 
numerous potential health hazards that could end up in serious infection unless a rapid 
method is developed to preempt the danger.  S. aureus has been frequently isolated from 
recreational waters using culture based methods (4).  The need for rapid methods of 
detection of S. aureus is necessary, especially now with the emergence of methicillin 
resistant Staphylcoccocus aureus (MRSA) and their isolation from marine waters (39).  
There is a real need not only to develop methods to rapidly detect low levels of S. aureus 
but also to assess the prevalence of S. aureus in seawater.  A study addressing the 
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abundance of S. aureus in Tampa Bay seawater could add to research that this organism 
is and indicator of contamination that should be routinely monitored for in seawater 
(281).    
 The majority of water related outbreaks of E. coli O157:H7 have been due to 
contaminated freshwater and drinking water.  At least one study in the past has suggested 
that toxigenic E. coli is not a health risk associated with coastal waters (148).  While not 
a prevalent health risk, enterotoxigenic E. coli has caused beachwater related illness in at 
least two instances. The first beach water outbreak of E. coli O157:H7 took place in the 
United Kingdom in 1999 (107).  Since then, there has also been an outbreak reported at a 
beach in Montreal in 2001 (22).    These outbreaks necessitate the need for a rapid assay 
for E. coli O157:H7 in seawater especially in those instances of disease outbreak.   
 Currently, outbreaks of cholera are ongoing in West Africa and are constantly being 
reported to the World Health Organization (WHO).  Some of those African countries 
include Benin, Mauritania, and Mali.  In Guinea alone, 1956 cases were reported from 
mid-July to September of this year.  Of those cases, 72 resulted in death (276).  Kaper  
et al. found in 1982 that there was a resident toxigenic strain of V. cholerae in the Gulf 
coast (128).  It is for this reason that there is a need for screening and detection methods 
to monitor this bacterium in seawater.  There is a requirement for rapid, specific, and 
sensitive methods for detecting V. cholerae in shellfish as well as in water, particularly in 
the third world.  Methods such as these are especially necessary for the complete 
assessment of seawater due to the presence of VBNC cells.  The infectious dose of Vibrio 
cholerae in food is between 104 and 107 CFU, but in seawater the infectious dose is 1010 
CFU because of the absence of food which can absorb stomach acid and improve the 
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chances of survival of the cells in the body (33).  The biosensor immunoassay could be 
used as a screening tool for consistent monitoring of beach water so that when 
temperatures started to increase and optimum conditions for the proliferation of V. 
cholerae in the environment arose, this shift could be detected and illness could be 
prevented. The biosensor has the potential to specifically detect low levels of V. cholerae 
in seawater and seafood as well if a high quality antibody can be found.  
 Biosensors are currently being used in marine science to detect various pollutants 
including algal toxins (brevetoxins, saxitoxin) (31), pesticides (264), phosphates (78), 
pathogens (150), and trace metals (lead, zinc, cadmium) (118, 166, 214) directly from sea 
water which can many times be a very complex matrix.  Biosensor immunoassays are 
ideal for the detection of small molecules like toxins or pesticides; however, detection 
sensitivity can be affected with large target analytes such as bacteria.  This problem can 
be resolved to some extent through signal amplification techniques and the use of novel 
capture and detection molecules; however, the task of detecting very low concentrations 
of microorganisms in a complex matrix without the use of selective enrichment will 
remain difficult.  The low numbers of enterococci required by the EPA to designate a 
beach uncontaminated or minimally contaminated necessitates a sensitive method for 
detection.  In the method developed in this study, such low levels of detection could be 
obtained using the Analyte 2000 biosensor in combination with sample concentration and 
selective enrichment in mE broth for 8-24 hours.  The biosensor assay alone took only 10 
minutes after the samples was attached to the waveguide and results could be obtained in 
24 hours or less.  This method could serve as an efficient preliminary screening tool for 
the assessment of recreational water quality. 
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